Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
Articles de Priya Anand
Genco Shipping augmente ses dividendes dans le cadre de ses bons résultats semestriels en 2026
Genco Shipping & Trading (GNK) a augmenté son dividende trimestriel de 400 % au deuxième trimestre 2026, en invoquant des résultats solides et l'expansion de son parc naval.
Aberforth Partners a accru sa participation dans Reach à 16,9 %
Aberforth Partners, basée à Londres, a augmenté ses droits de vote dans l'éditeur Reach PLC de environ 5,5 points de pourcentage, à 16,855 %, selon un document TR-1.
CVC Income & Growth revende 1,1 million d'actions de la trésorerie
Basée à Londres, la société a vendu 800 000 actions de 1,1758 livre sterling et 300 000 actions d'un euro à 1,0743 euro, ajustant son capital émis et ses droits de vote pour répondre à la demande.
L'action de CMS Energy baisse à 19,16 $, son plus bas de 52 semaines, au milieu des pressions du secteur
La participation de l'entreprise chute à son plus bas niveau depuis janvier 2024, avec une perte annuelle de 13,44% et un rendement du dividende de 7,2%.
Les actions de Cosmo baissent en dessous des niveaux d'avant la révolution, après que l'euphorie suscité par le médicament de croissance des cheveux ait disparu
Les actions de Biotech Cosmo ont chuté de plus de 50% depuis leur sommet à la suite de l'annonce d'un médicament révolutionnaire contre la chute des cheveux, alors même que les analytiques maintiennent leurs classifications d'achat en attendant la présentation de la demande d'autorisation de mise sur le marché auprès de la FDA, prévue pour début 2027.
Le fonds de revenu municipal de Nuveen atteint un plus bas de 52 semaines de 11,22 $
Le fonds a chuté à 11,22 $, en baisse de 9,51 % au cours de l'année, avec un rendement des dividendes de 8,37 % et 2,21 $ milliards d'actifs dans un contexte de pression sur les obligations municipales.
AGF Management manque ses estimations du 3e trimestre : les remboursements des institutions pèsent sur les résultats
Le gestionnaire d'actifs a déclaré un EPS ajusté de 0,49 $ CAD contre 0,58 $ CAD selon le consensus, alors que les revenus de 112,5 millions de dollars CAD ont chuté de près de 30 % par rapport aux prévisions. Les actions ont baissé lors des transactions avant le marché.
AZZ Inc. confirme ses prévisions pour 2026 en contexte d'une croissance record des ventes et d'un faible niveau de dette
AZZ Inc. a rapporté des bénéfices records pour l'exercice 2025 et a augmenté ses cibles de ventes et de profitabilité pour l'exercice 2026, invoquant l'expansion de l'activité et un meilleur effet de levier.
Fonix augmente ses prévisions de bénéfice pour l'exercice 2026, les actions se maintiennent près de leurs plus élevés
Fonix a annoncé un EPS ajusté de 0,059 $, dépassant les estimations, soutenu par une croissance de 12,8 % du bénéfice brut et par l'expansion des volumes de paiements mobiles dans cinq marchés européens.
Les actionnaires de Autins Group approuvent toutes les résolutions de l'AG
Les actionnaires de l'Assemblée générale du Groupe Autins ont unanimement approuvé les comptes financiers de 2026 et soutenu les résolutions de reconduite des administrateurs, d'allotissement d'actions et de rachat d'actions.
BlackRock augmente sa participation dans Public Policy Holding à 4,06 %
Le gestionnaire d'actifs BlackRock a accru sa participation dans Public Policy Holding Co. à 4,06 % contre 3,42 %, ce qui a été divulgué conformément aux règles de l'UK Financial Conduct Authority.
BlackRock annonce un intérêt de 3,42 % dans Public Policy Holding
Le gestionnaire d'actifs a notifié aux autorités britanniques la prise de contrôle d'une entreprise de taille importante après avoir atteint le seuil qui oblige à le faire, détenant plus de 1,04 million de droits de vote dans la société basée à Wilmington.
Les résultats du 3e trimestre d'AGF ressortent inférieurs aux prévisions, alors que les actifs augmentent de 31 % pour atteindre 74,2 milliards de dollars
AGF Management, basée à Toronto, a annoncé un manque de profit au troisième trimestre et une performance de revenus précaire, compte tenu de la contraction des commissions, même si les actifs gérés ont augmenté de 31 %, grâce à la croissance des alternatives.
Cambridge Cognition Chair achète 19 000 actions à 27,4 p
Le président non-exécutif Nick Rodgers achète 19 000 actions de Cambridge Cognition Holdings plc au prix de 27,4 pence par action, ce qui porte sa participation à 0,18 % du capital circulant.
Citi considère la politique commerciale entre l'UE et la Chine comme essentielle pour Volkswagen l'année prochaine
Citi maintient une note d'acheter et un objectif de 100 € pour Volkswagen, affirmant que la direction du titre au cours des 12 prochains mois dépendra fortement de la question de savoir si l'Union européenne imposera des mesures de protection commerciale contre la concurrence chinoise.
Fonix annonce une croissance pour l'exercice 26, étend ses activités en Europe avec des rendements à deux chiffres
Fonix plc a enregistré une croissance d'année en année en termes de revenus, de bénéfice brut et de EBITDA ajusté au cours de l'exercice 26, tout en s'ouvrant de nouveaux marchés en Europe et en améliorant son infrastructure de services de paiement et de médias.
Equillium présente des progrès dans les essais de phase I pour les maladies inflammatoires intestinales et pulmonaires grâce à son modulateur oral de l'AhR, l'EQ504
Le produit candidat majeur d'Immunologie des muqueuses d'Equillium, EQ504, est prêt pour sa première administration chez l'homme au cours du quatrième trimestre 2026, ciblant les maladies inflammatoires de l'intestin et les affections respiratoires par une administration colique et pulmonaire ciblée.
Les actions Prudential Financial baissent à 20,1 dollar, atteignant leur plus bas niveau des 52 dernières semaines
Les actions de l'assureur chutent de 19,1 % d'année en année, dans un contexte de pressions générales dans le secteur et de préoccupations internes.
JBS atteint son plus bas niveau de 52 semaines alors que l'ordre de bœuf de Trump pèse sur les actions du processeur
Les actions de JBS ont chuté à 11,48 dollars, en baisse de près de 24 % sur l'année, alors que UBS a souligné une amélioration des perspectives de résultats et une offre d'acquisition de Pilgrim's Pride.
Turkish Airlines a commandé jusqu'à 150 avions Boeing 737 MAX
Turkish Airlines et Boeing ont finalisé une commande portant sur jusqu'à 150 avions Boeing 737 MAX, dont une commande ferme de 100 737-8 et des options pour 50 autres avions 737 MAX. Cet accord, conclu à New York le 23 septembre 2026, représente la plus importante commande sur un seul pont de Turkish Airlines à ce jour.
Acushnet Holdings Projects $220M–$230M 2026 Revenue Amid Tariff Adjustments
Growth strategy, acquisitions and supply chain resilience drive small-cap first-aid and safety products leader.
Escalade reports $240m 2025 sales, eyes double‑digit EBITDA margins
The small‑cap outdoor and sporting‑goods maker posted net sales of $240 million in 2025, net income of $13.7 million and a 26.9% net margin, while targeting 30% gross margins and debt‑free status by year‑end.
Groupe Beneteau Reports H1 2026 Sales Growth, U.S. Losses Persist Amid Restructuring
Sales surged by double digits in the first half of 2026, while U.S. operations remain loss-making as the company restructures its American operations.
Newmark Stock Falls to 52-Week Low Despite Strong Second-Quarter Results
Shares of the real estate services firm hit $13.35 even as Q2 revenue beat estimates and S&P upgraded its credit rating to investment grade.
Groupe Beneteau H1 2026: Revenue up 11.2% as Turnaround Accelerates
Revenue reached €449.2 million in H1 2026, with EBITDA more than tripling to €29.4 million amid operational improvements and U.S. restructuring.
Texas Congressman Pete Sessions sells $100K–$250K in Apple shares from IRA
Sessions disclosed a $100,001–$250,000 sale of Apple Inc. (AAPL) common stock from an Individual Retirement Account on September 22, 2026, amid the tech giant’s 35% six-month rally.
Zillow Stock Falls to 52‑Week Low of $29.13 Amid Sector Headwinds
The decline comes despite Q2 2026 earnings beating estimates and a KeyBanc Overweight rating with a $48 price target, following an FTC settlement that preserves Zillow’s Redfin partnership through the mid‑2030s.
Groupe Beneteau H1 2026 Profitability Turns as US Exit Cuts Losses
Groupe Beneteau reported improved profitability in H1 2026, driven by revenue growth and strategic restructuring, particularly the exit from the U.S. market.
Congressman Allen Shifts Focus to Semiconductors with Broadcom, TSMC Investments
Richard W. Allen, Georgia’s representative, has reallocated capital toward semiconductor giants Broadcom and TSMC while divesting from Rollins Inc., reflecting industry sector preferences.
Liberty Global shares slip to 52‑week low of $9.29 amid cost‑cut plan
The stock fell 4.6% to $9.36 after hitting a yearly low, as the company confirmed 2026 guidance and announced £600m savings at Virgin Media O2.
Quadient H1 2026 Earnings Reflect Digital Growth, Improved Cash Flow
Quadient reported H1 2026 earnings with EUR 448 million in revenue, driven by digital growth and improved cash flow, as it continues to divest its lockers business.
BlackRock MuniHoldings California Quality Fund drops to 52‑week low of $9.99
The BlackRock MuniHoldings California Quality Fund (MUC) fell to a 52‑week low of $9.99, a 6.45% decline over the past year, while its dividend yield remains 6.35% after 29 years of payouts.
Judges Scientific H1 2026 Profit Drops Amid Revenue Decline
Revenue fell 21% year-over-year as cost cuts and order recovery partially offset losses, while analysts project cautious growth ahead.
Quadient Reports H1 2026: Digital Growth Drives Revenue, Lockers Sale to Improve Leverage
Quadient’s first-half 2026 results highlight strong digital expansion and a £65m sale of its UK lockers network, improving financial flexibility ahead of a broader divestment strategy.
Palisade Bio’s ASCENTRA-UC PDE4 drug advances to Phase 2 with ulcerative colitis focus
Palisade Bio’s oral PDE4 inhibitor candidate PALI-2108 enters a Phase 2b trial for ulcerative colitis, following promising Phase I results and regulatory milestones.
Hugo Boss Faces Scrutiny as Frasers Group Consolidates Control
British retailer Frasers Group raises stake to nearly 48% and gains a second board seat, increasing pressure on CEO Daniel Grieder to reverse the fashion brand's struggling share price.
Nasdaq Expands Always-On Trading Vision Amid 2026 Commerce Symposium
Nasdaq outlines a $3B–$6B market opportunity by 2030 in trading, tokenization, and fintech, with strategic moves to extend market hours and digitize asset servicing.
Meta, AMD, Akamai Lead Week’s Top Stock Movers with AI and Cloud Growth Catalysts
Meta Platforms, Advanced Micro Devices, and Akamai Technologies drove gains amid AI-driven demand, while Moderna’s cancer vaccine progress and Oracle’s data center delays shaped market sentiment.
FirstEnergy Corp. hits $43.72 low as 29-year dividend streak threatened
Stock falls 6.4% in six months amid revenue growth but earnings pressure
Vici Properties shares hit 52‑week low of $23.71
The REIT fell to $23.71, down 25.5% over the past year, while posting Q2 revenue of $1.06 bn and launching a $1.75 bn notes offering.
L.B. Foster reports rising margins, growth bets at Sidoti conference
L.B. Foster (FSTR) presented at the Sidoti & Company September 2026 Small-Cap Virtual Conference, highlighting improved margins and growth initiatives. The company reported a 390 basis point increase in adjusted EBITDA margin to 7.5% TTM, driven by portfolio changes and strategic investments.
China’s AI exposure gap may force investors to target Chinese stocks
A focus on China’s tech sector could offer emerging-market investors a way to capture AI-driven growth, despite recent declines in Chinese equities.
Trump discloses up to $100k Strategy stock purchase in ethics filing
President Trump reported buying $50,001–$100,000 of Strategy shares in July, according to a US Office of Government Ethics filing, amid broader portfolio activity and administration crypto‑policy moves.
Cava Group opens 500th restaurant in Minneapolis, expands to 30 states
Cava Group Inc. opened its 500th fast‑casual outlet in Minneapolis, bringing its footprint to 30 states and the District of Columbia and targeting 1,000 locations by 2032.
Okta CEO Sees Agentic AI as IAM’s Next Growth Frontier
Okta’s CEO projects a $100 billion-plus market for agentic identity management within five years, as the company bets on AI-driven security solutions.
Gossamer Bio Submits First NDA for Seralutinib in Pulmonary Arterial Hypertension
The biotech's first new drug application to the FDA covers seralutinib for PAH, backed by a Phase 3 trial the agency called a 'filing issue' rather than a regulatory obstacle.
IM Cannabis Regains Nasdaq Compliance After Maintaining $1 Share Price
Shares of IM Cannabis Corp. held a closing bid price of at least $1 for 18 straight business days, satisfying Nasdaq's minimum bid requirement and resolving a listing deficiency.
ATN International Declares $0.29 Quarterly Dividend, Payable Oct 9
The board of ATN International declared a quarterly cash dividend of $0.29 per share, with a record date of October 3 and payment scheduled for October 9. The company provides digital infrastructure and communications services in the United States and internationally, focusing on rural and remote markets.
ONE Nuclear completes SPAC merger, to trade as ONEN on Nasdaq
ONE Nuclear's business combination with Hennessy Capital Investment Corp. VII is complete, and the renamed firm will list on Nasdaq as ONEN, with trading expected to start Thursday.
Cytek Biosciences Expands Digital Ecosystem with Cloud Analysis Tool
Cytek Biosciences, Inc. (NASDAQ: CTKB) has launched a cloud-based analysis tool as part of its Cytek Cloud digital ecosystem, integrating the flow cytometry workflow from panel design to data analysis.
Genco Shipping Boosts Dividends Amid Strong Q2 2026 Results
Genco Shipping & Trading (GNK) raised its dividend by over 400% in Q2 2026, guided to exceed $1.00 per share in 2026, and reported robust fleet performance and debt management.
Global Industrial Raises Growth Plans at Small-Cap Virtual Conference
CEO Anesa Chaibi outlines strategic shifts, including digital expansion and private-label expansion, amid revenue growth of 8.4% in H1 2026 and a 34% Canadian sales surge.
Neovolta Q4 2026 Miss Drives Stock Drop Amid Strategic Shift
Neovolta’s earnings miss sparks after-hours decline as revenue and losses fall short of expectations, despite a strategic pivot toward commercial energy storage.
Soul Patts H2 2026 Profit Surges 502% as Shares Rise
Soul Patts reported a 502% increase in statutory net profit after tax for the 12-month period ending July 31, 2026, driven by the AUD 15 billion Brickworks merger. Shares rose 7.14% to AUD 48.76.
CVS Group reports 5.9% revenue rise as shares fall 5.7%
The UK veterinary services firm posted 5.9% higher revenue and 5.1% higher adjusted EBITDA for FY2026, but its stock slipped to £1,228, down 5.67% on the day.
Pacific Assets Trust shareholders approve liquidation scheme
Shareholders of Pacific Assets Trust plc have approved a liquidation scheme, with 99.62% of votes cast in favor. The scheme involves the reclassification of shares and the appointment of joint liquidators.
Vistry Group Reports £30M H1 Loss, Restructuring Charges Hit Shares
Vistry Group’s H1 2026 loss of £30 million and strategic charges pushed shares down 5.45% after CEO Adam Daniels announced cost-cutting measures and a shift toward simplified operations.
Swiss Finance Minister Calls UBS Exit Unlikely Despite Capital Rule Row
Karin Keller-Sutter says the bank's business model depends on Switzerland and that stricter capital rules are manageable, even as tensions with UBS remain high.
Baozun Inc. authorizes $10 million share repurchase program
Chinese e-commerce company Baozun Inc. has authorized a share repurchase program of up to $10 million over the next 12 months, demonstrating confidence in its business outlook.
Biodesix Expands MRD Testing Collaborations with Bio-Rad, Thermo Fisher
Biodesix Inc. advances molecular residual disease (MRD) testing programs with Bio-Rad Laboratories and Thermo Fisher Scientific, aiming to improve cancer detection via circulating tumor DNA analysis.
Kuehne+Nagel projects double‑digit AI data‑center logistics growth to 2029
The Swiss logistics group expects sustained double‑digit expansion in its technology and data‑center services through 2029, driven by AI infrastructure spending and a new seven‑year deal with Amazon.
United Airlines takes delivery of first Airbus A321XLR with Pratt & Whitney GTF Advantage engines
United Airlines has received its first Airbus A321XLR aircraft powered by Pratt & Whitney's GTF Advantage engines, marking the first GTF Advantage-powered aircraft in commercial service. The new engines offer enhanced durability and takeoff thrust capabilities.
Boxabl Names Ex-EY Audit Partner as Audit Committee Chair
BOXABL Inc. announces the appointment of Timothy Goldsmith to its board, chairing the Audit Committee and joining the Nominating and Corporate Governance Committee.
Sequans Completes Bitcoin Sale, Reports 80% Product Revenue Growth
Semiconductor company Sequans Communications S.A. (NYSE: SQNS) sold its remaining 314 Bitcoin holdings, ending its cryptocurrency holdings. The company also reported an 80% year-over-year increase in second-quarter product revenue.
Fervo Energy's Cape Station Achieves First Geothermal Power
Fervo Energy's Cape Station in Utah becomes first utility-scale enhanced geothermal system to synchronize with the grid and export power, marking a significant milestone for the company's renewable energy projects.
European equities decline amid rising yields and geopolitical risks
Indices fell as bond yields rose, US economic data fueled fears of further Fed tightening, and sectoral weakness persisted.
LEM shares rise on 25% upside potential
Swiss electronics components manufacturer LEM's shares are surging, with analysts expecting further gains as the company's turnaround continues.
Santander repurchases 10.9 million shares, spending €696.8 million
Banco Santander bought 10.9 million shares between Sep 17‑23, using €696.8 million and reaching about 38% of its authorised buyback allocation.
Vistry Reports H1 Loss as Overhaul Targets Capital-Light Model
UK homebuilder posts £36.2m operating loss on £578m exceptional charges, unveils strategic pivot to partner-funded model with five-year overhaul roadmap.
OVS H1 2026 Sales Rise 11% as Goldenpoint Boosts Margins
Italian retailer OVS reported consolidated net sales of about EUR 900 million in the first half, up 11%, driven by Goldenpoint integration and organic growth of 6%.
CTF Services Posts Stable FY 2026 with Insurance Growth Leading AOP
Hong Kong-based CTF Services reported a 3% year-on-year rise in attributable operating profit, driven by strong performance in insurance and logistics segments.
ABN AMRO Posts 30% Profit Growth, ROE Above 12% at Bank of America Conference
Capital gains, fee income and cost efficiencies drove a 30% year-over-year profit increase and a return on equity above 12%, while strategic AI adoption and NIBC integration aim to boost market share.
Ducommun unveils VISION 2032 growth plan targeting $300M–$500M acquisitions
The aerospace and defense contractor outlined its next strategic phase, targeting larger acquisitions and projecting mid-teens CAGR for its missile and radar business through 2032.
Satellos Bioscience gets FDA clearance for FSHD drug trial
The FDA approved Satellos' IND for forazapadin, enabling a Phase 2 study in facioscapulohumeral muscular dystrophy to start in Q4 2026, with up to $5 million in non‑dilutive financing from the FSHD Canada Foundation.
Vertical Aerospace reviews financing options amid eVTOL push
Company secures $100M funding, names Airbus veteran as chair amid strategic review
Vision Lithium to execute 15-to-1 share consolidation starting Monday
The TSXV-listed junior explorer said its reverse split will reduce outstanding shares from roughly 293 million to about 19.5 million, with adjustments also applied to options, warrants and convertible securities.
CTF Services Posts FY2026 Profit Growth as Insurance Segment Leads
Hong Kong-listed CTF Services reported a 3% rise in attributable operating profit to HK$4.591 billion in FY2026, with insurance surpassing roads as the group’s top profit driver for the first time.
UBS Says Rising Yields Are Narrowing European Equity Gains
UBS strategists note US 10-year yields surged to 5%, creating a 22-point breadth gap in the MSCI Europe index—the widest in their sample—signaling a regime change in how markets price rate risk.
TurboGen Reports $7.2M Cash Position, Posts $4.2M Loss in First Half
Israel-based microturbine developer raises $5M in private placement and completes first unit assembly; shares begin Nasdaq trading in August.
Delek US to Raise $460M via Convertible Notes Offering
The company plans a $400 million convertible senior notes issuance due in 2031, with an option to buy an additional $60 million within 13 days.
OVS H1 Sales Surge 11%, Margins Expand on Turnaround Push
Italian fashion retailer OVS reported €877.4M in H1 consolidated net sales, up 10.7%, with EBITDA margin rising 19 basis points to 13.0% as the company exits a two-year market slump.
OVS H1 2026: Net sales rise 10.7%, EBITDA margin expands to 13%
Italian apparel retailer OVS reported H1 2026 consolidated net sales of €877.4 million, up 10.7% year-over-year, with EBITDA reaching €114.3 million and adjusted net debt declining by €53.6 million.
Brightline Interactive Secures $1.25M PIPE Financing
Brightline Interactive, Inc. has secured a $1.25 million PIPE financing agreement, priced at $0.70 per unit, to support the development of its SpatialCore platform.
Guinness VCT Approves £262K Buyback, Directors Re-elected
London-based investment trust votes to repurchase up to 14.99% of shares at nominal value or market prices, while re-electing two directors.
Conagra Brands raises quarterly dividend to $0.175
Chicago-based food giant declares dividend of $0.175 per share, marking its 48-year streak of quarterly payouts.
Milestone Pharmaceuticals enrolls first Canadian patient in AFib Phase 3 trial
The biotech's etripamil nasal spray moves into a 150-patient Phase 3 study for atrial fibrillation with rapid ventricular rate, pursued via a single-study NDA pathway.
Annexon presents vonaprument data at retina meeting
The biotech firm shared results from its Phase 2 and Phase 3 ARCHER programs for vonaprument, an investigational treatment for geographic atrophy, at The Retina Society annual meeting.
Trident Digital Regains Nasdaq Compliance After Market Value Recovery
Singapore-based digital infrastructure firm Trident Digital Tech Holdings exceeded Nasdaq’s $35 million market value threshold for 10 consecutive days, restoring its listing compliance after a prior violation.
Nuvectis’ NXP200 gains China breakthrough therapy designation for BRAF-mutant gliomas
Breakthrough Therapy Designation from China’s Center for Drug Evaluation accelerates development of oral BRAF inhibitor for recurrent high-grade gliomas, while Nuvectis plans U.S. IND submission in Q4 2026.
Absci Plans Mid-2027 Phase 2 Trial of Endometriosis Drug ABS-201
The clinical-stage biopharmaceutical plans a dose-ranging study of its AI-engineered anti-prolactin receptor antibody in roughly 150 patients.
Elicio to Present Phase 2 Pancreatic Cancer Trial Data at ESMO 2026 Congress
The company will share results from its randomized Phase 2 AMPLIFY-7P study of ELI-002 7P in resected pancreatic cancer, which did not meet the primary disease‑free survival endpoint. Presentation is scheduled for Oct. 23, 2026, at the ESMO Congress in Madrid.
Qualcomm Renews Long-Term Patent Deal with Apple
A renewed licensing agreement helps ease Qualcomm’s revenue concerns amid Apple’s push for in-house chip production.
Lisata to Present MAR001 Phase 2b Trial Data at AHA Conference
Marea Therapeutics, a Lisata subsidiary, will report late-breaking results from its TYDAL study on ANGPTL4 inhibition at the American Heart Association Scientific Sessions in Chicago.
Collective Metals Appoints Curtis Riou to Board of Directors
The mining exploration firm adds Curtis Riou, a geoscientist with over 25 years in oil, gas and mining, to its board as it advances the Rocas uranium project in Saskatchewan.
HCW Biologics Prices $1.5 Million Private Placement Offering
The company issued 903,614 units at $1.6599 each to an existing stockholder, comprising pre-funded and common warrants, with proceeds earmarked for clinical trials and general corporate purposes.
Mobix Labs Forecasts Q4 Revenue Above Guidance Midpoint
The Irvine-based electronic components maker expects fourth-quarter 2026 revenue to exceed $1.6 million, surpassing the midpoint of its prior $1.4‑$1.8 million range, driven by stronger wireless systems and defense demand.
Digital Brands’ Collegiate Brand AVO Posts 221% Revenue Growth
AVO’s e-commerce and licensing unit saw explosive growth amid reduced marketing spend and targeted university expansions.
AI-driven Tech Titans strategy posts 213% return since launch
The AI‑selected tech portfolio has generated over 213% total return and a 93% monthly hit rate, outpacing the S&P 500 while subscription costs stay under $9 per month.
Glucotrack prices $3.1 million public offering at $2.04 per share
The biotech company sold 169,388 shares of common stock at $2.04 each and issued pre‑funded warrants for up to 1,350,220 shares at $2.039 per warrant, raising approximately $3.1 million in gross proceeds before fees.
FBS Global Completes 1-for-10 Reverse Stock Split to Meet Nasdaq Listing Rules
Construction firm consolidates shares ten-to-one after shareholder approval to satisfy the exchange's $1.00 minimum bid price requirement.
Uxin Q2 2026 Revenue Surges 75% YoY, Stock Climbs 11% in Premarket
The Chinese used‑car platform reported CNY 1.151 billion in revenue for the quarter ended June 30 2026, driven by an 89% jump in retail vehicle transactions, while its shares rose 11.14% to $1.211 in premarket trade.
US Stocks Face Pressure From Rising Oil and Bond Yields
Wall Street expects losses as oil prices climb on Middle East fears and 30-year Treasury yields hit levels not seen since 2004, weighing on technology shares.
Dextr AI Raises $6.7M to Scale Hotel AI Agents, Targeting Revenue Growth and Cost Savings
San Francisco-based Dextr AI, founded in July 2025, secures $6.7M seed funding to expand its AI-driven hotel agents, which boost revenue through bookings and cut operational costs by automating guest interactions and staff coordination.
Pasqal posts 14% revenue rise in H1 2026 as operating loss widens
The quantum‑computing firm reported EUR 4.9 million revenue, up 14% YoY, while operating loss grew to EUR 59.2 million; cash balances rose to EUR 110.8 million and shares slipped 2.3% pre‑market.
Krait Critical Minerals Closes First Tranche of $1.22 Million Private Placement
The company issued 1.63 million common shares at $0.75 each for gross proceeds of $1.22 million, paid finder's fees and issued warrants, and expects a second tranche next week to fund exploration at its Goldbar Spider Lake project and evaluation of Nevada Hills antimony assets.
BlackBerry Beats Q2 Estimates, Lifts Full-Year Guidance on Record QNX Revenue
BlackBerry reported Q2 adjusted EPS of 7 cents, beating estimates by 75%, and raised full-year revenue guidance to $616M–$636M driven by record QNX quarterly revenue of $80 million.
Ming Yang Smart Energy to Cancel 70 Million Shares in Capital Reduction
The board approved canceling 70 million repurchased A-shares previously earmarked for employee stock plans, cutting total share capital by roughly 3.1%.
UBS Upgrades Glencore to Buy, Raises Target to 650 Pence
The bank lifted its 12-month target on the miner from 620p and boosted 2026–27 EBITDA estimates, citing commodity strength and improving earnings visibility despite an ongoing legal dispute.
Oxford Biomedica chair buys 20,250 shares at £5.05 each
Chairman Dr. Roch Doliveux purchased 20,250 Oxford Biomedica shares for £5.05 per share on Sept. 23, bringing his total holding to 459,055 shares (0.379%).
SOS Ltd. Holds $75.6M in Digital Assets, Eyes 500MW Data Center
SOS Limited reported crypto holdings of roughly $75.6 million and disclosed a nonbinding framework to develop a major AI and cloud data center campus in Indonesia.
ARK Invest Tokenizes Venture Fund With OpenAI, Anthropic Stakes on Ethereum
Cathie Wood's firm partners with Securitize to put its ARKVX fund on blockchain rails, expanding beyond earlier tokenized Treasury products into private-market equities.
Oracle invokes force majeure on $165bn Project Jupiter data center
Oracle cited a force‑majeure clause after pipeline delays threatened its 2.45 GW, $165 billion Project Jupiter data‑center in New Mexico, sending the stock down about 4%.
BlackBerry Q2 FY27: QNX hits record, Alloy Kore wins major automotive deal
Revenue surged 26% year-over-year to $163 million, while adjusted EBITDA rose 29% to $47 million as QNX and licensing segments drove growth.
Michael Page Names Paul Harrison as Next Chairman
Michael Page plc has appointed Paul Harrison as chair-designate, succeeding Angela Seymour-Jackson when she steps down after the 2027 annual general meeting.
Cycurion Sees $843K From Chicago Public Safety Contracts in 2026
The Nasdaq-listed cybersecurity firm forecast roughly $843,028 in revenue from Chicago public safety engagements in calendar 2026, including a CAD administration role projected at $3.43 million over a decade.
EOG Resources Names New CFO, Ann Janssen Retires
EOG Resources, Inc. announced the appointment of Jeffrey Hibbard as chief financial officer and the retirement of Ann Janssen after more than three decades at the company.
Ming Yang Smart Energy to slash registered capital by 3.1% via share cancellation
Chinese wind-turbine maker cancels over 70 million A-shares from prior buyback, reducing registered capital from RMB2.26bn to RMB2.19bn after board approval.
Verbio Reports Stronger Q4 Results; Biofuels Producer Skids in Premarket Trade
German biofuels maker Verbio posted fourth-quarter EBITDA of EUR 88.2 million, snapping a year-ago loss, but shares fell 0.8% premarket after full-year guidance missed investor expectations.
EYDAP Reports H1 2026: Growth Plans, Execution Delays and €2.8B Investment Push
Athens water utility EYDAP outlines H1 2026 financials, including €17m revenue growth and a €2.8bn investment program, amid delays in peripheral utility consolidation and water service expansion.
Vicore Pharma outlines buloxibutid trial data, cash runway ahead of mid‑2027 readout
At a Stifel virtual forum, Vicore Pharma presented Phase II results for its oral AT2‑receptor agonist, highlighted a $93 million cash position lasting into late 2028 and noted a pre‑market share price of $9.61.
Kri-Kri Raises Full-Year Sales View but Trims Profit Outlook After H1 Surge
Greek dairy maker Kri-Kri reported H1 2026 sales of €204M, up 26%, driven by yogurt export growth, but cost pressures lead it to lower its full-year EBIT guidance.
AtlasClear Posts Strong Q4 2026 Revenue Beat, Shares Surge 38%
Fiscal 2026 revenue grew 85% to $20.1 million, driven by non-commission revenue growth and strategic correspondent broker-dealer expansion.
EQB Reports Growth Amid Credit Strain at CIBC Conference
EQB Inc. shares rose 22% YTD, 36% over past year, as it navigates housing backdrop and credit card risks.
Shearwater Group Plans Shareholder Vote on £19.9M Capital Reduction
The company seeks shareholder approval for a special resolution to cancel deferred shares and amend articles, requiring 75% support and court confirmation before implementation.
C4 Therapeutics Shows Immune Activation in Multiple Myeloma Trials with Cemsidomide
Biomarker data from Phase 1 trials highlights T-cell activation and safety at tested doses, advancing Phase 1b studies with elranatamab combination.
Core Scientific Names Jay Elms as CCO to Boost AI Data Center Sales
The Miami-based colocation provider expands its commercial leadership with a veteran from data center sales, targeting AI workloads and hyperscale clients.
CoreCivic Names Mayberry as CEO After Swindle Resigns Due to Health
CoreCivic, Inc. appointed Lucibeth N. Mayberry as CEO following Patrick D. Swindle’s resignation amid stage-four pancreatic cancer treatment.
Alten H1 Revenue Beats Forecast; Shares Rise 6.5%
Engineering services firm Alten reported H1 2026 revenue of €2.01 billion and raised full-year organic growth guidance to 1.7%-1.9%, sending shares up 6.5%.
ALTEN H1 2026 profit jumps 38% as margins improve
French engineering firm ALTEN posted a 38% rise in net income to €113.8 million in the first half of 2026, lifted operating margin to 8.9% and raised full‑year guidance.
Sellas Reports Preclinical Evidence for CDK9 Inhibitor SLS009 in Pancreatic Cancer
Sellas Life Sciences Group Inc. highlighted encouraging preclinical data for its CDK9 inhibitor SLS009, showing potential synergy with RAS-directed therapies in MYC-amplified pancreatic cancer models.
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.
Honeywell Declares $0.70 Quarterly Dividend
The Charlotte-based automation firm announced its latest quarterly dividend payment, with a record date of Nov. 13 and payment set for Dec. 4.
Leader's Advantage SPAC raises $150M in Nasdaq IPO
The SPAC completes a $150 million initial public offering on Nasdaq with units priced at $10 each, targeting healthcare, specialty chemicals, and defense sectors.
FMC Stock Hits 52-Week Low at $9.48 Amid Revenue Miss and Demand Headwinds
Ag-chemical maker FMC saw shares fall to $9.48, down 70% over the past year, after Q2 results showed a revenue shortfall driven by weak demand and pricing pressure.
Together Housing Pushes Back Audited Accounts to Oct. 26
Issuer of £350m secured bonds cites complex legal settlement as the reason for the delay beyond the 180-day regulatory window.
Coursera Shares Sink to 52-Week Low as Analysts See Upside
Coursera stock dropped to $4.98, nearly 60% below its 52-week high, despite strong second-quarter results and analyst upgrades driven by Udemy integration progress.
Canopy Growth Postpones Shareholder Meeting Until Oct. 23 Over Quorum Shortfall
Canopy Growth adjourned its annual meeting after failing to meet the 33 1/3% quorum threshold; the vote will reconvene Oct. 23 via webcast.
Veon Stock Surges to 52-Week High on Strong Digital Growth and Raised Guidance
Veon shares climbed to $74.60, up nearly 49% over six months, as the telecom operator raised its 2026 revenue and EBITDA outlook following a sharp second-quarter earnings beat.
Armour Residential REIT Hits 52-Week Low After Earnings Miss
Armour Residential REIT's stock touched $14.05 after second-quarter distributable earnings fell short of estimates, though the company kept its $0.24 monthly dividend.
Chip Stocks Extend AI-Driven Gains as Tech Picks Lead Market
AI-themed equity strategies posted monthly returns of 10% or more as semiconductor names rallied, extending outperformance against the S&P 500 that has persisted since late 2023.
ISS Backs Two ATG Capital Nominees for Empery Digital Board
Proxy advisory firm recommends shareholder support for ATG's board slate and withhold votes from two incumbent directors at Empery Digital's Oct. 14 annual meeting.
Moleculin Biotech Presents Preclinical Pancreatic Cancer Data at AACR
The company shared preclinical findings on its Annamycin candidate showing immune-mediated antitumor activity in pancreatic cancer, while its primary clinical program targets relapsed AML.
Turnium Technology raises up to C$3.5m via private placement, settles debt
Vancouver-based Turnium Technology plans a C$3.5 million non-brokered private placement and a C$2 million debt settlement under NI 45-106.
AllianceBernstein Names Onur Erzan as New CEO, Effective April 2027
Equitable Holdings selects former McKinsey executive to lead $919 billion asset manager as Bernstein steps down after a decade.
Accsys shareholders approve all 15 AGM resolutions, appoint Deloitte as auditor
Accsys Technologies PLC shareholders backed every proposal at its annual meeting, including a switch from PwC to Deloitte and new share issuance authorities.
OneMedNet Announces 1-for-10 Reverse Stock Split for Nasdaq Listing Compliance
The company will reduce outstanding shares to meet Nasdaq’s minimum bid price requirement, effective September 29, 2026.
Newron Halts US Recruitment for Evenamide Phase-3 Study Amid FDA Pause
Swiss biopharma firm pauses US patient enrollment in schizophrenia trial after FDA confirms temporary hold following a participant’s death outside the U.S., while expanding global recruitment for the drug’s development.
European equities end week with modest gains
EuroStoxx 50 closes at 6,302.82, up 0.48%, while Swiss SMI and UK FTSE 100 also rise. Analysts warn of persistent inflation and rising interest rates.
Strategy seeks shareholder vote to shift preferred stock dividends to daily schedule
Strategy plans to move its four preferred shares to daily dividend payments, pending a virtual special meeting on Oct. 28, with the first daily payout slated for Nov. 2.
CQS New City High Yield Fund raises 2M shares via blocklisting at 50.6p
The fund will use proceeds from the issuance to cover its blocklisting facility, with total voting rights unchanged at 727.6M shares.
DNP Select Income Fund hits 52-week low at $9.68
Fund’s valuation drops amid market pressures, despite 40-year dividend streak and stable returns.
OpenText reduces tender offer for 2028 senior notes to $300M
OpenText Corporation amends its tender offer for outstanding 3.875% Senior Notes due 2028, reducing the aggregate maximum tender amount to $300 million from $450 million.
Sasol Non-Executive Director Rhidwaan Gasant Resigns
Rhidwaan Gasant steps down from Sasol Limited's board for personal reasons, effective September 25, 2026. The move aligns with the company's succession plan.
Huntington Ingalls Shares Fall to 52‑Week Low of $263.44 Amid Mixed Q2 Results
The defense contractor’s stock slipped to its lowest level in a year after reporting second‑quarter earnings that beat estimates, while analysts issued mixed price‑target revisions and the firm secured a $336 million carrier contract.
Philogen H1 2026 cash tops EUR 300 million as pipeline advances
Philogen SpA reported cash reserves exceeding EUR 300 million in H1 2026, up from EUR 100 million in H1 2025 and EUR 64 million in H1 2024. The company also reported an EBITDA loss of EUR 20 million for the period.
Trifast to Reduce Capital via £38.9m Share Issue to Enhance Dividend Flexibility
Trifast plc plans to reduce capital by £38.9 million through a share issue and share premium account cancellation, aiming to bolster distributable reserves for dividend payments and improve flexibility in payouts.
Campbell’s Stock Drops to 52-Week Low Amid Earnings Weakness and Rating Cuts
The snack giant’s shares fell to $19.54 after Moody’s downgraded its credit rating and analysts trimmed price targets amid revenue declines and inflation pressures.
S&P 500 Utilities index slides to 52‑week low amid rising 10‑year Treasury yield
The utilities sector fell to 400.07, its lowest level in a year, as the 10‑year U.S. Treasury yield rose to 5.16%, triggering oversold technical signals.
Cegedim H1 2026: Revenue Growth Slips but Profit Rises Amid Cost Cuts
Revenue grew modestly while adjusted earnings improved as the healthcare services group trimmed costs and integrated acquisitions.
Cegedim H1 margins expand as revenue growth stays flat
French healthcare software firm reports adjusted EBIT up 6.9% to €19.7m on 0.7% revenue growth, with margin expanding to 6.1%.
Cegedim H1 2026: Margins Improve Amid Modest Revenue Growth
Revenue grew just 0.7% in the first half of 2026, yet adjusted operating income rose 6.9%, as the French healthcare services group tightened costs and expanded profitability across core segments.
Orbit Garant Drilling Reports Record Q4 Revenue, Posts Net Loss
Orbit Garant Drilling posted record Q4 and full-year revenue, but a drop in margins and higher costs drove a net loss. Stock fell after hours.
BofA lifts AMD price target to $720, sees server CPU market hitting $211B by 2030
Bank of America raised its AMD price target to $720, forecasting the server CPU total addressable market to grow from $61 billion in 2026 to $211 billion by 2030, with AI workloads accounting for most of the expansion.
Midterm Outlook: Which S&P 500 Stocks May Resist Election Headwinds
UBS and prediction models highlight stocks with defensive traits amid U.S. midterm election uncertainty, including Berkshire Hathaway and Microsoft.
Strategy MSTR to propose daily dividends for STRC to approach $100
Shareholder vote on Oct. 28 could shift STRC’s preferred stock dividends from monthly to daily payments, aiming to stabilize its price near $100 after a 12% dividend yield and $1B in buybacks.
Ferrellgas Reports Widening Q4 Loss Despite Higher Adjusted EBITDA
Propane marketer posts mixed fourth-quarter results as adjusted EBITDA rises 3% to $23.8 million but net loss widens to $31.5 million on higher interest expense and warmer-than-normal weather.
BioPharma Credit Reports Steady H1 2026 Returns Amid Portfolio Diversification
The life sciences-focused credit lender posted net income per share of $0.045 and a 13.89% total return year-to-date, with a market cap of $1.1 billion and a 10.23% dividend yield.
Eversource Energy Shares Hit 52-Week Low After Weak Q2 Earnings
The utility stock fell to $63.43 after second-quarter results missed Wall Street estimates, dragged down by non-cash charges linked to a water-asset sale and offshore wind project.
Lumen to Relocate Listing from NYSE to Nasdaq in October
Lumen Technologies Inc. plans to transition its NYSE-listed common stock and debt instruments to Nasdaq in late October, marking a strategic shift toward AI-driven enterprise networking services.
Aeternum Acquires Full Ownership of Cameroon Cobalt Project
The company will issue up to 133.3 million shares to complete the deal for the Nkamouna cobalt-nickel-manganese asset, replacing a prior joint venture structure.
Star Fashion Culture raises $9.6m in follow-on share offering at $0.80
The company plans to use proceeds for online marketing services, administration, and working capital
US-Aktien dominieren – aber Risiko wächst mit Abhängigkeit
Die Konzentration auf US-Titel, besonders Tech-Giganten, erhöht Portfoliorisiken. Diversifikation bleibt entscheidend für langfristige Renditechancen.
US Markts: Ölpreise, Nahost-Risiko und KI-Dynamik treiben Aktienkurse am Freitag voran
Ölpreise sinken leicht, Nahost-Diplomatie Hoffnung auf Marktstabilisierung; Nasdaq und Tech-Aktien dominieren die Erholungstendenzen.
Givaudan SMI-Titel steigt auf Elf-Wochen-Hoch nach Analystenaufschwung
Die Aktie des schweizerischen Duftstoffherstellers Givaudan erreichte in der vergangenen Woche ein Elf-Wochen-Hoch und übertrifft den SMI um 1,6 Prozent.
Cencora Names Former Ryder CEO Robert Sanchez to Board, Effective Oct 2026
Cencora Inc appointed former Ryder System CEO Robert Sanchez as an independent director, with the role starting October 1, 2026, citing his logistics, operations and finance experience.
Mortgage Advice Bureau Cuts H1 2026 Profit Guidance Amid Market Challenges
Revenue growth and operational efficiency remain robust, but cautious outlook reflects refinancing headwinds and cost pressures.
XCF Global Reports $10M August Renewable Diesel Revenue
XCF Global's New Rise Reno facility shipped 1.3 million gallons of renewable diesel in August, exceeding $10 million in revenue as production climbs past nameplate pace.
TruGolf Announces 1-for-10 Reverse Stock Split
The Nasdaq-listed TruGolf Holdings will reduce its share count with a 1-for-10 reverse stock split effective September 29, 2026, as part of a strategic equity adjustment.
Orosur Oversubscribes C$14M Private Placement for Colombian Drilling
Orosur Mining raised up to C$14M at C$0.32 per unit, with an option for another C$2M, as proceeds fund drilling at the company's Anzá project in Colombia.
Deutsche Bank Keeps Nestle at Hold, 82 CHF Target Cites Russia Exposure
The analyst maintained the rating after noting forced administration of two Nestle subsidiaries in Russia, estimating the country accounts for about 2% of sales and 2‑3% of EBIT, while Haleon’s Russian profit share is put at 4‑5%.
Tech Layoffs Surge in 2026 as AI Spending Drives Cost Cuts
U.S. tech firms have cut at least 94,046 jobs through August 2026, a 16.8% increase from the same period in 2025, as AI investments and restructuring accelerate.
Stocks Resilient Amid Rising Yields, $100 Oil: Two Key Factors
Market indices held steady despite higher Treasury yields and Brent crude above $100, driven by gains in AI-driven tech stocks and broader macroeconomic uncertainty.
Fitch affirms TAURON's BBB- rating, outlook stable
Fitch Ratings has affirmed TAURON Polska Energia's long-term foreign and local currency Issuer Default Ratings at BBB-, with a stable outlook. The company's €500 million foreign currency senior unsecured unsubordinated debt also retains a BBB- rating.
HSBC Names Alison Platt as Independent Non-Executive Director
Alison Platt joins the board as successor to Dame Carolyn Fairbairn, effective October 1, with a three-year term extending to 2030.
Bango H1 2026: Revenue dip offsets strong subscription growth
Reported revenue fell 3-5% from low-margin route restructuring, but ARR rose 31% to GBP 20.4m and adjusted EBITDA jumped 34% as subscription profitability surged.
SMI bleibt bei 13.953 Punkten, UBS unter Regulierungsdruck
Schweizer Aktienmarkt zeigt kaum Bewegung, während Ölpreise und Anleiherenditen leichte Stütze bieten – doch US-Iran-Drohungen bremsen Gewinne aus.
SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms
Swiss stock market shows slight gains; UBS and Givaudan see increased interest; semiconductor stocks rise; Nestlé underperforms; new ratings and price targets for Swiss stocks
Lombard Odier hires Asia private banking head in Zurich
Jingjing He joins the bank’s Zurich team to expand its private client coverage in Asia, following recent hires in Singapore and Hong Kong.
Xtrackers Emerging Markets ETF to pivot to active management with fee hikes
DWS-backed fund shifts from passive tracking to mid-to-long-term active strategy, adjusts ESG focus and fee structure ahead of October vote
Zurich Insurance Top Executive Sells Shares for Over 2.38 Million CHF
Executive-level sales of company shares by Zurich Insurance executives highlight a broader trend of insiders liquidating holdings amid a recent decline in the stock’s value.
SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles
Swiss stock market shows resilience, with ABB and UBS gaining while Nestlé lags. Oil prices and bond yields remain key market drivers.
AI-driven stock picks show September gains, but October performance remains uncertain
Five AI-selected semiconductor and tech stocks surged in September, but whether they repeat in October depends on broader market conditions and sector-specific catalysts.
SMI climbs as ABB and UBS gain; oil prices fall
Swiss stock market rises, with ABB and UBS among top gainers, while oil prices decline. Analysts warn of rising bond yields.
Sampo Repurchases Over 5 Million Shares in Latest Buyback Round
Sampo plc acquired 5.05 million shares in week 39, bringing its total A-share holdings to 37.83 million, or 1.42% of outstanding shares, as part of a €350 million authorized buyback programme.
SpaceX’s xAI plans to double Nvidia AI chip capacity at Memphis data center by year-end
Elon Musk’s Colossus 2 facility, under construction in Memphis, Tennessee, aims to nearly double its use of Nvidia’s latest AI chips by the end of 2026, according to early reports.
Logitech Aktie: Kursverluste bleiben ungebrochen trotz positiver Quartalszahlen
Logitech’s Aktie verlor am Donnerstag 6,11 % und blieb am Freitagmorgen ohne Gegenbewegung. Trotz starker Quartalsergebnisse und robusten Nachfrage belasten Lieferkettenengpässe die Erwartungen.
Avacta Group presents trial design for pancreatic cancer drug AVA6103
The AIM-listed biopharmaceutical company details the FOCUS-01 Phase 1 study design for its peptide-drug conjugate targeting pancreatic ductal adenocarcinoma, highlighting preclinical data and a dose-dense arm.
Sampo Repurchases 5.05 Million Shares in Latest Week
The Finnish insurer Sampo Oyj executed a share buyback totaling 5.05 million A-shares during week 39, averaging €8.97 per share across multiple exchanges.
SDCL Efficiency Income Trust proposes two new non-executive directors
Saba Capital and General Atlantic-backed nominees proposed for board seats at wind-down investment trust ahead of Oct 15 shareholder vote.
Swiss Stocks Set for Higher Open on Upgrades, SNB Holds Rates
The SMI looks to open 0.4% higher as UBS upgrades Glencore and analysts revise targets on Swiss shares; the SNB keeps rates at zero percent while oil prices ease.
DAX Set for Weekly Recovery as Oil Prices Ease
The DAX's pre-market X-Dax indicator showed a 0.7% advance to 25,437 points as oil prices stabilized following recent gains.
Logitech Shares Drop 6% Despite Strong Q1 Results and Rising Margin
Logitech fell 6.11% to CHF 82.62 on Thursday as higher overseas interest rates and a supplier plant closure overshadowed robust first-quarter earnings and wide margin expansion.
Dax verliert 0.2 % bei Ölpreisanstieg, Ifo-Index bestätigt deutsche Konjunkturresilienz
Ölpreise und geopolitische Spannungen belasten den deutschen Aktienmarkt, doch die deutsche Wirtschaft zeigt sich widerstandsfähig.
First Solar hits $183 low on 52-week low as analysts raise targets
First Solar Inc. trades at its lowest level in five years amid continued pressure, with analysts citing potential relief from Section 232 tariffs as a catalyst for recovery.
Carlyle Group stock hits 52-week low at $39.15
The Carlyle Group Inc. stock has declined 38.21% over the past year, reflecting a 31% year-to-date drop. Piper Sandler initiated coverage with an overweight rating and a $54 price target.
Zillow Group stock falls to 52-week low at $29.03
Zillow Group Inc. stock hits $29.03, down 1.23% from the previous close, marking a 61.45% decrease over the past year. The company reported strong revenue growth but posted a net loss in the second quarter.
Brightstar Lottery PLC stock dips to $9.89 low amid 36% one-year decline
Company reports Q2 earnings slightly below expectations, Jefferies upgrades to Buy with a $16 price target
Thalassa Holdings reports £0.36m loss in H1 2026 amid operational declines
Investment firm reports year-over-year losses and reduced asset values, while key subsidiaries face delays and divestitures.
Mobix Labs Raises Q4 Revenue Forecast to Exceed $1.6M
Irvine-based wireless connectivity firm reiterates guidance for a fiscal Q4 2026 revenue increase of over 100% sequentially, citing defense sector demand.
Mettler-Toledo Stock Reaches 52-Week High on Q2 Earnings, Analyst Upgrades
The precision instruments maker reported strong Q2 revenue growth and surpassed earnings estimates, prompting price target revisions from Wall Street analysts.
Thermo Fisher Scientific Stock Surges to 52-Week High on Strong Q2 Results
Life-sciences giant hits $671.69 as Q2 earnings and revenue beat estimates; UBS upgrades to Buy with double-digit EPS growth projected by 2027.
Agilent Technologies Stock Hits 52-Week High at $169.07
Shares of Agilent Technologies reached a new 52-week high as Wall Street raises price targets on strong third-quarter results and upgraded outlook.
Darden Restaurants Q1 Earnings Meet View as Shares Slip on Revenue Miss
Darden posted adjusted EPS of $2.05, in line with expectations, but revenue of $3.2 billion fell short of consensus. Same-restaurant sales rose 3.2%, beating the casual-dining benchmark.
Star targets $40 m EBITDA, merges with Harte Hanks in cash‑preferred stock deal
Star (HSON) outlined a $40 million EBITDA goal for the decade, announced a merger with Harte Hanks funded half in cash and half in preferred stock, and detailed growth targets for its Hudson division.
US equities extend losses as oil prices and inflation fears weigh
Dow Jones, S&P 500, Nasdaq all decline by 0.2–0.5% amid rising oil prices and geopolitical risks.
Raspberry Pi Shares Surge 16% on H1 Profit Beat
Revenue more than doubled and adjusted EBITDA doubled in the first half as the maker of popular single-board computers benefited from higher selling prices and a ballooning customer backlog.
TD SYNNEX beats Q3 2026 forecasts, shares slide 9%
The distributor posted non‑GAAP EPS of $5.68 and revenue of $21.6 bn, topping estimates, but its stock fell 9.4% after the call.
Melco Resorts Stock Slides to 52-Week Low After Weak Quarter
Shares of Melco Resorts & Entertainment hit $4.55, marking a 51.6% yearly decline, as Q2 earnings missed forecasts on soft visitation and an unfavorable VIP win rate at its Macau property.
Alkami Technology Stock Hits 52-Week Low as JPMorgan Cuts Price Target
Alkami Technology fell to $13.97, a 52-week low, after JPMorgan downgraded the bank-tech lender and slashed its price target to $14. Q2 revenue beat estimates but the company reported an adjusted loss.
BlackRock HY Fund Drops 18.6% to $7.77 on 52-Week Low
The BlackRock Corporate High Yield Fund (HYT) fell to its lowest point in 2026 at $7.77, marking an 18.6% decline from its 52-week peak of $9.55.
TD SYNNEX Posts Record Q3 Revenue, Shares Fall on Margin and Cash Flow Concerns
TD SYNNEX reported record gross billings of $31.8 billion in Q3 FY26, beating expectations, but shares tumbled nearly 10% as free cash flow turned negative and segment margins contracted.
Twist Bioscience shares reach 52‑week high of $170.69
The biotech firm’s stock surged to $170.69, up 527.55% over the past year and 400% YTD, as it announced a new partnership with Eli Lilly’s Lilly TuneLab and filed a prospectus supplement for a share resale.
Anavex elects six directors at annual stockholder meeting
Anavex Life Sciences Corp. (NASDAQ: AVXL) reported preliminary results from its 2026 annual meeting, with all six board nominees elected. Final tabulation and an SEC Form 8-K are pending.
Darden Restaurants Reports Q1 FY2027 Results, Reaffirms Full-Year Guidance
Darden posted total sales of $3.2 billion in Q1 FY2027, with adjusted diluted EPS of $2.05 meeting expectations, while reaffirming full-year outlook.
Anavex stockholders elect six directors at annual meeting
Shareholders of the clinical-stage biopharmaceutical company voted to reelect all six director nominees, with Dr. Jiong Ma retaining his role as independent chair.
Adaptive Biotechnologies stock reaches 28.87 USD, 52-week high
Revenue growth and analyst upgrades support a 117.5% year-over-year surge, though adjusted loss misses expectations.
Kamada Guides Full-Year Revenue to $200M–$205M as Q2 Hits Record
Specialty plasma biotech posts its strongest-ever quarter on rabies and AAT demand, while announcing a $50M annual plasma supply deal and continuing to return over half of profits to shareholders.
Iofina posts stronger H1 2026 profit on 29% production growth
Iodine producer's gross profit more than doubled and EBITDA doubled as output surged; IO#12 plant expected to come online in the Permian Basin within weeks.
Hilton Grand Vacations Shares Fall to 52‑Week Low After Q2 Earnings Miss
The timeshare operator’s stock slipped to $34.89, near its yearly low, after reporting Q2 EPS of $0.89 and revenue of $1.36 billion, both below analyst forecasts, while reaffirming full‑year EBITDA guidance.
Nuveen AMT-Free Municipal Credit Income Fund Hits 52-Week Low
The $2.39 billion NVG fund slipped to $11.04, down nearly 19% from its 52-week high of $13.59, though its 8.47% yield and 25-year dividend track record remain intact.
Patrick Industries shares hit 52‑week low of $68.41
Patrick Industries stock fell to a 52‑week low of $68.41, down more than 30% year‑to‑date, after Q2 earnings missed forecasts and analysts trimmed price targets.
Raspberry Pi Profit Doubles on Industrial Demand in H1 2026
Cambridge-based maker of single-board computers reported 108% jump in adjusted EBITDA to $40.3 million, driven by a shift toward industrial applications and rising average selling prices.
Grail Stock Hits All-Time High of $119.09 After Strong Q2 Results
Grail shares surged to a record $119.09 on FDA optimism for its Galleri cancer test and a revenue beat, marking a 140% gain over the past year.
Public Service Enterprise Group stock hits 52-week low at $67.11
The utility company's shares fell 16.93% over the past year, though second-quarter earnings per share beat estimates despite a revenue miss.
Raspberry Pi Posts H1 2026 Record Profits Amid Edge AI Growth
Revenue surged 90% to $256.9 million as unit backlogs quadruple, while adjusted EBITDA nearly doubled to $40.3 million.
Wall Street Extends Losses as Oil Surge and Bond Yields Pressure Stocks
The Dow, S&P 500 and Nasdaq 100 all posted fresh declines on Thursday, weighed down by rising oil prices, a selloff in bonds pushing 30-year yields to their highest since 2004, and mounting inflation concerns.
Hayward Holdings Stock Hits 52-Week Low of $12.63 Despite Q2 Beat
Shares of Hayward Holdings touched $12.63, its lowest level in a year, even as second-quarter earnings and revenue surpassed Wall Street estimates.
AT&T Stock Tumbles to 52-Week Low of $19.26
The telecom giant's shares hit a new yearly trough, down 17.4% over the past year, even as the company posts trailing-twelve-month profitability and offers a 6.91% dividend yield.
CRH Stock Drops to 52-Week Low Amid Acquisition Uncertainty
CRH plc’s shares fell to a five-year low of $83.65 amid a 31% year-to-date decline, as analysts adjust expectations ahead of a $150-per-share cash acquisition of Arcosa Inc.
Verbio Reports €194m EBITDA Surge in FY 2025/26 on Regulatory Shift
Verbio SE's EBITDA surged to €193.9 million in FY 2025/26, driven by regulatory shifts and increased production volumes. The company's net debt decreased to €91.5 million, and equity ratio improved to 59.7%.
Lowe’s stock dips to $188.22 amid analyst downgrades and housing market uncertainty
Lowe’s Companies Inc. hit a 52-week low of $188.22, reflecting a 26.26% year-over-year decline, as analysts revised price targets amid concerns over housing demand and strategic expansion needs.
JPMorgan Asset Management Crosses 5% Stake in Everplay Group
JPMorgan Asset Management Holdings Inc. disclosed a 5.16% voting-rights position in Everplay Group plc after filing a regulatory notification on Tuesday under UK disclosure rules.
Equifax shares dip to 52‑week low of $150.63
Equifax stock fell to $150.63, its lowest level in a year, as analysts trimmed price targets despite a beat on Q2 earnings and a steady dividend record.
NiSource stock dips to $39.01, 52-week low amid earnings and regulatory focus
NiSource Inc. hit a $39.01 low, just 1% above its 52-week floor, as earnings missed estimates and analysts trimmed targets amid regulatory scrutiny and growth challenges.
Rogers Communications projects CAD 2.5‑2.7 bn capex, cites 8.7% revenue growth at CIBC conference
At a CIBC investor event on Sept. 24, Rogers outlined 2026 capex of CAD 2.5‑2.7 bn, 8.73% revenue growth, a 4.35% dividend yield and an upcoming MLSE deal closing in early Q4 2024.
Duke Energy Stock Falls to 52‑Week Low of $113.88 Amid Sector Pressures
Duke Energy’s shares slipped to a 52‑week low of $113.88, down 6.75% over the past year, as the utility posted second‑quarter adjusted earnings of $1.43 per share and revenue of $7.59 billion while facing heightened regulatory review in Indiana.
Travere Shares Rise as FILSPARI Sales Jump 77%, Leadership Transition Set
Revenue reached $591 million over the trailing twelve months at the Stifel forum; outgoing CEO Eric Dube will step down Dec. 1, succeeded by Bradley Campbell.
Clover Health Appoints Former Senator Torricelli, Dr. Miller to Board
Clover Health Investments added former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its board, filling two vacancies and bringing the total to nine directors.
CoTec extends convertible debenture offering deadline to Oct. 15
CoTec Holdings extends its $20 million non-brokered debenture offering; Kings Chapel commits up to $5 million at final closing.
TELUS Cuts Dividend by 55% as It Shifts Focus to Profitability
The telecom giant plans to redirect CAD 2.7 billion in capital toward AI infrastructure and operational efficiency by 2028, while targeting a leverage ratio of 3.0x or lower.
Costco Beats Q4 Forecasts on Strong Comp Sales and Membership Growth
The retailer reported EPS of $6.75, top-line sales of $93.87 billion, and digitally enabled comps up nearly 20%, though gross margin narrowed as tariff refunds boosted per-share results.
WildBrain reports mixed Q4 2026 results amid restructuring
Revenue fell 29% year-over-year, but adjusted EBITDA guidance points to a turnaround by fiscal 2029.
Prestige Consumer Healthcare Reaffirms Growth Plan Amid Supply Constraints
Revenue declined 4.3% YoY in fiscal 2026, but free cash flow targets remain robust, with guidance for 10% CAGR through 2029.
Jumbo Reports H1 Growth With Margin Pressure; Keeps 2026 Outlook Intact
Greek retail chain posts 4% sales growth and EUR 546M cash balance in first half, but gross margin slips 33 basis points as Romania faces headwinds.
JPMorgan Chase Stock Rises to Near Record as Banking Giant Posts Strong Revenue
JPMorgan shares close near $366.50 record as CEO Dimon cites solid fundamentals; Q2 revenue of $57.35 billion supports full-year guidance despite rate cut sensitivity.
McCormick declares $0.48 quarterly dividend, pays 102nd consecutive year
The seasoning maker raised its quarterly payout to $0.48 per share, payable Oct. 26, marking the 102nd straight year of dividend payments from the Hunt Valley-based company.
Scholastic Reports Wider Q1 FY2027 Loss, Affirms Guidance Amid Revenue Decline
The children’s publishing giant reported a $3.63 loss per share in Q1 FY2027, a 44% increase from the prior year, as revenue fell 4% to $216.8 million.
Spin Master Raises View on Tariff Refunds, PAW Patrol Film Strength
Spin Master reported a $40 million tariff refund applied to debt, mid-to-high single-digit EBITDA growth outlook, and strong third-film box office for PAW Patrol at the CIBC Eastern Institutional Investor Conference.
Legacy Education posts record revenue, shares drop 8% after-hours
Company reported $80.1 million in annual revenue with 24.8% growth, but after-hours trading fell to $9.75 despite the strong results.
Rapid Micro Biosystems Seeks 50%+ Gross Margins by 2028
Company highlights early growth, recurring revenue and FDA-approved system adoption in pharma and advanced therapies
QuantumScape Shares Hit 52-Week Low as Q2 Losses Mount
Solid-state battery maker QuantumScape dropped to $4.76, marking a 61.7% decline over the past year, even as second-quarter adjusted EBITDA losses came in line with expectations.
Aon Stock Hits 52-Week Low Near $277.55 as Acquirer Weighs $17B USI Deal
Aon PLC shares touched a 52-week low near $277.55 amid a ~20% annual decline. The insurer is funding a roughly $17 billion acquisition of USI Advantage with a $13.4 billion senior-notes offering.
Octopus Investments trims stake in Everplay Group below 8% threshold
London-based Octopus Investments reduced its holding in Everplay Group to 7.99%, filing a major-shareholder notification with the LSE's Regulatory News Service.
Maximus Stock Falls to 52-Week Low as Profit Outlook Cut
Maximus Inc. hit a 52-week low of $52.72, down nearly half from its high, after adjusting its full-year profit outlook over a temporary pause in VA contract incentives.
Sempra Energy hits $19.43 low as 11.6% year-on-year drop continues
The utility’s shares fell to a five-year low amid broader market pressures and sector-specific challenges.
Aberdeen Intermediate Income Approves 1-for-6 Reverse Stock Split
The closed-end fund's board approved consolidating every six shares into one ahead of Oct. 8 trading, aiming to raise its per-share market price.
Dime Commercial Bancshares Declares $0.25 Quarterly Dividend
Bank holding company announces cash dividend payable July 24, citing continuation of its uninterrupted dividend track record.
Aberdeen fund approves 1-for-5 reverse stock split
The Aberdeen Government Markets Income Fund said its board approved a 1-for-5 reverse split effective Oct. 8, aiming to raise its per-share price and broaden platform eligibility.
Dow Slips 0.3% as Oil Swings Weigh on Wall Street
US markets showed little direction as Iran tensions lifted oil prices and bond yields, while Meta, Oracle and MGM posted notable moves.
TP Names Benoit Gabelle as New Group CFO to Drive Transformation
Benoit Gabelle takes over as Group Chief Financial Officer at TP, a global digital business services provider, to accelerate its AI-driven transformation and investor relations.
IG Design Group shareholders back 1p dividend, new directors at AGM
IG Design Group PLC shareholders approved a final 1-pence dividend and elected two new directors at its annual meeting, with near-unanimous support across all 13 resolutions.
H.B. Fuller Q3 2026 Results Show Margin Expansion Amid Volume Declines
The adhesive maker reported adjusted EPS of $1.52, topping analyst expectations, while revenue came in slightly below forecasts. Margins widened on pricing gains and cost‑saving actions, even as volumes fell.
Smithfield Foods Stock Hits 52-Week Low at $18.89
Pork producer touches session low of $18.89 as shares fall more than 63% from their 52-week high, despite recording a record operating profit in the second quarter.
Regency Centers Stock Falls to 52‑Week Low of $21.05
The REIT’s shares slipped to their lowest level in a year, reflecting a 10% decline over the past 12 months while offering a 6.8% dividend yield and a PEG ratio of 0.64.
Aktor Group H1 2026 Revenue Jumps 44% as Shift to LNG, Concessions Accelerates
Greek diversified group reports €649M revenue and €120M pro forma EBITDA in first half, while raising €950M in capital markets and laying out €3B five-year investment plan.
Miami International Holdings shares hit 52‑week low of $35.42
The stock fell to $35.42, a 38% drop from its 52‑week high, after Morgan Stanley cut its rating and price target despite a record Q2 revenue beat.
Clorox Stock Drops to 52-Week Low as Q4 Earnings Miss
Clorox shares fell to $82.47, a 52-week low, after fourth-quarter EPS of $1.66 missed consensus despite stronger revenue driven by advertising costs.
Essential Properties Realty Trust hits $26.46 low amid year-on-year decline
Stock falls 9.91% over 12 months as dividend yield holds at 4.76% and analysts set targets between $30 and $40.
Gaming stocks dip as Meta unveils AI game‑building tools
Meta announced AI‑powered Horizon Create and Horizon Studio at its Connect conference, sending Unity down 5% and pulling Roblox and AppLovin lower.
Lincoln Electric Outlines Growth Strategy Amid 9.3% Revenue Growth
The welding and automation leader highlights operational improvements, M&A plans, and pricing adjustments to sustain mid-single-digit CAGR through 2030.
Proto Labs Stock Surges to 52-Week High at $93.25
Company reports record Q2 revenue, adjusted EPS beats estimates, and raises full-year outlook amid analyst upgrades.
Former OpenAI Data Center Head Joins Nvidia as DSX VP
Chris Malone, who led OpenAI’s data center infrastructure, now oversees Nvidia’s DSX Platform, following his departure amid executive departures in August.
Third Point Reinsurance Hits Record High on Strong Earnings, RBC Upgrade
SiriusPoint shares surge to all-time high of $26.49 after second-quarter operating EPS beat estimates, while RBC Capital initiated coverage with an Outperform rating.
JPMorgan Picks European Chemical Stocks as China Pressure Mounts
JPMorgan highlighted Novonesis as its top long in European chemicals, citing strong organic growth and ROIC above 20%, while retaining underweight ratings on BASF and Wacker over valuation concerns.
Vecima Beats Q4 Revenue Estimate But Misses on Earnings
Record CAD 91M in revenue topped forecasts by 7.3%, but adjusted EPS of CAD 0.21 fell short of consensus as gross margin gains offset weak profitability.
MicroSalt launches retail offer to raise up to £100,000
MicroSalt PLC is offering up to 714,285 new ordinary shares at 14p each, targeting £100,000 and part of a broader £1.5 million fundraising round.
Knife River acknowledges activist letter from Starboard Value
Knife River said it received a letter from activist investor Starboard Value, welcomed dialogue and reaffirmed its growth strategy since its 2023 spin‑off.
Solaria shares drop 6.5% after H1 2026 results show record EBITDA
The Spanish solar producer posted a 50% rise in EBITDA and a 52% jump in net profit, but higher merchant exposure and a weaker current ratio sent the stock down 6.47% to $15.18.
Valmont Industries Eyes $35 EPS by 2029, Driven by Utility Growth
Valmont Industries projects revenue growth to $5.4B by 2029, with utility segment expansion leading to a $35 EPS target—despite rising input costs.
Crypto treasury firms lose premium as market value falls below holdings, DWF report shows
A DWF Ventures study finds only four of the 20 biggest digital‑asset treasury companies trade above NAV, indicating a collapse of the equity premium that once funded Bitcoin purchases without dilution.
iA Financial Group says growth on track as stock climbs over fourfold since 2017
CEO Denis Ricard highlighted a 19% CAGR in share price, strong capital generation and expanding wealth‑management earnings at the CIBC Eastern Investor Conference.
AKTOR raises €950mn to fund infrastructure expansion, eyes €600m EBITDA by 2031
Greek infrastructure group AKTOR completed a €950 million capital raise—€650 million in shares and €300 million in senior bonds—boosting cash to €1.1 billion and targeting a diversified portfolio by 2031.
Kyverna Reports One-Year Clinical Data for Autoimmune CAR T Therapy miv-cel
Kyverna Therapeutics shared 12-month results from its miv-cel CAR T-cell program in stiff person syndrome and generalized myasthenia gravis, with a rolling BLA still targeted for late 2026.
Living REIT posts modest H1 2026 growth after senior‑living acquisition
The UK REIT reported a 2.3% rise in rental income, EPS of 3.4p and lifted its 2026 dividend target, while expanding to 5,464 homes through a £185m senior‑living purchase.
System1 Raises FY27 Profit Guidance by 19% on Strong Half-Year Performance
The AI-driven marketing firm lifted its full-year adjusted profit before tax outlook to around £5 million, up from consensus of £4.2m, citing revenue growth and cost-efficiency gains.
Shaires Holdings opens AIM trading with $108m AI portfolio
London-based investment company lists on AIM with holdings in seven private AI firms, using the exchange's new Capital Access Window for its first retail tranche.
HSBC awards 7.9 million shares under UK employee share plan
Employees receive options to purchase shares at £12.17 each, with vesting over three to five years and exercise windows extending to 2032
CVS Group FY2026 earnings show modest growth as Australian expansion accelerates
Revenue rose 5.9% to £712.8 million and adjusted EPS increased 6.9% to 85.6 pence, while the company added sites in Australia and returned £31.7 million to shareholders.
Bentley’s $230K Torcal EV targets Ferrari’s market segment
Luxury EV debut aims to capture high-end buyers amid shifting sports-car trends
Nasdaq 100: Tech Stocks Resilient Amid Market Volatility
The Nasdaq 100 index has reached a record high, driven by strong growth in the AI sector and the dominance of major tech companies. Despite global uncertainties, tech stocks remain resilient.
Peter Raskin Joins 1875 Finance as Managing Director for Zurich Private Banking
Former Berenberg executive to lead growth in Zurich’s private wealth sector, focusing on client-centric expansion.
Peugeot Invest H1 2026 NAV falls 12.5% as Stellantis exposure drags
Peugeot Invest posted a 12.5% NAV decline to €144.8 per share in H1 2026, with an 8.5% portfolio return but a 61% discount to NAV and a 47.7% drop in its Stellantis stake.
DFS Furniture Profit Surges 49% as Gross Margins Reach Target
UK upholstery retailer posts £44.9 million underlying PBT for FY26, a 49% jump on improved margins and deleveraging, while order intake edges lower.
CVS Group FY2026 revenue rises 5.9% to £712.8m; shares drop on weather hit
UK pet-care operator posted solid top-line growth and higher adjusted EPS, but like-for-like sales slowed from 2.7% in the first half as poor weather weighed on visitation.
Banco de Sabadell Looks to Standalone Growth as Spain Economy Accelerates
The bank's CEO highlighted strong volume growth in Spain and a target return on tangible equity of 16% by 2027, as nominal GDP expands faster than the EU average.
Living REIT posts modest H1 2026 growth as shares slip 2%
The REIT reported a 2.3% rise in net rental income and a 2.2% increase in adjusted EPRA EPS, while its share price fell 2.14% after the results.
Oracle Japan Reports Q1 2027 Revenue Surge Amid Cloud Growth
Oracle Corp Japan’s first-quarter fiscal 2027 results show a 13% year-over-year revenue increase, with cloud services driving 34% of total sales.
South32 sets exchange rates for final dividend
South32 declared a US$0.054 fully‑franked final dividend for FY2026 and published the exchange rates used to calculate payouts in AUD, GBP, NZD and ZAR.
DFS Furniture H2 Profit Surges 49%, Gross Margin Hits 58% Target
DFS Furniture reports full-year revenue of £1.06bn with underlying PBT rising to £144.9m, as gross margin reaches strategic target for fourth consecutive year.
Clean Power Hydrogen reports £4.9m loss, raises £7.3m
UK-based green hydrogen technology company Clean Power Hydrogen plc reported a £4.9 million loss for the six months ended June 30, 2024, and raised £7.3 million in gross proceeds.
US equities retreat as S&P 500 slips 0.75%
Treasury yields rise, dollar strengthens amid global bond selloff and elevated inflation risks.
Glencore to Launch CDI Trading on ASX from October 14, 2026
Glencore PLC said its CHESS Depositary Interests will start trading on the Australian Securities Exchange on October 14, 2026, under ticker ASX:GLC, with Computershare managing the register. Each CDI represents one ordinary share, and holders may convert shares via the Jersey or South Africa registries, subject to exchange controls for South Africa.
flatexDEGIRO Expands in Germany with Retirement Savings Accounts
flatexDEGIRO launches three retirement savings account models in Germany, catering to the new state-supported market ahead of pension reform.
Peugeot Invest reports H1 2026 results amid Stellantis valuation pressures
Net profit rises 12% year-on-year, but NAV per share declines as divestitures and investments shape the portfolio’s performance.
CVS Group FY 2026 revenue rises 5.9% as Australia expansion gains pace
The veterinary services group posted £712.8 million revenue, 6.9% EPS growth and a 1.63x EBITDA leverage ratio, while shares slipped 5% on the results.
Bravura Solutions Reschedules AGM to November 26
The AIM-listed company extends its annual general meeting date to November 26, citing board succession and preparations as key factors.
H&M Shares Fall as Q3 Earnings Miss Even as Margins Improve
H&M reported Q3 profit gains and an operating margin of 10.6%, but missed market EPS estimates, sending shares down nearly 3%. Supply-chain delays and higher markdowns are expected to weigh on Q4.
Quantum Data Energy shares resume trading on London Stock Exchange
Shares of Quantum Data Energy PLC resume trading on the LSE after the FCA lifted its suspension following a one-month halt.
UBS Shares Drop Below 40 Francs After Swiss Capital-Rule Vote
The UBS stock fell to 38.84 francs after the Council of States approved stricter capital requirements for systemically important banks, drawing sharp criticism from the bank and its CEO.
Oriole Resources Confirms High-Grade Limestone at Wapouzé Project
Maiden diamond drilling at the Wapouzé limestone deposit in northeastern Cameroon returned marble units with calcium oxide grades suitable for cement manufacturing.
Quantum Data Energy Restored to London Exchange After FCA Delisting
Quantum Data Energy PLC’s shares returned to trading on the London Stock Exchange on September 24, 2026, following a suspension by the Financial Conduct Authority.
DAX set to widen losses as Brent climbs above $100 and US delays China tariffs
German DAX futures slipped 0.5% to 25,296 points, testing the 100‑day moving average, while Brent crude topped $100 per barrel and US tariffs on Chinese imports were postponed two months.
RWS Named Leader in Forrester Localization Services Report
RWS Holdings scored the highest possible rating in 18 of 27 Forrester criteria for its AI-driven localization platform in the Q3 2026 Wave report.
Hafnia Raises TORM Stake to 19.85% in $57.8M Buy
Tanker owner Hafnia will increase its TORM holding from about 18.2% to 19.85%, adding 1.66% in A shares at $34 each for roughly $57.8 million.
DFS Furniture Posts 48.7% Profit Growth, Debt Cuts Amid Strategic Margin Push
Revenue growth of 2.6% and £38m debt reduction support financial resilience ahead of medium-term targets.
Xlife Sciences reports strong first-half growth, Koterax Biotech listing a key milestone
Umsatz steigt um 25%, aber Verlust pro Aktie verschärft sich; Fokus auf Pipeline-Entwicklung und Partnerschaften bleibt zentral.
Schweizer Aktienmarkt sinkt vorbörslich: SMI-Aktien im Minus, SNB-Zinsentscheid im Fokus
Der Schweizer Aktienmarkt zeigt vor dem Handelssstart am Donnerstag Verluste, während die Schweizerische Nationalbank (SNB) um 09:30 Uhr ihre Zinsentscheidung trifft. Logitech und Nestlé sind unter den stärksten Verlierern.
V-Zug Names Carsten Liesener as 2027 Board President Candidate
The Swiss manufacturer V-Zug announced plans to replace Oliver Riemenschneider as board president at its upcoming 2027 general meeting.
Accelleron secures orders for over 100 next-gen low-speed turbochargers
The Swiss firm’s latest model, the ACCX300-L, has attracted global interest from shipyards, engine manufacturers and marine equipment suppliers within four months of launch.
Leclanché Files Insolvency for Two German Subsidiaries Amid Liquidity Crisis
Battery maker files precautionary insolvency proceedings for German units in Offenburg as funding remains unsecured; shares suspended from trading.
Roche Aktie fällt nach EU-Zulassung für Susvimo
Schweizer Pharmakonzern erhält grünes Licht für Augenmedikament in EU, doch Aktie reagiert mit Kursverlust
Novo Nordisk faces investor skepticism over pipeline diversification strategy
CEO Doustdar outlines plans to expand beyond diabetes and obesity but warns of patent cliff risks ahead of 2030
Worthington Enterprises Q1 Earnings Beat on Revenue Growth and Cash Flow Strength
The industrial company reported adjusted EPS of $0.82 and revenue of $344 million for fiscal Q1 2027, both topping forecasts, while free cash flow hit a company record.
NBPE Reports H1 2024 Earnings: Portfolio Returns and Buybacks Drive Gains
Net Asset Value (NAV) rose 1.9% in dollars and 3.4% in sterling, with buybacks and private equity portfolio performance key drivers.
Culp Reports Q1 Fiscal 2027 Growth Driven by Execution, Margin Expansion
Culp posted 6.5% sales growth and bedding segment gross margin of 13.6%, up 300 basis points, as the textile maker says earnings come from execution rather than market recovery.
Definium’s DT120 Shows Strong Phase III Results for GAD, MDD
Data from two GAD trials and one MDD study suggest efficacy without adjunctive therapy, with potential for FDA breakthrough designation.
Fortinet shares hit all-time high of $176.23 after earnings beat and AI acquisition
Fortinet stock rose to $176.23, its highest level, as revenue jumped 26% to $2.05 bn and the company announced the purchase of AI security firm Virtue AI. Analysts lifted price targets, with TD Cowen seeing $215.
Alliant Energy Shares Hit 52-Week Low After Earnings Miss
Alliant Energy dropped to 63.83 USD after posting a second-quarter earnings miss and disappointing revenue, prompting price-target cuts from Jefferies, BMO Capital, and Mizuho.
NBPE posts 4.2% NAV return on portfolio refresh through August
Neuberger Berman Private Equity Partners said net asset value rose to $28.13 as the fund returned $144 million to investors and deployed $164 million in new commitments year-to-date.
Pool Corp stock drops 47% to $165.21, hits 52-week low
Company reports Q2 2026 earnings but misses revenue expectations as analysts cut price targets amid broader market decline
Hub Group Stock Touched 52-Week Low as Nasdaq Compliance Risks Mount
Shares of the transportation and logistics firm fell to $31.37, down nearly 24% year-to-date, while accounting delays raise the prospect of a Nasdaq delisting.
Lemonade Shares Fall to 52‑Week Low of $46.12 Despite Q2 Revenue Beat
The insurtech’s stock touched its lowest level in a year after reporting second‑quarter 2026 revenue that beat estimates, while adjusted EBITDA loss narrowed and free cash flow remained positive.
Solidium reduces stake in Sampo to 3.55%, below 5% threshold
State-owned investor Solidium Oy cut its holding in Finnish insurer Sampo plc to 3.55% of shares and voting rights, down from just under 10% previously disclosed.
Helus Pharma’s HLP-003 Shows Promise in Phase III MDD Trial
The company’s deuterated psilocin candidate aims to advance to FDA filing by 2028, with early efficacy data supporting its adjunctive use in depression treatment.
General Mills Beats Q1 Estimates but Shares Slip on Share-Growth Concerns
General Mills reported Q1 adjusted EPS of $0.75 and revenue of $4.4 billion, topping estimates, but shares fell in premarket trading as management cautioned that dollar-share growth remains incomplete.
Atomo Diagnostics posts 41% revenue growth as FY2026 loss narrows
Australian diagnostic company Atomo reported AUD 5.3 million in revenue for FY2026, up 41% year-over-year, with OEM product sales surging more than 200% driven by the Lumos Diagnostics partnership.
Fonterra Beats Return Target in H2 2026, Eyes FY 2027 Guidance
The dairy cooperative reported that its return on capital exceeded the 10%–12% target range, citing strong stream returns and commodity tailwinds, while noting logistics challenges in the Middle East and plans for further investment.
Fonterra posts strong H2 2026, sees FY27 guidance hinge on stream returns
Fonterra reported FY26 return on capital above its 10%‑12% target, shares steady around $4.85, and said FY27 outlook depends on dairy stream return trends and shipping costs.
Elixirr AI Revenue Surges 185% as EBITDA Margin Tops 31% in H1 2026
Management consultant Elixirr reported H1 revenue of £89 million, up 25%, with adjusted EBITDA of £27.6 million. The London-listed firm saw AI-related income jump 185% year-over-year to roughly £8 million.
Elixirr H1 2026: AI revenue surges 185%, but valuation gap widens
London consultancy reports £89m revenue and strong AI growth, but says share price has not kept pace with sustained revenue outperformance versus the FTSE 100.
Alkami Board Reaffirms Independence, Full-Year Financial Guidance
The Dallas-based fintech company said its board unanimously concluded remaining independent best serves shareholders, while reaffirming FY revenue guidance of $528M–$531M and adjusted EBITDA of $96M–$98M.
Protolabs Robotics Revenue More Than Doubles in First Half 2026
Minneapolis-based Protolabs says robotics-customer revenue more than doubled in H1 2026 versus the prior-year period, as the global robotics market is projected to grow at a 20% compound annual rate through 2031.
ARK ETFs trade biotech stocks, sell Tempus AI, buy Scribe Therapeutics
On Sept. 23, 2026 ARK's thematic ETFs sold about $7 million of Tempus AI shares and added roughly $6 million of Scribe Therapeutics, Beam Therapeutics, Veracyte and other positions.
Aurora’s 2026 Investor Day: Driverless Trucks Scale on Dallas-Houston Route
Aurora Innovation Inc. showcased its autonomous trucking progress, including commercial deployments and fleet expansion plans, at its 2026 Analyst Day.
US Stocks Set for Weaker Open as Oil Reverses Slide
Futures point to a lower start for Wall Street as Brent and WTI recover from recent declines, while geopolitical risks from US-Iran and US-China talks linger.
US Futures Slip; Oil Bounces, SMI Erases Gains, Nvidia Pre-Market Down
Wall Street opens lower as oil stabilizes and geopolitical hopes offset by chip-sector pullback; SMI surrenders morning gains ahead of SNB decision.
AppLovin Stock Falls 3.5% Amid Edgewater Research Warning on Growth Stagnation
AppLovin’s shares declined 3.5% after analyst Joe Wittine from Edgewater Research downgraded the mobile ad platform’s outlook, citing slowed market share growth and intensifying competition.
E-Power Subsidiary Collects $9.2M for Battery Anode Design Phase
E-Power Inc.'s Chinese unit received a $9.2M payment, representing roughly 18% of a $51.2M turnkey contract for lithium-ion battery anode production lines.
XTEND Secures Phase III Contract for Special Operations Drones
XTEND announced it has been awarded a Phase III contract to supply special operations drones.
IM Cannabis Raises $1.31 Million in Registered Direct Offering
The medical cannabis company issued 655,000 common shares at $2.00 each, raising proceeds for working capital as it prepares to sell its German operations.
Aurora Cannabis files complaint over Curaleaf takeover bid
Aurora Cannabis has filed a complaint regarding Curaleaf's takeover bid, according to Investing.com.
Jayden Resources Closes Oversubscribed C$1M Private Placement
Vancouver-based mining firm raised C$1,030,614 by selling over 5.28 million units at C$0.195 each, exceeding its initial C$1 million target.
Stitch Fix Q4 2026 slides show transformation progress, FY27 concerns
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
Stitch Fix Q4 Earnings Beat on EPS, Shares Fall on Weak FY2027 Guidance
Stitch Fix reported a Q4 EPS beat and record revenue per active client, but shares tumbled as the company guided for lower FY2027 revenue and significantly reduced EBITDA outlook.
Abacus Founders Cancel Rule 10b5-1 Stock Sale Plans, Retain Shares
The three founders of Abacus Global Management terminated their pre‑arranged trading plans and decided to keep their current stakes in the NYSE‑listed firm. The move comes as they step back from day‑to‑day operations while remaining among the company’s largest shareholders.
Everpure reaffirms FY27 guidance, outlines FY28 outlook
Everpure kept FY27 revenue guidance at $5.03‑$5.07 bn and projected FY28 revenue of $7.0‑$7.3 bn, highlighting strategic growth areas and a capital‑management focus.
Capital Clean Energy Carriers Holds Annual Shareholder Meeting in Piraeus
The company re-elected seven directors, appointed Deloitte as auditor for 2026 and added former New York Chief Judge Janet DiFiore to its board.
First Merchants prices $100M subordinated notes offering
First Merchants Bank has priced a $100 million subordinated notes offering.
OceanaGold CEO Gerard Bond to Step Down in April 2027
Gerard Bond, OceanaGold president and CEO, will retire in the second quarter of 2027 after five years at the firm. Spencer Stuart has been engaged to lead the search for his successor.
Transoceanic chairman boosts stake to 19.43% with $390,000 share purchase
Fahad Al-Tamimi acquired 6 million shares at $0.065 each, pushing his ownership to nearly one-fifth of Transoceanic Investments.
TransUnion CFO Todd Cello to Step Down After 29 Years
TransUnion's chief financial officer Todd Cello is departing the company after nearly three decades with the credit reporting firm.
Runway Growth Finance starts unsecured notes offering
Runway Growth Finance has begun an unsecured notes offering, according to a company news release.
Auranova Resources Announces Private Placement for Up to C$4m
Auranova Resources said it is launching a private placement to raise up to C$4 million.
Minerals Technologies unveils rare earth, steel slag initiatives
Minerals Technologies announced new initiatives focused on rare earth materials and steel slag.
Lennar Announces $0.50 Quarterly Dividend for Both Share Classes
The homebuilder declared a $0.50 per-share dividend for its Class A and B common stock, effective for the third quarter of 2026.
Kontoor Brands Adds Two Directors, Expands Board to Nine
Kontoor Brands named former PepsiCo CFO Jamie Caulfield and Wingstop CEO Michael Skipworth to its board, raising director count from seven to nine.
GMEX Robotics Announces 1-for-9 Reverse Stock Split, Effective Sept. 28
The formerly Fitell Corp. shares will consolidate on the Nasdaq Capital Market next week; par value drops to $0.000001.
Viking Therapeutics Plans $400 Million Offering of Stock and Convertible Notes
The San Diego drugmaker said it will raise up to $400 million via a split public offering of common stock and convertible senior notes, with proceeds aimed at advancing its VK2735 and VK3019 programs.
Granite Point Mortgage approves 1-for-10 reverse stock split
The commercial mortgage REIT said its board approved a 1-for-10 reverse split effective Oct. 5, reducing outstanding shares from ~48.2M to ~4.8M as it explores strategic alternatives.
OpenText prices $1 billion senior secured notes offering
OpenText has priced a senior secured notes offering totaling $1 billion.
NWPX Infrastructure names John Schillie VP to oversee Texas water infrastructure operations
Schillie to lead Houston, San Antonio, Ferris facilities with 28 years in infrastructure, manufacturing and engineering
OGE Energy declares $0.42875 quarterly dividend
OGE Energy Corp. set a $0.42875 per share payout for the fourth quarter, with payment due Oct. 30 and a record date of Oct. 5.
Arq Highlights PFAS Initiative at Water Tower Research Virtual Conference
Arq discussed its PFAS strategy during the Water Tower Research Virtual Insights Conference, noting an improved outlook.
Sequans Communications receives NYSE noncompliance notice
The company disclosed that it has received a notice of noncompliance from the New York Stock Exchange.
European markets hold steady amid oil price focus
Indices show modest gains, with tech and retail sectors leading, while KI-driven valuations face scrutiny
Stoke Therapeutics Appoints Bo Cumbo to Board as Edward Kaye Retires
Stoke appoints Solid Biosciences CEO Cumbo to its board; former CEO Kaye steps down after eight years, with zorevunersen approval now eyed in early 2028.
MFA Financial declares $0.36 quarterly dividend per share
MFA Financial announced a quarterly dividend of $0.36 per share.
Park Dental adds Sapphire Dental Care to Arizona network
Park Dental has incorporated Sapphire Dental Care into its Arizona network.
Talos Energy appoints retired Air Force general to board
Energy company adds former military officer to its board of directors.
CooperCompanies Opens Global Innovation Hub, Unveils Product Pipeline
CooperCompanies announced the opening of a new global innovation hub and revealed an upcoming product pipeline.
Novo Resources presents drill catalysts, value case at precious metals summit
Novo Resources outlined upcoming drilling milestones and its investment thesis at a recent precious metals conference.
Teamshares secures $225M preferred equity investment from T. Rowe
Teamshares announced a $225 million preferred equity investment from T. Rowe.
Clarivate Announces Tender Offer Pricing for 2028 Notes
Clarivate has announced pricing for a tender offer related to its outstanding 2028 notes.
Alcoa Closes $2.6 Billion Senior Notes Offering
Alcoa has completed a senior notes offering of $2.6 billion, the company announced.
Wells Fargo chief risk officer to retire, COO to succeed him
Wells Fargo's chief risk officer will retire and be succeeded by the company's chief operating officer.
Oracle expands digital assets platform for banking operations
Oracle announced an expansion of its digital assets platform to support banking operations.
Heritage Insurance at Small-Cap Virtual Conference: turnaround deepens
Heritage Insurance addressed its deepening turnaround at a small-cap virtual conference, according to an Investing.com earnings call transcript.
Mosaic Minerals Raises $592K for Golden Island Gold Drilling
Mosaic Minerals closed its first tranche of a $592,031 private placement and outlined plans for at least 2,500m of drill testing at its Quebec gold project.
Huron Consulting at Sidoti Small-Cap Virtual Conference: Growth Stays Steady
Huron Consulting participated in the Sidoti small‑cap virtual conference and said its growth remains steady.
OceanFirst Financial Corp Stock Drops to 52-Week Low of 17.04 USD
Shares of OceanFirst Financial Corp touched a new 52-week low of 17.04 USD, according to Investing.com company news.
Alto Neuroscience Highlights Pramipexole-Ondansetron Combo for Treatment-Resistant Depression
Shares of ANRO fell 12% ahead of the TD Cowen summit where CEO Amit Etkin detailed the Phase IIb program ALTO-207 and its accelerated titration strategy for depression.
Orchid Island stock hits 52-week low at 5.96 USD
The share price of Orchid Island fell to its lowest level in the past year.
Rollins cites Google AI search shift for lead decline, maintains 6% organic growth guidance
Rollins Inc. told investors at the U.S. All Stars Conference that Google’s AI Overviews account for roughly half of its recent lead‑generation drop, but the pest‑control firm reaffirmed its full‑year 6% organic revenue growth target and a 10% incremental margin goal.
HUHUTECH reports 8.6% revenue growth, expands global operations
HUHUTECH International Group Inc. reported a 8.6% increase in total revenue to $10.67 million for the six months ended June 30, 2026, driven by growth in China and new markets in the United States, Germany, and Singapore.
Viasat wins $307M Marine Corps satellite services contract
Viasat has been awarded a $307 million contract to provide satellite services to the U.S. Marine Corps.
Tortoise Energy Infrastructure stock hits 52‑week low at 40.3 USD
Tortoise Energy Infrastructure shares fell to a 52‑week low of 40.3 USD, per Investing.com.
LB Pharmaceuticals Highlights lb-102 at TD Cowen Summit
LB Pharmaceuticals discussed its lb-102 candidate and its goal of safer psychiatric treatment at the TD Cowen summit.
Teamshares at Sidoti small-cap virtual conference: scaling a buy-and-build model
Teamshares discussed scaling its buy-and-build model at the Sidoti small-cap virtual conference.
Gevo highlights carbon stack at Water Tower conference
Gevo discussed its carbon stack and its positive impact on the company's outlook during the Water Tower Research Virtual Insights Conference.
Garanti BBVA Redeems EUR 30M MTN Issued in 2025
Turkish lender Garanti BBVA has completed redemption of a EUR 30 million medium-term note, originally issued abroad in September 2025.
Nvidia Trades at Decade-Low Valuation Despite Strong Growth Forecast
Nvidia shares trade at less than 17 times expected earnings, half the 2025 multiple, even as the company forecasts 90% revenue growth and 99% profit growth for fiscal 2027.
IonQ, Maplebear, Worthington Lead Premarket Moves
Shares of IonQ, Maplebear and Worthington Industries topped early movers ahead of the open on Wednesday, per CNBC's premarket watch.
Xenon Files Epilepsy Drug Bid, Pauses Psychiatry Programs on Safety Signals
Xenon Pharma submitted its first NDA for azetukalner in focal-onset seizures after strong Phase III data, while major depressive disorder and bipolar depression studies were halted following neuropsychiatric adverse events.
Target Declares $1.16 Quarterly Dividend, Marking 237th Consecutive Payout
Retailer raises payout to $1.16 per share with December 1 payment date; the quarterly distribution marks the company's 237th consecutive dividend since it went public in October 1967.
Surf Air Mobility signs second OperatorOS contract with SkyDance Air
Surf Air Mobility announced it has signed a second OperatorOS contract with SkyDance Air.
ING Raises 2027 Profit Targets on Revenue Growth, Cost Cuts
Dutch bank upgrades return-on-equity target to above 16% and lifts 2027 revenue guidance by EUR 1 billion, citing momentum in retail lending, mortgages, and wealth management.
Rapport Therapeutics at TD Cowen summit: bipolar data loom
Rapport Therapeutics presented at the TD Cowen summit, where upcoming bipolar disorder data were discussed.
United Therapeutics at Bernstein forum: growth bets widen
United Therapeutics discussed broader growth initiatives at a Bernstein forum, according to the earnings call transcript.
Pyrum shares rise 15% after H1 2026 earnings, lifts output guidance
The Swiss recycler reported a 37.6% revenue jump to EUR 1.7 million, announced higher 2026 output targets and disclosed a new plant contract in the Czech Republic.
Judges Scientific H1 2026 profit drops 66% as revenue falls 21%
The UK‑based buy‑and‑build group reported adjusted operating profit of £4.8 million for the six months to 30 June, down 66% year‑on‑year, while revenue slipped 21% to £55.7 million.
Judges Scientific H1 2026 profit falls 72% as orders recover
Judges Scientific reported a 72% decline in profit for the first half of 2026 while noting a recovery in orders.
MHD stock hits 52-week low at 10.65 USD
Finance Review Daily is tracking this developing story; further verified details were not immediately available.
British Smaller Companies VCT launches up to £40m share offer
The VCT announced a new share issue targeting up to £40 million for the 2026/27 tax year, with an optional £20 million over‑allotment and fees of 3% or 3.5% depending on the sales channel.
Cardiol Expands MAVERIC Phase III Trial to 150 Patients
Cardiol Therapeutics Inc. increased its MAVERIC phase III trial enrollment to 150 patients after the Steering Committee recommended the expansion, aiming to assess CardiolRx’s efficacy in reducing recurrent pericarditis.
Stifel upgrades Microsoft to Buy, lifts price target to $575
Stifel raised Microsoft to a Buy rating, increasing its price target to $575 and citing mid‑to‑upper‑teens revenue growth, Azure upside and a slowdown in AI spending.
JD Sports H1 FY27 slides: sales hold up but margins compress
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
DAX slips 0.5% to 25,460 as political uncertainty stalls recovery
The German DAX fell 0.5% to 25,460 points by midday, losing earlier gains and stalling at its 50‑day moving average. MDAX also slipped 0.4% to 31,400 amid mixed corporate moves and geopolitical concerns.
SThree Raises FY26 Profit Outlook Amid Q3 Revenue Recovery
Net fees fell 2% YoY in Q3 but improved sequentially, with U.S. and life sciences segments driving growth; share buyback and productivity gains support revised guidance.
European Stocks Hold Steady Ahead of US-China Talks
European equity markets traded cautiously Thursday as investors awaited clarity on US-China trade tensions, with the EuroStoxx 50 down 0.17% and the Swiss SMI flat.
Swiss Market Holds Steady Amid Mixed US Openings; UBS Regulatory Loss Weighs on Blue Chips
The Swiss Market Index (SMI) held near break-even, while UBS faced losses after a Ständerat ruling on stricter capital requirements. US markets opened mixed, with Nasdaq futures unchanged but Dow Jones and S&P 500 futures rising slightly.
General Mills Beats Q1 Earnings, Shares Rise on Stronger Than Expected Results
The snack and cereal giant reported adjusted earnings per share of $0.75, exceeding forecasts, while revenue surpassed expectations at $4.4 billion.
Silvia Repurchases 2.3% of Shares at Discount to NAV
Silvia, Inc. repurchased an additional 2.3% of its common stock outstanding at a discount to net asset value (NAV), continuing its buyback program since inception.
Oruka reports strong week-28 psoriasis data for ORKA-001
Phase 2a EVERLAST-A trial showed 71.4% of patients achieved complete clearance (PASI 100) with ORKA-001, while safety remained favorable with no injection-site reactions reported.
Biomea Fusion Abandons IPO Plans Amid Market Conditions
Biomea Fusion, a clinical-stage biotech focused on diabetes and obesity therapies, suspends its $30M+ S-3 shelf registration after determining current market conditions were not favorable for a public offering.
AC Immune Reports Positive Phase 2 Data for Parkinson's Immunotherapy ACI-7104
Swiss biotech AC Immune says all 25 patients on ACI-7104 developed target antibodies in its VacSYn trial, clearing a key step toward a phase 3 decision for early-stage Parkinson's disease.
Abasca files technical report for Loki graphite deposit in Canada
Abasca has submitted a technical report regarding its Loki graphite deposit in Canada.
Schweizer SMI knapp über Gewinnzone, UBS profitiert von Ständeratsentscheid
Der Schweizer Leitindex SMI bleibt am Mittwoch knapp über der Gewinnzone, während die UBS nach strengeren Eigenkapitalvorschriften des Ständerats profitiert. 11 von 20 SMI-Titeln verzeichneten Verluste, während US-Futures und globale Risikoströmungen uneinheitlich reagierten.
NIQ launches retail proximity targeting solution for advertisers
NIQ announced the launch of a retail proximity targeting solution aimed at advertisers.
CGI partners with D-Wave to offer quantum computing services
CGI and D-Wave have announced a partnership to provide quantum computing services, according to a company news report.
Teva at Bank of America Global Healthcare Conference: growth takes center stage
Teva highlighted growth initiatives during its presentation at the Bank of America Global Healthcare Conference.
AEVEX unveils Specter autonomous jet platform
AEVEX has introduced Specter, a new autonomous jet platform, according to company news coverage.
Boku Reports H1 2026 Growth, Stripe Partnership Highlights
Boku Inc. delivered 11% underlying revenue growth in H1 2026, with bundling surging 39% and a strategic Stripe partnership announced.
Peach Property Group Cuts Debt in Half, Beats Leverage Target on Track Early
The German-Swiss landlord reported a 25% rise in H1 adjusted EBITDA to EUR 30 million and cut total debt roughly in half, reaching its 2028 loan-to-value target two years ahead of schedule.
Garanti Bank Plans 150 Million Lira Warrant Offering
Turkish lender Garanti Bank has filed for a public issuance of 150 million Turkish lira in intermediary institution warrants, offering them to domestic investors.
Agilent Technologies reports 10% Q3 organic growth, expands margins
The life‑science tools maker posted 10%‑11% organic growth in Q3, lifted operating margin by over 100 basis points and set Q4 growth guidance of 5.2%‑6.2%.
Peach Property AG Posts HY 2026 Turnaround with EBITDA Up 25%
Gerald Klinck’s leadership drives revenue growth and debt reduction amid asset optimization efforts.
Peach Property cuts debt, halves vacancy rate in H1 2026 turnaround
Swiss-listed German landlord reports EUR 29.9m adjusted EBITDA, up 25%, as strategic portfolio shrinks to 80% of assets and LTV falls to 45.2%.
Schweizer SMI knapp in Gewinnzone, UBS-Regulierung bleibt zentraler Fokus
Der Schweizer Leitindex SMI bleibt am Mittwoch knapp über der Nulllinie, während die UBS nach Ständeratsentscheidung zulegen konnte. Tech-Werte dominieren die positiven Entwicklungen, während andere SMI-Titel unter Druck geraten.
Julius Bär strategist flips Galderma again; Swiss Life board sells biggest stake in years
A prominent Swiss equities strategist reversed course on SMI newcomer Galderma after being stopped out at a ~14% loss. Meanwhile, an unnamed Swiss Life supervisory-board member disclosed a ~4.7m CHF share sale.
Boku H1 2026 slides: 11% underlying revenue growth, Stripe partnership
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
Boku Posts 11% H1 Revenue Growth, Raises Full-Year Outlook on Strong Take Rates
Mobile payments company Boku reported underlying revenue of £66.5 million for the first half of 2026, driven by double-digit growth in digital wallets and local payment methods.
André Näpflin joins Inventx’s banking leadership
Swiss fintech Inventx promotes André Näpflin to head its banking division, effective November 1, with a phased transition starting October 1.
Ceres Power H1 2026 earnings call highlights gains from cost cuts and pipeline growth
The transcript shows Ceres Power reporting improved first-half 2026 results, citing cost reductions and an expanding project pipeline as key drivers.
JD Sports H1 2026 sales decline prompts stock drop as margins tighten
Organic sales fell 0.7% and operating profit dropped 19.5% year-on-year, while the company adjusted its full-year guidance amid a maturing retail market.
GSK Outlines £40B Revenue, 31% Margin Targets Amid Oncology Focus
GSK projects over £40 billion in sales by 2026, aiming for 7% annual revenue growth and a 31% EBIT margin, with oncology driving key pipeline advances and restructuring efforts.
Pollen Street Explores Strategic Options Including Going Private
Pollen Street is considering a range of strategic alternatives, among them the possibility of taking the company private.
Central Asia Metals court hearing adjourned to October 14
Finance Review Daily is tracking this developing story; further verified details were not immediately available.
Renishaw posts 14% revenue rise, 36% profit jump in H2 FY2026
Renishaw reported H2 FY2026 revenue of GBP 816 million, adjusted operating profit of GBP 153 million and lifted its dividend, while targeting 20% operating margin in FY2027.
Dax opens flat as political uncertainty weighs on German equities
Moderate gains from early trading failed to sustain, with oil prices offering limited support amid mixed geopolitical and domestic developments.
KWS SAAT Reports Resilient Margins as Sales Decline in FY 2025/26
German seedmaker posts €1.63 billion in sales, down 3%, but net income climbs 13% on FX gains and AgReliant deconsolidation. Shares fall 7.6%.
Swiss Market Index holds gains as UBS leads SMI; 8 of 20 SMI stocks advance
The Swiss SMI closed slightly above 14,000 points after UBS led gains, while regulatory uncertainty over its capital requirements weighed on the index.
KWS Shares Fall Nearly 8% as Organic Sales Miss Despite Margin Gains
German seedmaker KWS reported resilient adjusted EBITDA margins of 19.3% in fiscal 2025/26, but organic sales growth of minus 1% missed targets, sending shares down 7.76% to $72.50.
B&M European Value Retail Taps Ex-Tesco CFO Mike Iddon as Director
The value retailer has appointed Mike Iddon as an independent non-executive director, effective Jan. 4, 2027, adding a veteran of Tesco, New Look and Pets at Home to its board.
Triple Point Venture VCT announces 2p interim dividend
Triple Point Venture VCT Plc declared a 2 p per share interim dividend for its Venture Share Class shareholders, with payment expected around 16 December 2026.
Zuckerberg’s Muse speech amid Meta rally, oil prices dip as Iran talks gain momentum
Meta’s AI agent Muse propelled the company’s shares up by over 20% since its September 8 launch, while Brent crude fell below $100 per barrel. U.S.-Iran diplomacy showed signs of progress, and geopolitical tensions in the Middle East persisted.
GM Outlines 2026–2030 Growth Plan at JP Morgan Conference
General Motors expects robust cash flow, truck production and digital revenue expansion, with a $20B digital target by 2030.
Deutsche Bank CFO Highlights Revenue Shift, Wealth Growth Amid Strategy Adjustments
Deutsche Bank’s CFO underscored a 60% revenue shift toward non-investment banking divisions and EUR 60 billion in private banking asset inflows, while outlining capital targets and commercial real estate risk reductions.
Renalytix shifts year-end to December 31, extends reporting cycle
Precision medicine firm aligns financial reporting with operational goals, partners with Quest Diagnostics for kidney diagnostics platform
Solid Biosciences Eyes FDA Approval for Gene Therapy in Duchenne, Friedreich’s Ataxia
The biotech firm outlines clinical progress, regulatory milestones and platform expansion ahead of key FDA discussions in late 2026 and 2027.
KWS SAAT posts resilient FY 2025/26 results, shares drop 7.5%
The seed producer reported €1.63 bn in sales, €158 m net income and a €1.30 dividend per share, while its stock fell 7.5% after the earnings release.
AGF Management Sees Alternatives Drive Growth Amid CAD 75B AUM Expansion
CEO Judy Goldring highlights EBITDA leverage, AI adoption, and a focus on alternatives to bolster returns amid stable dividend policy.
U.S. Stock Futures Flat Ahead of Trump–Xi Summit as Iran Talks Lift Risk Sentiment
Wall Street futures held steady Tuesday night as investors weighed declining oil prices after U.S.–Iran meetings and tech strength driven by Meta's Muse AI agent, with eyes on Thursday's Washington summit.
FTSE 100 rises as U.S.-Iran diplomacy eases oil-price pressures
U.S. and Iranian envoys held a three-hour meeting in New York, lifting European stocks and pushing Brent crude below $99 a barrel.
Ampeak Energy appoints David Taaffe as CEO
Ampeak Energy announced David Taaffe will serve as its next chief executive officer.
Chip stocks rally in September: Arm, Intel, AMD among leaders
Arm, Intel, AMD and Marvell posted sharp September gains driven by strong data-center demand and AI supply deals, as ProPicks AI models flagged the names for continued outperformance.
Pacific Assets Trust Shares Suspended From London Trading
The London Stock Exchange has halted trading in Pacific Assets Trust while the suspension is in effect.
Airtel Money Plans London IPO Through Secondary Share Sale
The mobile money service is moving toward a London listing via a secondary share sale, according to company announcements.
TotalEnergies approves Ima gas field development in Nigeria
TotalEnergies has approved development of the Ima gas field in Nigeria.
Burger King Spain founder eyes bid to regain control of company
A report says the founder of Burger King Spain is reportedly planning a bid to take back control of the chain.
Pearson names three new non-executive directors for October board intake
Pearson appointed independent directors Michael Barkin and Vivek Sharma plus Cevian Capital partner Alex Svensson to its board effective Oct. 1, 2026.
Nexus Infrastructure Reports £70m Revenue, CEO to Step Down
UK infrastructure firm posts £70m in revenue as it announces an upcoming chief executive departure.
Aurrigo reports 19% revenue growth in first half of 2026
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
DAX Gains as Iran-U.S. Talks Ease Oil Price Concerns
Germany's benchmark index opened higher Thursday as falling Brent crude and record Nasdaq gains offset political uncertainty at home.
Judges Scientific CFO Brad Ormsby to leave in September 2027
Chief Financial Officer Brad Ormsby will step down on Sept 23, 2027 after a 12‑month notice, ending an 11‑year tenure at the scientific‑instrument group.
Lexicon Pharmaceuticals CEO Highlights Focus on Obesity and Cardiomyopathy Programs
Lexicon Pharmaceuticals reported share declines amid strategic emphasis on obesity and heart disease programs, including a $45M upfront deal with Novo Nordisk for its ACSL5 inhibitor.
Braveheart Bio Outlines Dual HCM Pipeline at Cantor Conference
CEO Travis Murdock highlights Phase II results for BHB-1893 in obstructive and non-obstructive hypertrophic cardiomyopathy, with Phase III trials and regulatory timelines in focus.
Adobe Beats Q3 Estimates, but Soft Q4 Outlook Dampens Shares
Adobe posted record Q3 results with $6.76 billion in revenue and $6.13 adjusted EPS, but flagged a revenue midpoint below consensus for Q4, sending shares down 2.7% in premarket trade.
Oracle Raises Profit Outlook After Beating Q1 Earnings on AI Cloud Demand
Oracle posted adjusted EPS of $1.92 vs $1.73 expected, booking more than $30 billion in new AI cloud contracts. The company raised its full-year profit forecast amid strong demand.
Trinity Industries Raises Quarterly Dividend to 31 Cents
Dallas-based rail equipment maker marks 250th consecutive dividend payment, raising the quarterly payout to $0.31 per share.
Aclaris Therapeutics Details Pipeline, Cash Runway at Cantor Fitzgerald Conference
The company says cash on hand funds programs through 2028. Top-line data for its ITK inhibitor in lichen planus is due in the second half of 2027.
Roche Nominates Former Takeda Chief Weber for Board Election
Pharmaceutical giant Roche has put forward Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to its board of directors at the upcoming spring general assembly.
Royal Caribbean to acquire 50% stake in Sandals Resorts for $3B
Royal Caribbean announced plans to purchase a half‑interest in Sandals Resorts for $3 billion.
Ionis and Roche announce positive Phase 3 results for kidney drug
Ionis and Roche said their Phase 3 trial for a kidney treatment yielded positive data.
Parallel49 Equity-affiliated holders launch $PMTS secondary offering
CPI Card Group stockholders linked to Parallel49 Equity are selling up to 2.34 million shares in an underwritten secondary offering; the company receives no proceeds.
Asian equities rise driven by tech and AI demand while oil prices soften on Middle East supply reports
Asian stock markets advanced as technology and artificial‑intelligence demand boosted equities, while oil prices fell following reports on Middle East supply.
SMI leicht vorab höher, UBS-Kapitalvorschriften und Ölpreis im Fokus
Schweizer Aktienmärkte zeigen leichte Gewinne vor dem Handel, während die US-Börsen uneinheitlich schließen und Ölpreise weiter sinken.
Trisura hits CAD 1B book value ahead of schedule at Scotiabank summit
Canadian specialty insurer reaches capital milestone 18 months early, outlines U.S. expansion and growth targets across surety, corporate insurance and programs lines.
Immunocore Reports $431M Revenue, $880M Cash as Clinical Trials Advance
Immunocore’s KIMMTRAK leads growth in oncology pipeline, with trials expanding into cutaneous and adjuvant melanoma, while cash reserves support strategic flexibility.
Immuneering Pancreatic Cancer Data Draws Cantor Healthcare Conference Attention
Shares of Immuneering (IMRX) gained focus as the company presented Phase II results for its MEK inhibitor atebimetinib showing a 104% improvement in median overall survival versus historical benchmark.
Empower India hits 5% upper circuit on acquisition of Valiance Engineers; other small‑cap stocks rally
Empower India surged to the 5% upper circuit at ₹2.48‑₹2.50 after agreeing to acquire Valiance Engineers in a cash‑free share swap. NHC Foods, Elitecon and A‑1 also posted upper‑circuit gains amid deal‑related news.
ADI Global Distribution Targets $80M in Savings as Tariff Benefits Reverse
The commercial security distributor raised its full-year margin outlook on tariff-related pricing gains but warned of an 80 basis-point headwind next year as benefits unwind.
ADI Global Distribution Posts Spin Reset Amid ERP Transition and Cost-Cutting Push
The company targets $80M in annual savings by 2027, leverages tariff benefits and e-commerce growth to drive organic revenue growth of 4%–6% through 2030.
Nick Clegg’s Nscale Flotation Could Boost His Portfolio by £30m
UK ex-politician Nick Clegg’s stake in AI datacentre startup Nscale may yield a £30m windfall with its planned US IPO, despite the company’s recent losses and a $14.6bn valuation from a prior funding round.
OC Oerlikon Shares Hit Three-Year High on Growth Targets
Industrial group posts 5.5% gain as analysts upgrade outlook following capital markets day strategy update.
RBC Upgrades Zurich Insurance to Outperform, Sets CHF 650 Target
Canadian bank raises view on insurer citing Beazley acquisition and capital return plans from recent strategy update.
Amer Sports Stock Falls to 52‑Week Low of $27.31
The Finnish sporting goods maker’s shares dropped 25.8% over the past year and 25.7% year‑to‑date, even as several brokerages maintained Buy or Overweight ratings citing strong second‑quarter sales and growth prospects.
Hillman Solutions Corp shares slip to 52‑week low of $6.96 after Q2 beat
The stock’s decline comes despite a second‑quarter earnings beat and a raised full‑year outlook, with the company also announcing a $315 million acquisition to bolster its industrial segment.
First Citizens BancShares Preferred Series C Stock Falls to 52‑Week Low Near $20
The preferred shares hit a 52‑week low of $19.94, down 11.2% over the past year, while the bank reported second‑quarter adjusted net income of $691 million and a dividend yield of 7.0%.
Constellation to buy Rhode Island gas plant for $715M
Acquisition to bolster New England power portfolio, expected to boost earnings immediately.
Arch Capital Group ADR Hits 52-Week Low at $18.70
The insurer's ADR fell to its lowest level in a year, slipping nearly 15% over 12 months despite a dividend yield above 7%, as selling pressure pushes the stock into oversold territory.
No premarket stock move details provided in source
The supplied source contains only boilerplate text and lacks any substantive data on premarket movements for Netflix, Nucor, Xenon Pharmaceuticals or other equities.
Nasdaq hits record close as AI valuation and corporate developments draw attention
The Nasdaq index closed at a new record level, with focus on AI valuations and corporate developments.
Arvinas Highlights Pipeline at Cantor Fitzgerald Healthcare Conference
Arvinas discusses its clinical pipeline and strategic partnerships at the 12th Annual Cantor Fitzgerald Global Healthcare Conference, emphasizing its focus on degrader programs and commercialization efforts.
Definity Financial lifts growth after Travelers Canada integration
Definity Financial said the CAD 3.3 billion Travelers Canada deal boosted its market rank to No. 4 in Canada’s P&C sector and drove 35% first‑half revenue growth, while keeping full‑year revenue near CAD 6.5 billion.
Optima Health Shareholders Approve All Resolutions at AGM
Optima Health plc (AIM: OPT) secured full shareholder approval at its annual general meeting on September 22, 2026, following the March acquisition of PAM Healthcare.
Bernstein lifts Siegfried price target to CHF 140, sees potential stock double
Bernstein raised its target price for Swiss pharma contract manufacturer Siegfried to at least CHF 140 from CHF 126, keeping an Outperform rating as the company expands US API capacity.
Swiss Market Rebounds Amid KI, Oil and Fed Uncertainty
Defensive sectors lead gains as SMI recovers 0.7% but smaller caps and tech stocks underperform.
AdvancedAdvT buys back 243,453 shares in latest tranche
AIM-listed AdvancedAdvT acquired another tranche of shares between Sept. 7-11 at 175.200p-177.500p, bringing total repurchases under its programme to over 6.1 million.
SentinelOne Raises Full-Year Outlook After Q2 Beat, Cites AI Security Momentum
Cybersecurity firm posts strong quarterly results and raises guidance as AI-focused products Prompt Security and Purple AI triple year-over-year ARR.
FTI Consulting stock dips to $137.23 amid revenue miss and EPS shortfall
FTI Consulting Inc. reached a 52-week low at $137.23, reflecting a 12.79% one-year decline and a P/E ratio of 16.6.
Host Digital Lists on NYSE American with AI Data Center Expansion Plans
The company debuts on the NYSE American under the ticker HOST, securing a second data center site to bolster its AI infrastructure portfolio.
Biomea Fusion Launches Public Offering of Common Stock and Pre-Funded Warrants
The diabetes and obesity drug developer announced an underwritten public offering of common stock and pre-funded warrants, with an option for the underwriter to purchase up to 15% more.
Spire Global wins $33.2 million NOAA satellite data contract
Spire Global has been awarded a $33.2 million contract by NOAA for satellite data.
GE HealthCare Appoints AT&T CFO Pascal Desroches to Board
GE HealthCare named AT&T Senior EVP and CFO Pascal Desroches to its board effective Jan. 4, 2027. Desroches brings decades of finance and governance experience from AT&T, WarnerMedia, and Honeywell.
Shoe Station Group declares $0.17 quarterly dividend
Retailer announces cash payout of $0.17 per share with October payment date, maintaining its quarterly distribution program.
StubHub Stock Drops to $5.73 as Analysts Revise Downwards
StubHub Inc. reached a 52-week low of $5.73 amid declining analyst targets and mixed revenue growth.
JOYY Stock Reaches 52-Week High at $80.94
Joyy Inc. hit a 52-week high of $80.94, closing at $81.05 after a strong Q2 2026 earnings report.
Prairie Operating’s Valuation Gap Widens Amid 2026 Guidance
CEO Greg Patton discusses production targets and regulatory hurdles as the company’s market valuation diverges from its asset base.
Cathie Wood’s ARK sells Alphabet stock, buys Rocket Lab
ARK Investment Management has sold shares of Alphabet and added Rocket Lab to its portfolio, according to a recent filing.
BWX Technologies Hits 52-Week Low as Stock Drops Nearly 26% Over Six Months
Shares of the nuclear technology firm fell to $144.06, marking its lowest level in a year despite ongoing analyst support and a U.S. Army contract for advanced reactor technology.
Italian Wine Brands Posts Lower H1 Profit on Margin Squeeze
Italian Wine Brands reported H1 2026 revenue of €175.3m, down 5.3%, with EBITDA margin contracting to 10.9% despite a premium-product push and debt reduction.
Karman Holdings Stock Falls to 52-Week Low at $33.99
Shares of Karman Holdings tumbled to a 52-week low as short-seller JCap raised valuation concerns, despite strong quarterly revenue growth and an increased full-year outlook.
CareDx Stock Hits 52-Week High as Q2 Results Surpass Estimates
CareDx shares touched $55.21 after reporting Q2 adjusted EPS of $0.37 vs. $0.23 expected and revenue of $131.9M beating expectations, driven by 61% testing revenue growth.
Cloudflare Stock Surges to All-Time High as AI Demand Fuels Rally
Cloudflare hit $353.04, lifting its market cap to $125 billion. Analysts cite 36% revenue growth and strong AI product momentum, though some flag the stock as overvalued.
US Markets Mixed as Nasdaq Hits Second Straight Record, Oil Retreats
The Nasdaq extended its record streak to two sessions, fueled by Meta's AI success, while crude oil fell on Iran-Hormuz negotiations and a looming US-China summit dampened energy demand fears.
Roche Obesity Drug Candidate Clears Phase-2 Study, Paving Way for Phase 3
Enicepatid met its primary endpoints in a Phase 2 trial, lowering blood sugar by 2.65% and body weight by 15.5% over 48 weeks in patients with type-2 diabetes.
GoodVision AI Secures $30M Forward Purchase Agreement
GoodVision AI announced it has secured a forward purchase agreement worth $30 million.
PIMCO Corporate & Income Opportunity Fund Hits 52‑Week Low at $11.13
The fund’s shares fell to their lowest level in a year, extending a 1‑year decline of 22.47% while maintaining a 24‑year streak of dividend payments.
Opko Health shares hit 52‑week high of $1.74
The stock rose to $1.74, up 34% year‑to‑date, after Q2 2026 results beat forecasts and posted a loss of $0.01 per share.
Mortimer BTL 2023-1 Redeems £415M in Notes, Delists From London Stock Exchange
The structured product issuer called in approximately £415 million across six classes of notes ahead of their December 2056 maturity and requested immediate delisting from the LSE.
Elanco Reports 10% Growth, Outlines Multi-Year Margin Expansion Plan
Animal-health company targeting ~2x leverage by end of 2025 as CEO flags pipeline strength and sustained price-volumegrowth.
MillerKnoll Q1 EPS Beating Estimates, Revenue Misses as Tariff Refunds Boost Margins
Furniture maker reported adjusted EPS of $0.53 vs. $0.35 expected, with tariff refunds adding $0.11 per share to results. Revenue of $923M missed forecasts.
SuperCom wins Indiana monitoring contract, enters 21st state
SuperCom has secured a monitoring contract in Indiana, marking its entry into a 21st state.
Digitalbridge Stock Hits 52-Week High at $15.99
Digitalbridge Group shares reached a one-year peak on Wednesday, climbing 29% over the past year as analysts project growth and profitability ahead.
Apple Stock Hits Record High of $344.94 Amid Mixed iPhone 18 Feedback
Apple’s shares climbed to an all‑time high of $344.94, pushing its market capitalization above $5 trillion. Analysts offered divergent views on the iPhone 18 line, while over 1,600 Italian store employees struck during the launch.
Omeros Stock Hits 52-Week High at $19.75, Eyes $22 Target After Strong Quarter
Omeros Corporation's shares touched a new 52-week high of $19.75, buoyed by second-quarter results that crushed estimates and the successful launch of its newly approved drug Yartemlea.
RingCentral Stock Hits 52-Week High as Earnings, Analyst Upgrades Fuel Rally
RingCentral shares touched $78.21, up 153% over the past year, after Q2 earnings beat expectations and RBC Capital and Needham raised price targets to $85.
MillerKnoll Q1 EPS Beats on Margin Expansion, Lowers Full-Year Sales Outlook
Furniture maker MillerKnoll reported adjusted EPS of $0.53 vs. $0.35 consensus as tariff refunds and pricing helped offset a 3.4% sales decline; it trimmed full-year revenue guidance.
L3Harris Stock Drops to $244.75 Low Amid Earnings Beat and Investor Caution
L3Harris Technologies’ shares fell to a 52-week low of $244.75 despite strong second-quarter 2026 earnings, as concerns over future growth and capital spending weighed on investor sentiment.
Natera Hits Record $373.58 on Q2 Revenue Beat
Shares of the genetic testing firm surged to a record after second-quarter revenue topped forecasts, fueling a sharp rally.
HighPeak Energy Focuses on Debt Paydown as CapEx Drops Below $300 Million
Oil producer cuts capital spending from over $1 billion to well under $300 million, targeting $8–$9 per share in value relocation from debt to equity at its Water Tower Research conference.
Blackrock Muni Target Term stock hits 52-week low at 22.04 USD
Blackrock Muni Target Term share fell to a 52‑week low of 22.04 USD.
FDA Extends Fee Waivers for Jaguar Health’s Two Drugs
San Francisco-based Jaguar Health Inc. secured PDUFA and veterinary medicine fee waivers for two drugs, covering fiscal 2027.
Laredo Oil signs LOI for Argentina project using gravity drainage tech
Texas-based energy developer said it will evaluate deploying its proprietary Underground Gravity Drainage technology in selected Argentine fields.
CrowdStrike Stock Rises to All-Time High of $250.36 on AI Cybersecurity Optimism
Shares of the cybersecurity firm hit a record as analysts cite accelerating revenue growth and expanding demand for AI-driven security solutions.
Kroger outlines AI strategy at GroceryShop conference
Kroger presented its AI strategy at the GroceryShop conference, according to a company news release.
Zions Bancorporation ADR Hits 52-Week Low at $17.66
Shares of Zions Bancorporation drop to their lowest level in a year, extending a 20% annual decline while a P/E of 8.15 and dividend yield above 6% draw valuations attention.
Nasdaq hits a new record close powered by ongoing artificial intelligence trade momentum
The Nasdaq closed at a record high, driven by continued artificial intelligence trade momentum.
Analog Devices Sees Strong Growth Amid Cyclical Recovery
Analog Devices (ADI) highlighted robust revenue growth and strategic acquisitions at J.P. Morgan’s 2026 U.S. All Stars Conference, projecting further expansion in 2025 and beyond.
Barclays Projects £8.2bn UK NII for 2026, Sees 20pc+ ROTE in US Consumer Bank
The lender expects group net interest income to reach £13.7bn for the fifth straight year, while deploying most of its £30bn business-growth RWA target and returning £9bn via buybacks in H1.
Thermal Energy International posts record FY2026 earnings, shares up 6.25%
The company reported CAD 33.9 million in revenue for fiscal 2026, a 13% year‑over-year increase, and posted net income of CAD 1.34 million. Shares rose 6.25% to close at CAD 0.17 following the earnings call.
DAVIDsTEA Q2 Fiscal 2026: Canadian sales up 5.5%, gross margin hits record 61.9%
Revenue growth and improved margins offset U.S. sales decline and higher expenses, as the tea retailer expands its Canadian footprint and optimizes fulfillment costs.
Oxford Biomedica Shares Rise After Missed H1 Results as Backlog Strengthens
Oxford Biomedica reported a wider-than-expected loss and missed H1 forecasts, but shares rose 2% as contracted revenue and full-year guidance held firm.
Frankfurt Stocks Rebound as Oil Prices Retreat From Middle East Tensions
Falling crude eased inflation worries and lifted the DAX 0.6% to 25,739; the MDax gained 1.7% to 31,764 amid geopolitical developments and strong US tech gains.
US Stocks Expected to Hold Gains, Oil Price Support Seen
US stock indices are likely to maintain their gains from Monday, with falling oil prices providing support. The Nasdaq 100 is close to its record high, while the Dow Jones Industrial Average is expected to rise slightly.
European stocks climb as oil prices fall, M&A buzz lifts Evonik
Fallen crude prices and Middle East diplomacy boost European equities, while KI enthusiasm and takeover speculation add further gains.
On surges on buyback and guidance; US markets edge higher ahead of earnings
US futures opened narrowly; Swiss SMI rose 0.4%. On lifted 6% on a $1B buyback and 2029 revenue target of at least CHF 5.6bn.
FDA Approves Phase 2 Trial for Palisade Bio's Crohn's Disease Drug
Palisade Bio's PDE4 inhibitor prodrug, PALI-2108, advances to Phase 2 trial for moderate to severe Crohn's disease, with first patient dosing targeted for Q1 2027.
FDA Demands Survival Trial for Compass’ Tovecimig in BTC Cancer
Compass Therapeutics faces FDA push for an additional survival study before seeking approval of tovecimig in advanced biliary tract cancer, despite existing Phase 2/3 trial results.
Nativo Resources Reports Progress at Peru Gold Operations
The Perth-based explorer said surface sampling confirmed high-grade gold mineralization at its Bonanza mine and secured project finance for the La Patona processing plant in its half-year results.
Mizuho Ups Meta Price Target to $750, Sees Bull Case Playing Out
Mizuho analyst Lloyd Walmsley raises Meta's price target to $750, citing rapid growth of Muse AI agent and upcoming Meta Connect event as evidence of a bullish outlook.
Standard Chartered CEO Highlights Growth, AI Push Amid Caution at Bank of America Conference
Bill Winters outlines strategic priorities, including AI-driven efficiency and risk management, while maintaining income growth targets and operational resilience.
Aprea Therapeutics to present APR-1051 Phase 1 data at Barcelona symposium
Aprea Therapeutics (NASDAQ: APRE) will share interim Phase 1 results of its WEE1 inhibitor APR-1051 at the EORTC‑NCI‑AACR symposium in Barcelona on Nov 20, 2026.
Playtech COO Acquires 110,806 Shares via Options Exercise
Shimon Akad, COO of Playtech plc, exercised options to acquire 110,806 shares on September 17, 2024, under the Playtech Long Term Incentive Plan 2022.
Nuburu aims to close 70% Tekne acquisition by early October 2026
Nuburu announced it will acquire a controlling 70% stake in Italian defence firm Tekne S.p.A., targeting completion in early October 2026 after receiving Golden Power clearance and providing €7 million toward the €9 million closing requirement.
UBS Shares Fall as Capital Rules Weigh on Margins and Q2 Earnings Miss
UBS Group reported Q2 EPS of $0.87, below consensus, as proposed Swiss capital requirements threaten to cut earnings by up to 10%.
Evonik shares jump 4.8% on BASF merger talk reports
Evonik stock rose nearly 5% after media cited Dealreporter and Mergermarket reports of BASF discussions on a possible transaction, while the firm continues its restructuring plan.
Roche reports strong Phase II data for diabetes drug Enicepatide
Roche's Phase II trial of Enicepatide showed HbA1c drops of up to 4.13 points and 15.5% weight loss in Type 2 diabetes patients, clearing the way for Phase III start in 2027.
Valion Bio regains Nasdaq $1 bid price compliance
Valion Bio received written notice from Nasdaq confirming it met the $1 minimum bid price requirement after its shares closed at $2.38, up 12.26%, on Sep 21.
Enlivex Ends $200M+ Private Placement After Rain Foundation Deal Termination
Enlivex Ltd. (ENLV) halted a planned $66.7M share sale to Rain Foundation, citing shareholder approval failure and exercising termination rights under the agreement.
Scynexis Names Former Akebia Chief Medical Officer to Its Board
The clinical-stage biotech has added Steven K. Burke, currently SVP and chief research and development officer at Akebia Therapeutics, to its board of directors effective Sept. 18.
PDS Biotech Reports 39.3-Month Median Survival in HPV16 Head-and-Neck Cancer Trial
The Phase 2 VERSATILE-002 study showed a median overall survival of 39.3 months for patients with HPV16-positive recurrent or metastatic head and neck squamous cell carcinoma who were naïve to checkpoint inhibitors and had PD-L1 CPS ≥1. The combination of PDS0101 and pembrolizumab yielded an objective response rate of 36% with a manageable safety profile.
Here Group Q4 Loss Widens as Revenue Doubles, Stock Slumps
Here Group reported Q4 revenue more than doubled to CNY 127.7 million but posted a wider net loss of CNY 169.6 million, weighed down by a CNY 124.1 million goodwill impairment tied to its Fastone acquisition.
Electra AI signs multiple commercial deals ahead of Nasdaq listing
Electra AI, valued at about $250 million, announced a series of partnerships with D‑Orbit, Naoris Quantum, Propel Industries, Omega Seiki, MinTech and Mooving as it prepares for a Nasdaq debut via a SPAC merger with Iron Horse Acquisition II.
CNSide Diagnostics signs in‑network agreement with Blue Cross Blue Shield of Michigan
CNSide Diagnostics, a Cerenome subsidiary, will provide its CSF tumor cell assay to Blue Cross Blue Shield of Michigan, expanding coverage to about 158 million lives.
US-Märkte vor Eröffnung ohne klare Richtung: SMI gedämpft, UBS unter Druck
Schweizer Aktienindex leidet unter globaler Unsicherheit; UBS fällt unter Regulierungsfragen, während On-Aktien durch Wachstumsprognosen und Rückkaufprogramm unterstützt werden.
Beta Bionics and Senseonics Partner on Glucose Monitoring Integration
Beta Bionics Inc. and Senseonics have partnered to integrate their automated insulin delivery systems with the Eversense 365 continuous glucose monitoring system, expected to launch in Q4 2026.
Greenbrier Secures $600M Railcar Order from Saudi Railway
The Greenbrier Companies secured 3,400 railcar orders valued at $600 million, including a significant Saudi Railway deal for tank cars and intermodal units.
Borsa Istanbul to drop over a quarter of BIST-100 constituents
More than 25% of the stocks currently in Turkey's BIST-100 benchmark will be removed next month as the exchange tightens eligibility rules, without citing a specific trigger.
CollPlant Regains Nasdaq Compliance After Share Price Dips Below $1
The Rehovot-based biotech firm restored its Nasdaq listing after its shares closed at or above the $1 minimum for 10 consecutive business days.
Arrive AI to Showcase Autonomous Delivery Tech at Investor Event
The Indiana-based logistics firm will demonstrate its Arrive Point network, AMR handoff system, and simulated drone deliveries during a virtual investor event Wednesday.
Wave Life Sciences appoints Monika Vnuk as chief business officer
Wave Life Sciences has appointed Monika Vnuk to the role of chief business officer.
Lantern Pharma Secures Patent for LP-284 Cancer Drug
USPTO grants Notice of Allowance for LP-284, targeting mantle cell lymphoma and double-hit lymphoma, with broader claims covering combination therapies and a 2042 patent expiry.
BBVA CEO highlights 22.2% ROTE and strong Mexico growth at BofA conference
BBVA reported a 22.2% first‑half return on tangible equity, 62% loan‑book expansion since 2021 and a surge in digital customers in Mexico, while warning of higher inflation and rates in Turkey.
Alibaba, Quest Diagnostics, On Holding, GameStop Lead Premarket Moves
Shares of Alibaba, Quest Diagnostics, On Holding and GameStop are among the standout movers ahead of the opening bell on Tuesday.
Bruker Raises Full-Year Outlook on Stronger Mix, Margin Expansion
Bruker upgraded its full-year guidance at the BofA healthcare conference, citing an improving revenue mix toward higher-margin instruments and aftermarket services, and expecting at least 250 basis points of operating margin expansion in fiscal 2026.
Pfizer at U.S. All Stars Conference: growth shifts beyond covid
Pfizer discussed at the U.S. All Stars Conference how its growth is shifting beyond covid, according to a transcript of the remarks.
IDEAYA Biosciences Shares Drop Amid 2026 Pipeline Updates at Citigroup Summit
IDEAYA Biosciences reported progress on its oncology pipeline, including regulatory milestones for Darovasertib and IDE849, amid a market cap of $3.66 billion and a 55% year-to-date return.
ProMIS Neurosciences presents interim Alzheimer's data at Moody Capital; shares climb
ProMIS reported zero ARIA-E and a 15% p-tau217 drop in its PMN310 interim safety analysis at the Moody Capital conference, sending shares up nearly 8%.
Arm Holdings Surges 17% on 'Off-the-Charts' AI Chip Demand
Semiconductor architect reports 22.8% revenue growth and targets $2 billion in AGI CPU business as AI-driven chip demand accelerates.
Santacruz Silver Completes $14M Bolivia Mill Acquisition
Santacruz Silver Mining has completed its acquisition of a 500-tonne-per-day milling facility in Bolivia, adding processing capacity near its Reserva mine.
GoldQuest Mining appoints Martin Wafforn to board of directors
GoldQuest Mining announced the appointment of Martin Wafforn to its board of directors.
iShares to Wind Down iBonds Dec 2026 Corp ETF
BlackRock's fixed-income ETF will cease trading Dec. 23 and redeem all shares compulsorily, with payments expected Jan. 7, 2027.
Playtech raises €350m via senior secured notes due 2031
The gaming technology firm secured a €350 million bond offering as it expands financing ahead of global expansion plans.
Merck’s Winrevair gains FDA approval with 76% risk reduction in PAH clinical trial
Updated labeling reflects Phase 3 HYPERION trial showing 76% lower risk of worsening events for newly diagnosed pulmonary arterial hypertension patients on sotatercept-csrk.
Kainos Group Shareholders Approve All AGM Resolutions
Belfast-based Kainos Group plc secured unanimous support for key resolutions at its annual general meeting, including financial approvals and director elections.
Endeavour Silver halts ball mill at Guanacevi Mine
Endeavour Silver Corp. suspends primary ball mill at Guanacevi Mine due to mechanical issue, expects repair in three weeks with minimal cost impact.
Pentair Names Bob Hau as CFO, Effective November 1
Bob Hau joins as executive vice president and CFO, succeeding interim CFO Bob Fishman with a focus on driving financial performance and shareholder value.
Zillow Sees Growth Broadening Amid Flat Housing Market Outlook
Zillow executives outlined mid-cycle targets of $5 billion in revenue and 45% EBITDA margins, projecting mid-teens growth even as the housing market remains depressed at roughly 4 million annual sales.
Credo raises FY2027 revenue growth outlook to 85% on optical demand
The AI connectivity company guided its optics revenue target at $600 million and projected accelerating quarterly growth toward a potential billion-dollar quarter by early FY2028.
Alector CEO Highlights Brain-Shuttle Pipeline Amid Alzheimer’s Focus
Alector’s Dr. Arnon Rosenthal outlines Phase I plans for AL137 and preclinical data for tau and alpha-synuclein siRNA programs at Cantor Healthcare Conference.
AbbVie Declares $1.73 Quarterly Dividend; Marks Over 330% Increase Since Inception
AbbVie Inc. announced a quarterly cash dividend of $1.73 per share, part of a payout trajectory that has risen more than 330% since the company launched in 2013.
W.P. Carey raises quarterly dividend to $0.95 per share
The REIT increased its quarterly cash payout to $0.950, an annualized $3.80, with payment set for Oct. 15. The company now owns 1,748 net‑lease properties covering about 188 million sq ft.
AL Sydbank Announces Week 37 Share Buyback for DKK 22.8m
The bank executed 33,000 shares in Week 37 under a DKK 1.1bn buyback program, reducing its share capital by 1.34% through purchases averaging DKK 693 per share.
Boston Beer Co. Shifts Focus to Premium Growth, Innovation Amid Stock Decline
The company highlights Sun Cruiser’s rapid sales growth and supply chain efficiencies, while addressing declining stock performance and shifting ad spend toward high-impact initiatives.
Recruit Holdings Boosts Efficiency with AI-Driven Hiring Model
Recruit Holdings CEO highlights AI’s role in reshaping hiring costs and efficiency amid labor market pressures, as the company targets higher margins and global expansion.
Galantas Gold exercises 25,000 warrants at C$0.12 ahead of AIM listing
The company said it will seek admission of the newly issued shares on the London Stock Exchange's AIM market around Sept. 18.
Olema Oncology Delays Palazestrant Data, Details Pipeline Timelines at Citi Summit
The biotech pushed top-line OPERA-01 results to Q1 2027 and outlined market opportunities of up to $10 billion-plus for its breast cancer assets.
BioMarin Sees VOXZOGO on Track for $1B in 2026 Sales at Citi Summit
BioMarin's CEO highlighted strong VOXZOGO momentum and a broadening pipeline at the Citi Biopharma Back to School Summit, projecting $1.0B–$1.05B in full-year revenue.
Arista projects 40% revenue rise, AI mix to drive 2028 scale‑up revenue
Arista Networks forecasts $12.6 bn revenue for 2025, 62‑64% gross margins and zero scale‑up Ethernet revenue in 2026, with AI‑driven sales expected to start in 2028.
Corvus Pharmaceuticals expands pipeline bets on Soquelitinib at Cantor conference
The clinical-stage biotech outlined progress across cancer and immune indications for its oral ITK inhibitor, citing $214M cash and a runway through mid-2028.
CNO Financial Raises ROE Target, Backs $170M Tech Overhaul at KBW Conference
Insurance maker raises return-on-equity target to mid-teens and announced a $170 million three-year technology investment as broker-dealer assets hit $19 billion.
ANI Pharmaceuticals Sees Rare Disease Focus Drive Revenue to $1.1B+ in 2026
Cortrophin Gel and ILUVIEN lead growth amid $100M share buyback and $266M Q2 2026 earnings
Amcor Raises Full-Year Free-Cash-Flow View After Strong Synergy Capture
Packaging maker Amcor reported year-one synergy gains of $285 million against a $260 million target and trimmed its FCF outlook to about $1.3 billion as working-capital investment weighs on results.
Holcim Aktie: Technische Erholung und geopolitische Chancen
Die Aktie von Holcim erholt sich nach einem Rückgang und zeigt erneut Potenzial für kurzfristige Kursgewinne, getrieben durch geopolitische Entwicklungen und die Baubranche.
US equities retreat as Brent crude hits 107 USD, Fed focus intensifies
Wall Street declines further amid Brent crude’s 107 USD peak and inflation concerns, with tech and mining sectors hardest hit
Europäische Aktien unter Druck: Schwäche vor Fed-Zinsentscheidung und Energie-KI-Konflikt
Europäische Indizes verlieren weiter an Wert, getrieben durch Erwartungen an eine Fed-Zinserhöhung und steigende Energiepreise, während KI-Investitionen neue Kapazitätsengpässe erzeugen.
Apple iPhone 18 lead times improve globally, but Pro Max demand persists
JPMorgan notes shorter delivery windows for iPhone 18 models compared to the iPhone 17 series, with regional variations and cautious optimism for foldable phone adoption in China.
TSX Drops to Five-Week Low as Oil Surge and US Inflation Data Weigh on Markets
Oil prices rise but inflation data and Federal Reserve watch loom as Canadian and global equities face pressure.
RB Global Shares Drop to 52-Week Low Despite Quarterly Beat
RB Global hit a 52-week low around $80.62 even as Q2 revenue beat estimates; adjusted EPS missed, dragging shares down nearly 32% over the year.
Danaos Stock Hits 52-Week High as Q2 Earnings Beat
Danaos Corp shares reached $155.89, their highest level in a year, after second-quarter results beat estimates on stronger dry bulk rates and lower interest costs.
Frankfurt opens lower as oil surge and AI fears weigh on Europe's benchmark
Germany's DAX slipped 0.5% to 25,431 and the MDAX fell 1.1% on Monday morning, pressured by rising oil prices from Middle East tensions and new warnings about artificial intelligence risks.
Newron reports first-half loss amid Evenamide R&D surge
Revenue and R&D costs rise sharply as biopharma firm focuses on schizophrenia candidate
Swiss Market Slides as SMI Dips 0.16% Amid Mixed Sector Performance
Industrial shares OC Oerlikon and Reiter gain, while Novartis and UBS underperform; analyst upgrades and downgrades dominate Swiss equities.
U.S. Stock Futures Steady After AI Rally Lifts Wall St; China Summit in Focus
Futures flat as markets digest Monday's AI-fueled rally pushing the Nasdaq to a record close, while investors await Xi-Trump talks and developments on oil.
Seed Capital Solutions reports £92,600 loss, launches fundraising
London-listed Seed Capital Solutions posted a half-year loss of £92,600 and has cash of just £10,900 after a proposed Spanish acquisition fell through, prompting a share fundraising.
Forterra Non-Executive Director Gavin Hill Buys £40,030 Stake
Gavin Hill purchased 28,944 ordinary shares at £1.383 each, with his total beneficial holding now standing at 28,944 shares.
Swiss stocks start week higher as Galderma added to blue-chip index
Swiss equities opened the week on a positive note after Galderma was added to the SIX Swiss Exchange blue‑chip index.
RBC Downgrades LVMH, Cuts Price Target to €475 on Luxury Weakness
RBC Capital Markets lowered its rating on LVMH to sector perform and trimmed its 12-month target to €475, citing softening luxury demand and margin pressure ahead of third-quarter results.
Metlen invests €25m to expand recycled aluminium capacity
Metlen has committed €25 million to increasing its recycled aluminium capacity, according to a company news report.
Talisman Metals appoints two senior geologists
London‑listed Talisman Metals PLC announced the hiring of Vernon Shein as Lead Geologist and Driss El Bouhli as Country Manager/Senior Geologist, while confirming its September drill program continues.
Corvex Requests Shareholder Vote for Whitbread Board Seat
Activist investor Corvex has called for a shareholder vote to place a representative on Whitbread's board of directors.
Oxford Biomedica reports 10% revenue growth in first half
Oxford Biomedica reported a 10% increase in revenue for the first half of the year.
Swiss Re posts $2.8B in H1 profit, on track for full-year target — AM Best
Reinsurer's first-half net profit of $2.8 billion already exceeds 60% of its $4.5 billion annual goal, earning a stable outlook from AM Best.
Kingfisher launches third tranche of share buyback program
Kingfisher announced the launch of the third tranche of its share buyback program.
Mission Group chair David Morgan to step down, CEO Carey to succeed
Mission Group announced that chair David Morgan will step down and be succeeded by CEO Carey.
Quadrise grants 35 million share options to staff and directors
Quadrise has granted 35 million share options to its staff and directors, according to a company announcement.
Supply@ME delays H1 2026 results, awaits funding confirmation
Supply@ME has pushed back the release of its H1 2026 results while it awaits confirmation of funding.
Alien Metals JV partner secures license near Elizabeth Hill
Alien Metals’ joint venture partner has secured a license near Elizabeth Hill.
Image Scan unit secures first detection systems contract
Image Scan's unit has announced winning its inaugural contract to supply detection systems.
DAX Expected Little Changed as Pre-Market Shows Slight Gain at 25,585
The German benchmark holds near its 50-day moving average after a strong Monday open, with US tech gains and AI-related momentum providing support.
AeroVironment Sees Strong Q1 2027 Results, Expands Defense Franchises
CEO Wahid Nawabi highlights record backlog, revenue visibility and strategic integration of BlueHalo, while guiding toward $3.5B–$4B by fiscal 2030.
Travere Therapeutics reports $489M cash and $3B sales potential for FILSPARI at Cantor conference
At the 12th Annual Cantor Fitzgerald Global Healthcare Conference, Travere outlined a mid‑20% gross‑to‑net range for FILSPARI, a cash balance of $489 million and a peak‑sales outlook above $3 billion.
Madrigal Pharmaceuticals Highlights Q2 Growth, Pipeline Expansion at Conference
Rezdiffra sales hit $364 million with over 50,000 patients on therapy, while a $300 million pipeline includes Phase II studies for three assets.
Shift4 Cuts Guidance on FX Headwinds, Announces $300M A2A Platform Acquisition
Shift4 cut full-year guidance by roughly 200 basis points at midpoint due to foreign exchange headwinds, while also disclosing a $300 million account-to-account payments platform acquisition and reaffirming strong organic growth.
Abbott Declares Quarterly Dividend of 63 Cents Per Share
Healthcare giant Abbott raised its quarterly payout for a 54th consecutive year, marking its 411th straight quarterly distribution since 1924.
Delek US Energy hits $81.50 all-time high on earnings, refinery exemptions
The stock surged past its 52-week high and delivered strong second-quarter results, though analysts flagged refining sector risks.
SMI Gains 0.7%, Defensive Stocks Offset AI Selloff as Oil Pushes Above $107
The Swiss benchmark index recovered part of last week's losses thanks to Roche, Novartis and Nestlé, while AI-linked tech names and building-material stocks fell on rising energy costs and Fed rate-hike expectations.
LPP Group Posts Strong Q2 Profit Growth, Raises Margin Outlook
Polish retailer LPP reported Q2 revenue growth of 18% and EBITDA up to PLN 1.7 billion, pushing full-year gross margin guidance higher amid robust back-to-school demand.
Texas Rep. Brandon Gill purchases $50k-$100k of Invesco RSP ETF
Representative Brandon Gill of Texas' 26th district disclosed a personal purchase of between $50,001 and $100,000 of the Invesco S&P 500 Equal Weight ETF (RSP) on Aug. 13, 2026, filing the report under the STOCK Act on Sep. 9, 2026.
Florida Rep. Salazar Buys Berkshire Hathaway, Sells Chubb Stock
Maria Elvira Salazar made purchases in Berkshire Hathaway and Merck while selling Chubb and IBM shares across multiple UBS accounts in August.
TransDigm Stock Drops to 52-Week Low After Stifel Downgrade
Shares of the aerospace parts maker fell to $1,123.56, down 23% from their 52-week high, as Stifel cut its rating to Hold and lowered its price target citing regulatory and demand headwinds.
Uber Shares Gain After CEO Khosrowshahi Buys $10M in Stock
Uber CEO Dara Khosrowshahi purchased $10 million worth of shares, pushing the stock higher on Thursday despite a rough year-to-date.
Congresswoman April McClain Delaney's August Stock Trades Filed
Maryland lawmaker's congressional disclosure reports sales in Brown & Brown, BWX Technologies, ITT Inc. and Martin Marietta Materials, with purchases in C.H. Robinson and others.
AMS Osram surges 22.9% on AI datacenter chip breakthrough
The semiconductor firm rallied to a 3.5-month high after announcing a thin-film VCSEL breakthrough for AI-powered data centres.
Cullinan to discuss zipalertinib trial results Monday
The clinical-stage biopharma will host a virtual analyst event on Phase 3 REZILIENT3 data for its EGFR mutation-positive NSCLC treatment, following a positive interim read.
Asian Stocks Rise on U.S. Tech Rally; Trump-Xi Summit in Focus
Asian equities advanced broadly, led by technology shares, as Wall Street's Nasdaq recorded a record close. Investors also looked ahead to the Trump-Xi summit in Washington on Thursday.
Smithfield Reports Record Profit as Packaged Meats Cushion Pork Headwinds
Smithfield Foods posted record Q2 and first-half 2025 operating profit, with packaged meats profits holding at 13.1% as the company offset significant pork spread compression through operational execution.
NVIDIA's Huang Sees AI Buildout Still Early Amid $5.27 Trillion Valuation
NVIDIA CEO Jensen Huang said AI infrastructure spending could hit $3 trillion to $4 trillion by 2030, even as the company posts $303 billion in trailing revenue and a P/E of 27.6.
Rubrik Raises Full-Year Guidance on Accelerating Revenue Growth
Rubrik shares rose after the cybersecurity firm reported 35% net new ARR growth and raised its annual outlook, driven by demand for AI-ready data resilience and autonomous recovery.
HPE Raises Full-Year Cash-Flow Targets on Strong Demand for AI, Networking
Hewlett Packard Enterprise lifted fiscal 2027 free-cash-flow guidance to at least $5 billion, citing record quarterly FCF, a $30 billion purchase-commitment balance, and AI-server backlogs nearing $7 billion.
T-Mobile Raises FWA Target to 15M by 2030, Posts Strong Postpaid Growth
T-Mobile upgraded its fixed wireless access customer target and reported 500,000 postpaid net additions in Q2, while highlighting a growing strategic moat across consumer and enterprise markets.
Datadog CFO Details AI Monetization Strategy at Goldman Sachs Conference
Datadog CFO David outlined the company's AI platform play, citing 31.5% revenue growth, near-80% gross margins, and a push into enterprise accounts as cloud adoption remains early.
Snowflake Raises FY Growth Guidance to 36% as AI Initiatives Expand
The company lifted its full-year revenue growth outlook to 36% year-over-year, citing strong demand for its AI-powered products and better-than-expected quarterly performance.
ATS Targets 15% EBIT Margin as It Shifts Portfolio Toward Regulated Sectors
Canada-based ATS aims to return to 15% EBIT margin through fixed-cost transformation, aftermarket growth and supply-chain optimization as it pivots away from ICE and transportation OEMs.
Harbour Energy to buy $200m of its shares from BASF in off‑market deal
Harbour Energy will acquire roughly $200 million of its ordinary shares from BASF, with any amount above $150 million offset against its $250 million share‑buyback programme.
Avio Reports 18% H1 Revenue Growth as Backlog Tops €2 Billion
The Italian aerospace firm posted €276 million in first-half revenue, driven by launch-systems activity and a €110 million equity investment from Advent International.
INPP NAV rises 1.3% in H1 as dividend cover improves
International Public Partnerships reported net asset value of 153.4p per share for the six months to June, with cash dividend cover strengthening to 1.3 times.
StandardAero shares hit 52‑week low of $23.81
StandardAero stock fell to $23.81, its lowest level in a year, as the company posted modest revenue growth but raised its 2026 outlook and kept an Outperform rating with a $39 target.
INPP NAV rises 1.3% to 153.4p; dividend cover improves to 1.3x
International Public Partnerships reported a 1.3% rise in net asset value per share to 153.4p for H1 2026, with dividend cover strengthening to 1.3x from 1.1x a year earlier.
Polestar stock drops to $7.53 as 52-week low amid earnings and guidance cuts
The electric vehicle maker’s share falls 73.96% year-over-year, with adjusted EPS at -$2.19 and guidance revised to low-to-mid single-digit growth.
Mirabaud Appoints Ballard and Parkinson for New Global Equity Strategy
The Swiss asset manager named two former Aviva Investors colleagues as global equity portfolio managers, launching a benchmark-oriented strategy on Oct. 1, 2026.
Great-West Lifeco Reports ROE Surpasses 19% in Q2, Expands Growth Platform
CEO David Harney highlights operational improvements, capital deployment, and strategic acquisitions as the insurer boosts returns and diversifies revenue mix beyond traditional capital-intensive segments.
Ardelyx Seeks Profitability by 2027 Amid Payer Challenges
The biotech firm highlights strong IBSRELA growth but faces reimbursement pressures and competitive threats in its chronic constipation and dialysis markets.
Celldex’s Barzolvolimab Faces Upcoming Phase III CSU Data as AD Milestone Approaches
Celldex Therapeutics is poised to present Phase III clinical data for its barzolvolimab in chronic spontaneous urticaria (CSU) by late 2025 or early 2026, following a robust Phase II trial showing superior efficacy over placebo.
Rigel reports Q2 revenue rise, details VEPPANU launch economics at Cantor conference
Rigel Pharmaceuticals posted second-quarter revenue of $67 million, a 14% increase, while outlining the economics and market potential of its newly launched VEPPANU oncology drug.
CrowdStrike reports record Q2 FY2026, lifts ARR targets amid AI demand
The cybersecurity firm posted its best quarter ever, adding $333 million in net new ARR and raising long‑term revenue goals while highlighting AI‑driven growth.
Frankfurt Stocks Fall on ECB Rate Hike and Oil Surge
Germany's DAX declined 0.84% after the ECB raised its deposit rate to 2.5% and inflation forecasts, while Middle East tensions drove crude prices higher and weighed on industrial shares.
European Stocks Slide After ECB Rate Hike as Oil Stays Above $100
The ECB's second interest-rate increase this year failed to calm markets. Brent crude remains above $100 and inflation concerns weighed on European equities, with mining stocks leading losses.
Harworth Group Receives Increased Takeover Offer at 177.5p
The UK property firm said its board is reviewing a revised cash bid of 177.5 pence per share from Peel Pepper (UK) Limited, up from 172.5p, and advised shareholders to take no action.
ARK Invest Buys $34M of Meta, Sells $6.7M in CrowdStrike on Sept. 21
Cathie Wood's ARK ETFs added roughly $34 million in Meta stock and trimmed positions in CrowdStrike and other holdings during trading on Monday.
Gauzy Receives Nasdaq Delisting Notice, Plans Appeal
The company said its shares closed below $1 for 30 straight days and it failed to file its 2025 Form 20‑F, triggering two Nasdaq listing rule violations. Gauzy intends to request a hearing before the Nasdaq Hearings Panel to stay any delisting action.
Hycroft Mining Advances Underground Development, Adds Two Drill Rigs
Nevada-based miner updates metallurgical testing and processing plans while unveiling a refreshed brand and website.
Newcleo Completes SPAC Merger, Begins Nasdaq Trading
Newcleo plc raises $247 million in SPAC deal, valuing the nuclear technology firm at $2.4 billion ahead of Nasdaq listing.
Elemental Royalty acquires $290M asset portfolio from Orion
Elemental Royalty Corporation secures five streams and royalties in U.S., Guinea, Mexico, and New Zealand, closing in Q4 2026 after equity and cash payment.
First Internet Bancorp Declares $0.06 Quarterly Dividend
The board of First Internet Bancorp approved a $0.06 per-share dividend, reflecting its $5.6 billion asset base as of June 30, 2026.
Toro Corp. to Spinoff AI OKTO Corp. on Oct. 1
Toro Corp. has set October 1, 2026 as the record date for its spinoff of AI OKTO Corp., with shareholders receiving one AI OKTO share for every eight Toro shares held.
Georgia Power, Google Secure $900M Nuclear Uprate Deal for Grid Expansion
Google will subscribe to extended uprates at Georgia Power’s Vogtle and Hatch nuclear plants, unlocking 96 MW of capacity and generating $900M in customer benefits over the project’s lifespan.
US Tech Stocks Lead Gains Amid KI Hype and Oil Price Drops
US indices advanced sharply on Monday, driven by tech stocks and falling oil prices, while diplomatic hopes and Meta’s KI launch boosted select sectors.
American Savings Bank completes IPO and over-allotment option
American Savings Bank, a Hawaii-based bank, completed its IPO on September 17, selling 8.06 million shares at $16 each. Underwriters exercised their option to purchase an additional 1.21 million shares.
Kimberly Boynton Joins NBT Bancorp Board as Healthcare and Real Estate Expert
NBT Bancorp Inc. announced Kimberly A. Boynton’s appointment to its board of directors, bringing over two decades of executive experience in healthcare, finance, and commercial real estate.
Industrial Logistics Properties Trust Names Anthony Paula as New CFO
RMR Group executive replaces Tiffany Sy at industrial logistics REIT; transition takes effect Oct. 1 amid portfolio expansion across 39 states.
Taltson Critical Minerals appoints CFO, raises $85,000 in private placement
The Vancouver‑based explorer named Casey Forward as chief financial officer and closed a $85,000 non‑brokered private placement of 2.125 million units, with an insider buying 23.5% of the issue.
PACS Group Appoints Patrick Murphy as New Chief Legal Officer
Patrick Murphy takes over as Chief Legal Officer and Corporate Secretary, succeeding John Mitchell who retired after 15 years at the company.
Pentair raises dividend for 50th straight year, sets $0.27 quarterly payout
Water solutions provider marks half-century of annual dividend increases with a $0.27-per-share quarterly payout, payable Nov. 6 to shareholders of record Oct. 23.
Roche receives EU approval for Susvimo, eyeing new market opportunities
Pharmaceutical giant Roche has obtained EU approval for its eye medication Susvimo, opening up new sales channels and bringing the stock back into focus.
Vireo Growth acquires Nevada dispensary for $500K in cash and shares
Minneapolis-based Vireo Growth completed a $500,000 acquisition of M3 Wellness in Nevada, paying $290,000 in cash and issuing subordinate voting shares at a $15.12 valuation.
Nyxoah appoints interim CFO, reaffirms 2026 revenue and margin guidance
Nyxoah SA said President International Loïc Moreau will serve as interim chief financial officer after John Landry's departure on Oct. 2, and confirmed its 2026 revenue, margin and expense targets.
Vicor Raises Q3 Revenue Guidance on Licensing Royalties
Andover-based Vicor Corporation boosted its third-quarter revenue outlook by more than a decade, citing royalties from a recent licensing deal on its Vertical Power Delivery technology.
Qnity Electronics Added to PHLX Semiconductor Sector Index
The Wilmington-based chip maker joins the benchmark index tracking the 30 largest eligible U.S. semiconductor companies, following its NYSE listing.
Toro adds Tennant CEO David Huml to board of directors
The Toro Company appointed David Huml, chief executive of Tennant, to its board effective immediately, citing his expertise in robotics and smart‑connected technologies.
Travere Therapeutics Names CEO Bradley Campbell to Succeed Eric Dube
Eric Dube steps down as CEO on December 1, with Campbell taking over after a board-led search for a successor focused on rare kidney disease therapies.
CVRx Names John Landry as New CFO, Succeeding Oasheim
John Landry, former CFO of Nyxoah SA, will take over as chief financial officer of CVRx starting October 12, 2026, following Jared Oasheim’s transition.
Novartis Q1 Revenue Falls 1% as Generics Erode Drug Market Share
Pharmaceutical giant Novartis reported a first-quarter revenue decline of 1% and a 12% drop in core operating profit, driven by patent expirations and intensified generic competition.
Scinai Regains Nasdaq Compliance After 19-Day Bid Price Hold
Scinai Immunotherapeutics Ltd. returned to full compliance with Nasdaq’s minimum bid price rule after a 19-day period of adherence, following a prior violation in March.
Alkermes sees dose-dependent ADHD signal in Phase 1b data for ALKS 7290
The Dublin-headquartered company reported exploratory improvements in ADHD symptom scales from its Phase 1b study, with a larger cohort now moving into Phase 2.
FDA grants platform technology designation to Precigen's AdenoVerse
The U.S. FDA has awarded platform technology status to Precigen's AdenoVerse immunotherapy platform, which underpins the approved PAPZIMEOS treatment and several HPV‑related cancer studies.
Latam Lithium to hold shareholder vote on 3-for-1 consolidation
Latam Lithium Corp. has scheduled an annual general and special meeting for October 22, 2026, to vote on a three-for-one share consolidation, which will reduce the number of outstanding shares from approximately 35.3 million to 11.8 million.
SEC’s Tokenized Stock Rules Face TD Cowen’s Skepticism on Adoption
The SEC’s new framework for tokenized stock trading may not spur near-term demand, as investors already have efficient access to traditional markets, analysts warn.
Moderna Stock Hits 52‑Week High at $176.75
The biotech firm’s shares rose to their yearly peak amid strong vaccine‑related developments, a $2 billion convertible notes offering and mixed analyst ratings, while its market cap stands near $70.4 billion.
US Stocks Rise on Oil Price Decline, Nasdaq 100 Hits 3-Month High
US stock markets saw significant gains on Monday, supported by hopes for diplomatic progress in the Middle East and falling oil prices. The Nasdaq 100 reached its highest level in three months.
Ethan Allen faces proxy battle over CEO succession process
Activist shareholder Doug Bergeron challenges board’s succession plan, seeking independent CEO search and director nominees
Post Holdings Shares Hit 52-Week Low as Analysts Cut Forecasts
Cereal maker's stock fell to $75.38, down 36% from its 52-week high, after five analysts revised earnings estimates lower despite a solid third quarter.
Seven Steps to Successful Investment: A Guide for Beginners
A seven-step guide to investing and building wealth, suitable for beginners and experienced investors alike. Learn how to define goals, assess risk tolerance, and choose the right investment instruments.
Kromek’s Shares Drop Amid Revenue Shift as Non-Licensed Business Expands
Kromek Group plc’s shares fell on Tuesday as the AIM-listed company reported a revenue mix shift toward non-licensed business, with growth in photon-counting CT and SPECT imaging driving a 112% forecast rise in non-licensed revenue by FY 2027.
LeMaitre Vascular Shares Fall to 52‑Week Low at $78.22
The stock traded 33% below its 52‑week high of $118.01 and is down 14.55% over the past year. LeMaitre Vascular missed second‑quarter earnings and revenue estimates while maintaining a 15‑year dividend raise streak and a strong balance sheet.
Schweizer Aktienmarkt schließt mit 1,2 % Gewinn, Ölpreise bleiben unter Druck
Der SMI stieg am Wochenstart um 1,2 Prozent, während Ölpreise weiter auf 99,54 Dollar pro Barrel (Brent) fielen – ein Tief seit September. Givaudan führte die Gewinne an, während Tech- und KI-Aktien weltweit stiegen.
Texas Rep. Pete Sessions Sells Shares in AbbVie, Alphabet
The congressman’s office disclosed sales of stock in AbbVie and Alphabet on Sept. 18, each transaction valued between $15,001 and $50,000.
Twilio shares reach 52‑week high above $258
Twilio stock rose to $258.83, its highest in a year, as Q2 revenue topped $1.5 billion and analysts lifted price targets to $270‑$280.
ARK ETFs Drive Kalshi’s Stock Buy, Reduce Brera Holdings Stake
On September 21, 2026, ARK Invest’s ETFs—including ARKK, ARKW, and ARKF—boosted Kalshi Inc.’s shareholding while reducing Brera Holdings PLC’s position by nearly 310,000 shares.
Universal Corp posts loss, hits 52-week low as tobacco segment falters
Shares of Universal Corp fell to $43.35 after the company reported a first-quarter loss and a sharp drop in tobacco operating income, though management says demand should normalize.
Meta AI Agent Muse Drives Tech Rally as Semis Soar
Meta's consumer AI assistant Muse posts rapid early adoption figures, pushing shares up 6.5% and sending Arm, Intel and AMD sharply higher.
Equinox Gold to Redeem $172.5M Convertible Notes Due 2028
Equinox Gold Corp. to redeem $172.5 million in convertible notes due October 15, 2028, with a redemption price of $1,000.66 per $1,000 principal amount.
Turning Point Brands Names David Glazek as CEO, Adjusts 2026 Financial Guidance
Louisville, Ky.-based Turning Point Brands reaffirmed 2026 sales and adjusted EBITDA guidance amid leadership transition and operational challenges.
InspireMD Amends Warrants Ahead of CGuard Prime FDA Decision
InspireMD adjusted exercise prices and termination triggers on about 14.3 million warrants so they expire 20 trading days after FDA approval of its CGuard Prime 80 cm carotid stent system.
Microchip Acquires Hailo in Edge AI Expansion
Microchip Technology Inc. finalized its acquisition of Hailo, bolstering its AI-driven semiconductor capabilities for embedded systems and robotics.
Strategy Adds 950 Bitcoin in First Weekly Buy Since August
The bitcoin-focused firm spent $75.7 million on 950 BTC last week, funded by a common-stock sale, and now holds 846,000 coins.
DTE Energy stock hits 52-week low at 126.23 USD
Shares of DTE Energy reached a 52-week low of 126.23 USD, according to Investing.com company news data.
Roche Gets EU Approval for Eye Drug Susvimo
The European Commission approved the wet macular degeneration treatment, delivered via a once-implanted device requiring only two refills annually instead of monthly injections.
Coherent Highlights Full-Stack Optics for AI Data Centers at ECOC 2026
Coherent said it is promoting full‑stack optical technology for AI data centers during the ECOC 2026 event.
VusionGroup Reports H1 2026 Growth, EBIT Surges to 11.4%
Revenue up 29% year-over-year, EBITDA margin expands by 2.4pp as company scales digital retail solutions.
Europe's STOXX 600 Rallies on Tech and Banking Strength as Oil Retreats
The pan-European index climbed as tech and banking shares led gains, while lower oil prices reduced commodity-related pressure on markets.
US equities rebound on oil price declines, KI optimism
Dow Jones, S&P 500, Nasdaq rise as crude prices drop amid geopolitical hopes and tech sector gains
Pineapple Power director converts £29k loan notes into shares
Nicholas Nelson, a non-executive director of Pineapple Power Corporation PLC, converted £29,000 in loan notes into 11.6 million shares, raising his total holding to 11.6 million shares.
Otis Worldwide stock dips to 52-week low amid valuation concerns
Revenue beats expectations but EPS guidance cut as CEO transition looms ahead
Privia Health Group shares hit 52‑week low near $19.52
The stock slipped to a 52‑week low of $19.52, even as Q2 earnings beat forecasts. Market cap stands at $2.5 billion and analysts see targets up to $40.
ZIM Stock Hits 52-Week High as Acquisition Bid Takes Shape
ZIM Integrated Shipping hit a 52-week high of $30.42, while Hapag-Lloyd and FIMI are revising their $4.2 billion acquisition offer alongside the Israeli government.
PPL Corp hits 52-week low at $33.19 amid year-on-year decline
Stock falls 7% over 12 months, with analysts mixed on outlook despite dividend stability and regulatory approvals for utility rate increases.
Leonteq shareholders approve share buyback and elect new president
Derivate provider Leonteq's shareholders approved the proposed share buyback and all other motions at the extraordinary general meeting on Monday. Andreas Casutt was elected as the new president of the board of directors.
US equities rebound as oil prices ease, aiding markets ahead of UN and US-China talks
Dow Jones, S&P 500, Nasdaq rise as oil prices decline, while geopolitical hopes and AI discussions boost investor sentiment.
Dax stabilisiert sich trotz Ölmarkt-Druck und Wahlrisiken
Ölpreise sinken, aber politische Unsicherheiten und Immobilienrisiken belasten deutsche Aktienmärkte
US equities rally on oil price drop, KI optimism and diplomatic hopes
Dow Jones and Nasdaq 100 advance as energy markets soften and tech stocks lead gains on KI trends and geopolitical expectations.
Anheuser-Busch allocates $23M to Colorado brewery expansion as part of $600M U.S. push
The brewery’s expansion includes new canning capacity for Michelob ULTRA and workforce upskilling programs, as part of Anheuser-Busch’s broader Brewing Futures initiative.
Reaves Utility Income Fund Hits 52-Week Low at $35.81
The utility-focused ETF dropped to its lowest level since last July as sector headwinds and a 6.93% annual decline weigh on investor sentiment.
Nuveen Municipal Value Fund hits $8.48 low amid municipal bond market pressures
The $1.78 billion fund’s 52-week low reflects broader challenges in municipal bonds amid rate volatility and economic uncertainty, despite a 40-year streak of dividend payments and a low beta of 0.38.
Moderna presents cancer therapy data at ESMO congress
The company shared data on a cancer therapy at the ESMO congress, according to company news coverage.
Amneal Pharmaceuticals Stock Reaches 52-Week High on Q2 Surpasses
Amneal Pharmaceuticals Inc. hit a 52-week high of $19.32 amid strong second-quarter results and biosimilar growth.
Goodyear shares hit 52‑week low of $5.03
The tire maker's stock fell to a 52‑week low of $5.03, down 39.8% year‑to‑date, after reporting Q2 revenue of $4.3 bn that topped estimates.
Weyerhaeuser Stock Drops to $21.17, 52-Week Low
Timber and real estate firm Weyerhaeuser’s shares fell to a 52-week low amid broader market pressures, while earnings and valuation adjustments offer mixed signals.
Scotts Miracle-Gro Stock Drops to $51.98, 52-Week Low
Stock falls 10.77% year-over-year amid earnings beat and analyst upgrades, though remains in oversold territory.
Zoetis stock falls to 52-week low at $70.97
Zoetis Inc. shares hit a 52-week low of $70.97, reflecting a 50.51% decline over the past year. Analysts downgrade ratings and targets following Q2 earnings.
Dick’s Sporting Goods stock falls to $120.39, 52-week low
Valuation at $10.7 billion amid analyst downgrades and Foot Locker integration challenges
Red Rock Resorts Stock Drops to $50.52, 52-Week Low
The resort operator’s shares fell to a fresh low amid ongoing construction delays and mixed analyst outlooks.
CMS Energy stock dips to 52-week low amid earnings shortfall
Utility firm CMS Energy’s shares fell to a 52-week low of $65.13 as second-quarter earnings missed expectations, while clean energy transition plans remain a focus.
Datavault AI to Sponsor Dream Bowl XV College Football Game
Datavault AI announced it will sponsor the Dream Bowl XV college football game.
Evolution Metals Joins Russell 2000, Russell 3000 Indexes
U.S.-based rare-earth magnet producer Evolution Metals Corp. enters benchmark indexes with commercial-scale production and $400M–$460M 2027 revenue guidance.
US Stocks Rise on Diplomatic Hopes, Crypto and Tech Stocks Gain
US stock markets show gains as investors await Trump-Xi meeting and benefit from falling oil prices. Crypto and tech stocks also see gains.
AMC Entertainment Tender Offers $360M in Senior Notes with $3.97B Financing Requirement
AMC Entertainment Holdings Inc. is seeking to buy back $360 million of senior secured notes under a tender offer, contingent on securing $3.97 billion in debt financing by October 5, 2026.
Beacon Financial appoints Sean Gray as CEO
Beacon Financial Corp named Sean Gray chief executive of the holding company and its bank subsidiary, succeeding retiring veteran Paul Perrault.
PetMed Express appoints Tamar Elkeles as independent director and compensation committee chair
PetMed Express (NASDAQ: PETS) named former Qualcomm executive Tamar Elkeles to its board, effective Sept. 17, as chair of the Compensation and Human Capital Committee.
Clene raises $4 million in insider direct offering
Clene Inc. completed a $4 million registered direct offering of common stock to existing shareholders, extending its cash runway to mid‑Q1 2027 and supporting its ALS drug program.
Kühne+Nagel deepens Amazon partnership, targets multi-billion dollar revenue growth
Kühne+Nagel is expanding its partnership with Amazon, focusing on data centers, and aims to increase revenue with the US giant to several billion dollars. The company's shares rose by 6%.
Establishment Labs Expands Breast Augmentation Tech with New Product Lines
The company showcased clinical data at a global symposium and introduced expanded sizes for its Mia and Preservé platforms, aiming to broaden access to minimally invasive breast augmentation.
Enphase's IQ Meter Collar gains approval from 80 US, Canada utilities
Enphase Energy's IQ Meter Collar, a microgrid interconnection device, has received approval from 80 utilities serving 38 million customers across the US and Canada. The device enables whole-home backup without requiring additional equipment or wiring complexity.
Kodiak AI, PrePass to Integrate Autonomous Truck Inspections in Texas, Louisiana
Partnership aims to streamline state enforcement for driverless commercial vehicles under CVSA’s inspection program, with national rollout planned by year-end.
Innventure Slashes Parent Expenses by 56% as It Hires New CFO
Orlando-based Innventure Inc. reduced quarterly parent-level cash expenses by 56% to $3.2 million by year-end 2026, while appointing a new CFO and adding a director amid board restructuring.
CAE wins $300M Air Force contract extension through 2035
Finance Review Daily is tracking this developing story; no further verified information could be confirmed at this time.
Lakewood-Amedex to launch Phase 2a trial of Nu-3 Gel for diabetic foot ulcers
Lakewood-Amedex Biotherapeutics (NASDAQ: LABT) said it will begin a Phase 2a study of Nu-3 Gel in infected diabetic foot ulcers and disclosed a $7.5 million private placement of Series C convertible preferred stock.
Remgro FY2026 slides show earnings surge 42% on portfolio overhaul
Remgro's FY2026 presentation indicates earnings rose 42% following a portfolio overhaul.
AI-driven tech picks surge 201% vs. S&P 500 as AI demand fuels outperformance
Machine-learning strategies have delivered outsized gains for AI-related tech stocks, defying Fed rate hikes and outperforming broader indices since late 2023.
Waraba Gold appoints Adam Cegielski as director
Waraba Gold Limited added Adam Cegielski to its board, granting him a C$50,000 annual retainer payable in deferred share units. The move coincides with the company's evaluation of Côte d'Ivoire projects and potential capital raises.
U.S. Physical Therapy appoints Myra Davis to board
The company announced the appointment of Myra Davis to its board of directors, according to a company news item.
Helus Pharma presents data on depression drug candidate HLP003
Finance Review Daily is tracking this developing story; further verified details were not immediately available.
Almonty receives permits to start commercial tungsten sales
Almonty has received the permits needed to begin commercial sales of tungsten.
ZettaJoule appoints Kian Granmayeh as chief financial officer
ZettaJoule has named Kian Granmayeh as its chief financial officer, according to a company news brief.
Coca-Cola Europacific Partners buys back 397,500 shares
Coca-Cola Europacific Partners announced a share repurchase of 397,500 shares.
CanAlaska appoints James Sykes as exploration chief
CanAlaska has named James Sykes as its new exploration chief.
Army Corps Begins Environmental Review of Trilogy’s Arctic Project
The U.S. Army Corps of Engineers has started an environmental review for Trilogy’s Arctic project.
Solidion Technology Insiders Buy Shares Around $7
Three executives at the battery technology firm purchased shares in recent transactions, with board member Karin-Joyce Tjon acquiring the largest stake.
Vertical Aerospace appoints former Airbus CEO as board chair
Vertical Aerospace has named a former Airbus chief executive to serve as chair of its board, according to the announcement.
Ethan Allen Sets June 2027 Deadline for CEO Succession
Board of Directors initiates internal and external search for successor to current CEO Farooq Kathwari, aiming for a leadership transition by mid-2027.
Hawaiian Electric Sells Stake in American Savings Bank, Raises $29.5 Million
Hawaiian Electric Industries offloaded roughly 2 million shares in newly public American Savings Bank as part of an ongoing divestiture to fund wildfire settlement obligations.
AL Sydbank Repurchases 35,000 Shares in Week 38 as Buyback Programme Continues
The Danish lender bought back 35,000 shares at a total cost of DKK 24.3 million during the week of Sept. 14-18, raising cumulative repurchases to 1.214 million shares under its DKK 1.1 billion programme.
Telekom Shares Drop Without Company News as Investors Ponder AI Risk and Penny Stocks
Deutsche Telekom fell today without a specific corporate catalyst, while analysts flagged rising risks in AI-linked equities and highlighted five high-reward penny stocks with corresponding danger.
Dividend payouts announced on Sep 21, 2026 across 30 issuers
A range of companies disclosed cash dividends for 2026, with amounts varying from €0.007 to €1.44 per share.
Volkswagen exits Euro Stoxx 50 amid profit warning and EV transition challenges
German automaker’s 27.5% year-to-date decline and downgrade to 1% operating return on sales mark deeper pressure as restructuring intensifies.
Ölpreisrückgang stärkt europäische Aktienmärkte trotz geopolitischer Spannungen
Technologiewerte dominieren, während Ölpreise und diplomatische Hoffnungen die Börsen ermutigen – aber KI-Aktien bleiben unter Beobachtung.
Eurozone equities rise on oil price drop, KI optimism
European markets advanced Monday on lower crude prices and diplomatic hopes for Middle East stability, with tech stocks leading gains amid US-China KI talks.
Nvidia Eyes All-Time High as Chip Demand Outstrips Supply
Nvidia has beaten analyst estimates for 15 straight quarters, with CEO Jensen Huang forecasting $1 trillion in order backlog through 2027 and Q3 revenue above $100 billion.
Schweizer SMI startet mit 15 von 20 Titeln im Plus – Givaudan führt Blue Chips an
Der SMI erholt sich nach Wochenverlust und zeigt sich dynamisch am Montagmorgen, während Technologie- und Gesundheitssektor besonders stark performen.
AI Stock-Picking Strategy Delivers +77%, +35%, +29% YTD Returns
An AI-driven investing model has posted nearly 199% returns since its November 2023 launch, outpacing the S&P 500 by 118 percentage points, with Energy Elite, Mid-Cap Movers and Small-Cap Sprinters leading the way.
SMI Index Effect Fails for Galderma, Sandoz as Myth Persists
Two pharmaceutical firms gain SMI inclusion but fail to benefit from the expected index premium, undermining long-held market assumptions.
Amgen reports Q2 revenue above $10 bn, outlines pipeline progress at Wells Fargo conference
Amgen posted second‑quarter sales of more than $10 billion, up 10% YoY, and gave full‑year margin guidance while highlighting growth in six key product drivers and several late‑stage trial results.
Crown Castle Sees 2026 Growth Rebound Amid Structural Shifts
Organic growth is projected at 3.6% in 2026, excluding Sprint attrition, as the tower company focuses on consulting and AI-driven infrastructure services.
INPP H1 2026 NAV Rises as Dividend Cover Improves
International Public Partnerships (INPP) reported a 1.3% increase in NAV per share to 153.4 pence, driven by improved dividend cover and strategic capital recycling.
SAB Bio’s SAFEGUARD Trial Progress and T1D Expansion Strategy Highlighted at Citi Summit
SAB Biotherapeutics outlines clinical milestones for its SAB-142 candidate and a broader Type 1 diabetes (T1D) market opportunity, while emphasizing manufacturing scalability and a strategic field launch.
Avio Posts H1 2026 Growth Amid Stock Decline
Revenue up 18% to EUR 279.7m, EBITDA rises to EUR 12m as backlog exceeds EUR 2bn; U.S. expansion and private equity funding drive expansion plans.
Omnicom Reports 2026 Revenue Guidance Rise Amid Media Integration Progress
Omnicom Group raised its 2026 organic revenue growth outlook to 4.5%-5.0% as its media integration with Interpublic Group progresses, though advertising integration faces challenges and headcount cuts accelerate.
Kymera Therapeutics Raises Oral Immunology Ambitions at Citigroup Summit
Kymera Therapeutics highlighted progress in its oral immunology pipeline, targeting atopic dermatitis and autoimmune diseases, amid a 2.5% stock rise to $118.36.
Navan Raises FY2027 Revenue Guidance to 32% as AI-Driven Growth Accelerates
Navan’s AI-powered travel platform highlights record bookings and gross margins of 75% amid a $4B TBY revenue run, with BoomPop acquisition on track for profitability contributions.
Chemed CEO Highlights Vitas Growth Amid Roto-Rooter Challenges at Jefferies Conference
Chemed Corporation’s hospice business Vitas outperformed expectations, generating over $35 million in Medicare cap cushion, while Roto-Rooter’s plumbing segment faces margin pressures from Google algorithm shifts and rising paid-lead costs.
SL Green Reports Leasing Surge Boosts 2026 Outlook Amid NYC Office Demand
SL Green Realty Corp. highlighted a strong year-to-date leasing performance, exceeding targets and signaling robust demand for office space in New York City.
Groupe Dynamite Posts Q2 2026 Record Margins on Luxury-Focused Shift
Revenue surged 29.8% YoY while adjusted EBITDA margin hit 44.3%, the highest since IFRS adoption, as the retailer expands its premium brand portfolio.
Beowulf Mining's £4.3m fundraising blocked by Swedish FDI review
Sweden's strategic products inspectorate has opened a Foreign Direct Investment review of Beowulf Mining's £4.3m financing, potentially delaying the deal by up to six months and intensifying the miner's cash crunch.
Barclays Sees UK Equities at 20% P/B Discount Amid M&A Boom
UK equities trade at a 20% price-to-book discount and face heightened M&A activity, despite investor outflows, as Barclays highlights sector-specific attractiveness.
European stocks retreat on AI safety concerns, Fed rate bets dampen gains
European indices decline as AI sector stocks falter amid regulatory uncertainty, while oil prices rise on geopolitical tensions and Fed rate hike expectations weigh on risk appetite.
Veeva AI Push Accelerates Amid 2026 Growth Momentum
Veeva Systems highlights AI-driven innovations and revenue growth in life sciences software, with 98% of revenue tied to vertical solutions.
Ingersoll Rand Sees Demand Recovery in Industrial Compressors Amid Geopolitical Shifts
Company highlights improved order trends in North America and China, while restructuring and pricing pressures continue to shape earnings outlook.
Frankfurt Stocks Edge Higher Ahead of US Rate Decision
Germany's Dax rose 0.17% to 25,450 as investors awaited the Federal Reserve's rate decision Wednesday, with AI-themed shares leading gains.
Qorvo Stock Reaches 52-Week High at $109.87
Semiconductor firm Qorvo Inc. hit a key milestone with its stock trading near a 52-week high amid investor optimism.
Applied Nutrition Plc Executives Plan Secondary Share Sale
London-based Applied Nutrition plc’s CEO and COO plan to sell around 6 million shares via an accelerated bookbuild, reducing their combined stake by roughly 2.4% of issued capital.
NCLH Stock Drops to $14.53, 52-Week Low Amid Guidance Cuts
Norwegian Cruise Line Holdings Ltd’s share price fell to a 52-week low of $14.53 amid downward revisions to full-year yield guidance and mixed analyst reactions.
FingerMotion Secures 9.9 MW Power Site in Alberta’s Newell County
The company plans to develop a modular data center hub with behind-the-meter power generation, supported by BlueFlare Group Holdings.
Frasers Group seeks additional seat on Hugo Boss board after takeover
Frasers Group agreed that Hugo Boss chairman Stephan Sturm will step down, allowing the retailer to add Robert Palmer to the German fashion house’s supervisory board. Michael Murray already sits on the board following Frasers’ completed voluntary takeover.
UIL Limited reports 10.8% NAV gain in August
UIL Limited's net asset value (NAV) total return rose 10.8% in August, outperforming the FTSE All Share Total Return Index by 10.1%.
OTE Buys Back Nearly 300,000 Shares for €5.9 Million
Greek telecom operator OTE repurchased 299,531 shares between Sept. 7-11 at an average of €19.76, bringing its treasury holding to 3.46 million shares or 0.877% of outstanding stock.
Sun Hung Kai Properties Posts Higher H2 Profit, Raises Dividend
Hong Kong developer reports underlying profit of HKD 22.9 billion for FY2026, up 4.6%, as property development gains and healthier balance sheet offset cautious 2027 sales guidance.
ICU Medical Shifts Focus to Cash Returns Amid Growth Stability
CEO Vivek Jain outlines plans to reduce leverage by 2024 and prioritize shareholder returns, while maintaining mid-single-digit growth in core segments.
Tyson Foods trims beef, chicken guidance and highlights brand growth at Barclays conference
At a Barclays consumer conference, Tyson Foods cut its beef, chicken and pork forecasts, announced an incoming CEO and outlined a push to develop several emerging brands.
ALX Oncology Details Biomarker Strategy for CD47 Program at Cantor Conference
The biotech highlighted ASPEN-06 gastric data and an upcoming Phase II breast cancer study as it pushes a companion diagnostic with Ventana for its Evorpacept program.
Pennant International raises £400k short-term loan from shareholder
London-based AIM-listed Pennant International secures £600k unsecured loan to fund restructuring and bridge working capital needs ahead of Q4 2026 deliveries.
Pulsar Helium names David Young as CFO and director
Pulsar Helium has appointed David Young to serve as its chief financial officer and a director.
Mkango Resources Renamed Mkango Magnetic Materials
Mkango Resources announced a name change to Mkango Magnetic Materials.
ZenaTech Gains Irish Aviation Authorization for Aerial Crop Treatment Services
The Nasdaq-listed ag-tech firm received SORA approval from the Irish Aviation Authority to conduct drone-based fertilizer and bio-stimulant application on Irish farmland.
New Jersey Resources raises quarterly dividend to $0.50 per share
The utility company said the increase, to $2.00 on an annualized basis, marks its 31st consecutive year of dividend hikes, reflecting board confidence in its financial strength.
Enhertu receives EU committee backing for early breast cancer
Enhertu has been backed by an EU committee for use in early breast cancer, according to the announcement.
Gaming & Leisure Properties Hits 52-Week Low at $41.16
GLPI stock falls to its lowest level in a year despite reporting strong Q2 2026 results that beat on revenue and earnings.
CXMT Shares Jump 2.6% After Fifth-Gen DRAM Platform Mass Production Announced
ChangXin Memory Technologies’ shares surged as the company’s new G5 DRAM platform entered production, marking a milestone in China’s push for self-sufficiency in advanced memory technology.
Sampo Repurchases 2.26 Million Shares in Week 38 at €9.41 Average
Sampo plc bought back 2.26 million A shares between Sept. 14-18 for an aggregate of roughly €21.3 million at its third weekly repurchase under the €350M program.
Sampo Buys Back 2.26 Million Shares in Third Week of Repurchase Program
The Finnish insurer repurchased 2.26 million A-shares at a weighted average of €9.41 during Sept 14–18 under its €350 million program.
SMI opens higher with Galderma, Sandoz debuts amid KI chip demand
Swiss equity markets expected to start the week on a positive note, with the SMI index poised for gains as pharmaceutical firms Galderma and Sandoz make their debut. Meanwhile, oil prices retreated despite escalating tensions in the Middle East.
Galderma, Sandoz enter SMI; Kühne+Nagel and Swisscom exit
SIX says Galderma and Sandoz will join the Swiss Blue Chips index Monday, replacing logistics firm Kühne+Nagel and telecom group Swisscom, which drop to the SMIM.
Speedy Hire Plc Approves Annual Meeting Resolutions with Strong Shareholder Support
London-based logistics firm Speedy Hire Plc secured unanimous approval for key resolutions at its annual general meeting, including dividend payouts and board changes.
Sun Hung Kai Reports 4.6% Profit Growth, Gearing Halved in FY2026
Hong Kong property developer Sun Hung Kai Properties Limited reported a 4.6% increase in profit attributable to shareholders and a significant reduction in gearing to 10.7% in FY2026, marking a 47% decline from its December 2023 peak.
Galderma CEO reaffirms growth outlook amid SMI ascent
Galderma’s Flemming Ørnskov highlights expansion in emerging markets and product innovation as key drivers of expected continued high growth.
Swiss Market Index faces seasonal volatility amid central-bank rate hikes
Analysts highlight dividend-paying stocks as a stable long-term wealth accumulation tool amid cautious optimism for Swiss equities.
SMI drops 0.47%, oil above $100 weighs on global equities
Swiss benchmark closed lower as crude prices surpassed $100 a barrel for the first time since May, while ECB raised rates as expected and US producer prices came in hotter than forecast.
SpyGlass Pharma’s Glaucoma Lens Nears Phase III Milestones with $920M Runway
The biotech firm’s BIM-IOL drug-delivery implant shows promising efficacy in reducing glaucoma medication use, with Wall Street targeting $37–$62 per share.
Mereo BioPharma shows pipeline progress at Cantor healthcare conference
CEO says three major regulatory and development milestones are weeks away for its alvelestat, setrusumab and vantictumab programs.
Groupe Dynamite beats Q2 EPS forecast and lifts FY guidance
Adjusted diluted EPS rose to C$0.96, topping the C$0.41 outlook, while revenue jumped 29.8% YoY to C$423.6 million.
Arcturus Therapeutics Highlights Data Catalysts at Healthcare Conference
CEO Joseph Payne discusses Phase II readouts for OTC deficiency and cystic fibrosis programs, regulatory clarity, and platform advancements ahead of Q4 funding decisions.
Oregon Bancorp Declares $0.20 Quarterly Dividend
The Willamette Valley Bank parent sets a payable date of Oct. 15, 2026, reinforcing its commitment to shareholder returns.
Entergy Texas Declares $0.3359 Quarterly Dividend on Series A Preferred Stock
The utility’s board approved a quarterly cash dividend of $0.3359375 per share on its Series A preferred shares, payable Oct. 15 to shareholders of record on Oct. 2. Entergy Texas serves about 538,000 customers across 27 counties in Texas.
SBA Communications: 2026 growth stalls as 6G waits beyond 2028
Executive guidance highlights near-term financial pressures, including higher churn and interest costs, while long-term expansion hinges on 6G deployment.
Bernstein Maintains Outperform on Richemont, Keeps CHF 240 Target
Bernstein Research analyst Luca Solca reviewed Swiss watch export data and maintained Richemont remains his European luxury sector favorite, with the gradual demand recovery still intact.
Brady Tops Q4 Estimates but Shares Drop as Guidance Weighs on Investors
Brady Corp reported Q4 adjusted EPS of $1.48 on $436.9M revenue, beating estimates, but shares fell premarket as the company issued modest full-year guidance and highlighted integration costs from its Honeywell acquisition.
Graham Holdings Declares $1.88 Quarterly Dividend
The Arlington, Virginia-based company said the dividend will be paid on Nov. 5, 2026 to shareholders of record on Oct. 15, 2026.
BioMarin Expands Growth Strategy Beyond VOXZOGO with Pipeline Expansion
BioMarin Pharmaceutical Inc. outlined a broader growth plan at the Cantor Fitzgerald Global Healthcare Conference, highlighting new clinical assets and international expansion opportunities beyond its lead product VOXZOGO.
American Tower Projects 2027 Growth as 5G Cycle Inflects
U.S. tower company forecasts mid-single-digit AFFO growth, margin expansion and FX/rate headwinds in outlook beyond 2026
4D Molecular Therapeutics Eyes Wet AMD Breakthrough with Gene Therapy 4D-150
The biotech aims to disrupt wet age-related macular degeneration with a novel aflibercept-expressing gene therapy, targeting a paradigm shift in treatment burden and persistence challenges.
Travere Therapeutics Stock Hits 52-Week High on Strong Q2 Earnings
Travere Therapeutics shares peaked near an all-year high as second-quarter revenue of $169.6 million topped forecasts, driven by a near-doubling in FILSPARI sales.
Tsakos Energy Q2 EPS Surges 557% on Strong Tanker Rates
The Athens-based tanker operator reported $4.40 per share in Q2, tripling operating income as Time Charter Equivalent rates climbed 50% year-over-year.
Imperial Petroleum Posts Record Q2 Revenue on Geopolitical Shipping Tensions
Maritime tanker operator reports $87.1M in quarterly revenue, up nearly 140% year-over-year, as Strait of Hormuz disruptions drive freight rates higher.
Honeywell targets $12 EPS by 2029, aims for 4‑6% organic growth
Honeywell said it will pursue 4‑6% organic growth, lift software ARR to about $1 bn by 2026 and set a $12 earnings‑per‑share floor for 2029, with modest margin expansion.
SMI opens higher; Fed rate-hike odds near 93% as traders wait for Wednesday decision
The Swiss benchmark rose 0.1% to 13,815.84 as ABB led gainers. Investors stayed cautious ahead of the Federal Reserve's rate decision, where a 25-bp hike is priced in at over 90%.
Zenith Energy Sees 22% Jump in Italian Operations Cash Flow
Zenith Energy reported a 22% rise in net operating contribution from its Italian electricity business, driven by higher power prices even as production held steady at around 8,000 MWh.
Rokmaster Acquires 100% Stake in Chile's Cristal Copper Project
The TSXV-listed miner satisfied initial option terms to take full control of a porphyry copper property in northern Chile, offering 7 million shares and $70,000.
Athens Airport H1 Revenue Drops 2.8% as Traffic Grows; €500M Bond Exceeds Target
Athens International Airport reported a 2.8% revenue decline in H1 2026 despite record passenger growth, while its euro bond sale was oversubscribed more than five times.
Swiss Stocks rebound early week; Roche, Novartis lead, ABB and tech drag
The SMI rose 0.6% to 13,854 in a first countermove after last week's >4% slide. Pharmaceutical giants led gains while AI-linked and construction-materials names faced pressure from rising Brent crude above $107.
Manulife says Asia growth offsets near-term headwinds on path to 18% ROE
Manulife reported 14% core EPS growth YTD and CAD 2.6B returned to shareholders, but CEO Phil Witherington said progress toward an 18% core ROE target is lagging due to Canadian disability experience and currency headwinds.
Sanlam H1 Core Earnings Grow Just 1% as Severe Weather Eats Into Profits
South African insurer Sanlam reported a sharp slowdown in core earnings growth for the first half of 2026, with weather-related claims and abnormal losses eroding results by roughly 8%, offsetting gains in asset management.
Wiley Reports Q1 Miss, Reaffirms Guidance Amid Segment Challenges
Revenue fell 3% YoY to $386 million as AI licensing comparisons weighed on Learning segment, while Research Publishing growth drove adjusted EBITDA expansion.
Victoria's Secret Shares Drop 16% on Weak Q3 Operating Income Outlook
Victoria's Secret stock fell more than 16% in premarket trading after the company guided for a mid-point operating income of just $15 million in Q3, well below analyst expectations of $24.4 million, citing higher strategic marketing investment.
Braze Raises Operating Margin Guidance Amid AI Acceleration
Braze’s CEO highlights AI-driven growth and early hiring push to bolster 2025 revenue, despite trailing losses and seasonal revenue pressures.
Dell CFO says AI server demand surges, lifts FY27 guidance by 70%
Dell Technologies reported $13.2 bn of AI bookings over the past year and a 122% rise in traditional server revenue, prompting a 70% increase in its fiscal 2027 outlook.
B&C Speakers H1 Revenue Falls 7%, Margins and Cash Flow Hold Up
Revenue slid to €47 million as U.S. DIY demand weakened, but EBITDA stayed above €9 million and free cash flow hit €5.1 million, reflecting cost discipline and better FX management.
Mizuho Cuts PG&E Price Target to $14 After Utility Trims 2027 Capex
PG&E slashed its 2027 capital spending by $2 billion to $11.4 billion as wildfire liability reforms stalled in California, prompting Mizuho and other banks to lower their outlook.
Transat Posts Q3 Loss as Jet Fuel Prices Sink Profitability
Canadian leisure carrier reported an adjusted loss of $2.18 per share on CAD 793M in revenue, as 56% fuel price growth wiped out operating profit and forced reliance on government lending.
Stifel Raises Snowflake Price Target to US$450 Amid AI-Driven Growth
Snowflake Inc. saw its price target rise to US$450 from US$350 as analysts highlight accelerating AI adoption and robust client growth.
Five Below Raises Price Target to US$295 Amid Strong Q2 Fiscal 2026 Results
Analysts raised expectations for Five Below Inc. after the retailer reported robust Q2 fiscal 2026 earnings and revised guidance upward, citing sustained comparable sales growth and operational resilience.
Russia shares close lower, MOEX index flat
Russian equities fell at the Moscow close on Sunday while the MOEX Russia Index held steady. Declining stocks outnumbered gainers 133 to 99, with modest moves in major shares, commodities and currencies.
Schweizer Aktienmarkt erholt sich nach Vorwochenverlust: Roche, Novartis dominieren
Der SMI steigt um 0,6 % auf 13.854 Punkte, während KI-Aktien und Bauwerte unter Druck bleiben. Analysten revidieren Kursziele für Roche und Straumann, während Ölpreise und Fed-Zinsentscheidungen die Märkte prägen.
AI Warnings from US Hit Swiss Stocks as SoftBank Plunges
OpenAI's delayed IPO and Anthropic's safety alarms spooked markets Monday, dragging down Japanese tech giant SoftBank over 13% and pressuring Swiss shares across semiconductors and data-center plays.
US indices close out a flat week with modest gains for the S&P 500 and DJIA
US equity indexes ended the week little changed, with the S&P 500 and Dow Jones Industrial Average posting modest gains.
AB Foods Shares Plunge 9% on Weak Primark Guidance
Associated British Foods lowered fourth-quarter Primark sales expectations and issued a wider sugar loss outlook for 2027, driving shares down more than 9% in early London trading.
Imperial Petroleum Posts Record Q2 Revenue on Shipping Rate Strength
The shipping firm reported $87.1 million in quarterly revenue and $34.8 million in net income, both company records, driven by soaring tanker and drybulk charter rates.
Evolution Metals Forecasts $400‑460M Revenue by 2027
The company projects 2027 revenue between $400 million and $460 million as it scales magnet production and expands power capacity at its Pohang site. It also notes a conditional $20.7 million grant from Korean authorities and expects 2026 revenue of $5 million to $8 million.
Vishay Launches Bidirectional TVS for Automotive Powertrain Protection
The company introduces a new series of transient voltage suppressors designed to safeguard advanced automotive systems, including ADAS and battery management units.
UBS Posts $2.8B Q2 Profit, Eyes $3B Buyback Despite Swiss Capital Rules Tension
Switzerland's largest bank reported a 17% jump in quarterly profit driven by wealth-management inflows, even as regulatory debates with Bern cast uncertainty over its capital-return plans.
US Futures Rise as Brent Surges Past $100 Ahead of Oracle, Adobe Earnings
Stock futures gained on Thursday even as Brent crude topped $100 a barrel and the 10-year Treasury yield hit its highest level since 2023, with Oracle and Adobe set to report.
Artisan Partners Seeks Board Changes at Novartis After Trial, Acquisition Setbacks
Major shareholder Artisan Partners has called for a board shake-up at Swiss drugmaker Novartis citing recent clinical trial disappointments and failed acquisitions.
GSK's Ris-Rez cuts death risk 54% in relapsed small cell lung cancer trial
Risvutatug rezetecan doubled median overall survival versus topotecan in the ARTEMIS-008 phase III study, with pivotal EMBOLD data expected in 2027.
Athens International Airport Reports 4.5% Passenger Growth in H1 2026, Raises Full-Year Profit Guidance
The airport posted record passenger traffic and raised its full‑year profit outlook despite a slight dip in revenue, while detailing a revised expansion plan and a successful bond issuance.
Imperial Petroleum Posts Record Q2 Revenue, Beats EPS Estimates
Greek shipping firm reports $87.1M in quarterly revenue, up 140% year-over-year, as tanker and dry-bulk rates surge alongside higher crude prices.
ADF Group Misses Q2 2026 Profit Expectations, Shares Drop 7%
ADF Group Inc. reported a sharp earnings shortfall in Q2 2026, with revenue growth outpacing expectations but profitability falling short of forecasts, prompting a 7% premarket decline in its shares.
Faeth Therapeutics Highlights Oral PI3K/AKT Pathway Inhibition in Phase I-B Data
Faeth Therapeutics presented Phase I-B results for its dual-oral PI3K inhibitor PIKTOR at the September 2026 Cantor Fitzgerald Healthcare Conference, showing a 47% overall response rate and a pharmacokinetic advantage over intravenous competitors.
Goldplat declares 0.87p special dividend amid excess cash assessment
The mining-services company says £1.5 million in surplus liquidity will be returned to shareholders, with payment due mid-October.
Macy's raises revenue and profit outlook on luxury chains' strength
US department store chain benefits from high-income consumers, lifts full-year projections. Macy's focuses on premium products, closes unprofitable stores.
Cornerstone Strategic Value Fund hits $6.55 low on 10% YTD losses
The fund’s shares fell to a five-year low amid broader sector pressures and a corporate name change by its lithium exposure.
Culp swings to operating profit on restructuring gains in Q1 FY27
Culp Inc. reported a profitability reversal in its first fiscal 2027 quarter as restructuring saved roughly $22.5 million annually, pushing adjusted EBITDA positive and shares higher in after-hours trade.
Wall St Futures Steady as Investors Weigh Earnings, Oil
U.S. stock futures showed little movement Thursday after a strong close, with Nvidia rising on its $12.9B Hugging Face deal and the S&P 500 near all-time highs ahead of Friday's jobs report.
Schroders Capital Global Innovation Trust raises NAV, extends wind-down progress
Schroders' INOV trust posted a 1.3% NAV rise to 22.53p in H1 2026 while advancing its managed wind-down, with fresh portfolio gains offsetting delayed realisations.
US Stocks Slide as Inflation Fears Mount; Oil Surges Past $100 a Barrel
Dow, Nasdaq and S&P 500 all fell Thursday as hotter-than-expected producer prices stoked fears of further Fed rate hikes. WTI crude reclaimed $100 for the first time since May.
US Stocks Slip as Oil, Fed Rate Hike Fears Weigh on Markets
The Nasdaq 100 and S&P 500 gave up ground Thursday as rising oil prices, the ECB rate hike, and inflation concerns overshadowed chip-sector losses tied to Deepseek competition.
AdvancedAdvT authorises fresh £10m share buyback
AIM-listed software group extends capital return programme after completing prior £10m repurchase; says market price does not reflect intrinsic value.
Replimune Details TujuCare Launch Strategy, Pipeline Milestones at Cantor Conference
Oncology biotech outlines commercial rollout for newly approved TujuCare and shares update on late-stage melanoma, skin cancer, and uveal melanoma programs.
D2L posts modest revenue growth, narrows loss as ARR rises 5% in Q2 FY2027
Revenue climbed 2% to $55.6 million and ARR grew 5% to CAD 223.4 million, while net loss narrowed to CAD 3.1 million; the company trimmed its FY2027 guidance.
BridgeBio Highlights $8B Pipeline, Attruby Leads Growth Amid Genetic Disease Focus
BridgeBio Corp. outlined a $8 billion-plus pipeline at the Cantor Fitzgerald Global Healthcare Conference, with Attruby leading revenue growth and upcoming launches for skeletal dysplasias and hypoparathyroidism.
Scholar Rock Eyes September FDA Call on SMA Drug Apitegromab
Shares rose as CEO David Hallal highlighted strong clinical data and manufacturing progress ahead of a September 30 PDUFA deadline for the myostatin inhibitor.
X4 Pharmaceuticals Raises Outlook After Trial Reset at Wells Fargo Conference
X4 Pharmaceuticals lowered its Phase III 4WARD trial sample size to 126 patients and adjusted statistical power, but executives say the redesign strengthens the path to data in early 2026 and potential approval by 2028-2029.
PTC Therapeutics Outlines Growth Strategy Amid Revenue Challenges
CEO Matthew Klein and CFO Pierre Gravier highlight cash reserves, pipeline progress and strategic acquisitions to drive long-term sustainability.
Middleby Raises 2026 Guidance Amid Portfolio Restructuring
Middleby Corporation (MIDD) outlined a lean operational push and portfolio reset, raising 2026 organic net sales growth to a 7% midpoint and EPS guidance to 12%, following spinoffs and divestments.
Culp Beats Q1 Estimates on Margin Expansion, Shares Rise in After-Hours
Culp posted Q1 fiscal 2027 EPS of $0.47 versus $0.44 expected, with revenue of $54 million and gross margin doubling to 28.5%. Shares gained 4.9% after hours.
RTW Biotech Opportunities reports August NAV rise to $2.92 per share
The biotech-focused fund saw a 3.9% monthly gain but trailed broader biotech benchmarks, with recent acquisitions and portfolio adjustments narrowing its discount to net asset value.
OppFi CEO Purchases $24.542 in Company Shares
Todd G. Schwartz, OppFi's CEO, acquired 3,550 shares at an average price of $6.9133, totaling $24,542, amid a challenging market context and recent financial performance.
GE Aerospace CFO projects strong 2026 growth on backlog and CPP acquisition
At Morgan Stanley's Laguna conference, GE Aerospace highlighted a $210 bn backlog, a $200 m synergies from the Chromalloy acquisition and guidance for double‑digit profit and cash‑flow growth in 2026.
Global Ship Lease Hits 52-Week High as Jefferies Raises Target
Shares reached $46.52, their highest level in a year, after Jefferies lifted its price target to $50 on strong container-ship leasing fundamentals.
Ford Expands Digital Services with $10 Subscription Platform, Targets 90% EV Fleet by 2030
Ford CEO Jim Farley and Integrated Services President Mike Aragon outlined a push toward software-driven revenue growth, including a $10/month subscription model and autonomous driving advancements at Morgan Stanley’s Laguna Conference.
NEXT Reports H1 2026 Revenue Beat, Stock Rises 2.5%
NEXT plc reported a 9% increase in total group sales and a 10.5% rise in profit, exceeding revenue expectations by $200 million. The stock climbed 2.5% to $14,920.
AGNC Investment Hits 52-Week High at $25.36 on Dividend Appeal
The mortgage REIT's shares reached a one-year peak of $25.36, supported by an 8.25% dividend yield and a 10.4% total return over the trailing 12 months.
Blackstone Mortgage Trust hits 52-week low at $13.60
Blackstone Mortgage Trust Inc. shares fall to $13.60, trading 34% below their 52-week high of $20.66. The company reported distributable earnings of $0.31 per share for Q2 2026, exceeding revenue expectations.
Brookfield Stock Drops to $37.93, 52-Week Low
The asset manager’s shares fell to a five-year low amid weak earnings and analyst downgrades, though revenue exceeded forecasts.
MORhomes approves £2.1m share allotment, names new chair and board members
At its AGM, MORhomes PLC authorized a share issue up to £2.1 million and implemented a planned board rotation, installing Michael Hinch as chair and adding two new directors.
Compass Group PLC issues €250m notes on London Stock Exchange
Compass Group PLC has admitted €250 million of 3.500% notes due 2035 to the London Stock Exchange, consolidating with existing debt. The company operates food services in 25 countries with over 590,000 employees.
Quantum Data Energy’s Hindlip power plant operational as flexible asset enters UK market
The 7.5 MW plant joins Pyebridge as second operational asset, meeting March 2026 timeline and delivering below budget.
Legal & General starts second £600m share buyback tranche
The insurer begins its second tranche of a £1.2bn repurchase programme, with J.P. Morgan executing purchases on the London Stock Exchange until at least March 2027.
PennyMac Financial Hits 52-Week Low After Second-Quarter Earnings Miss
PennyMac Financial Services fell to a 52-week low after reporting second-quarter earnings and revenue that significantly missed analyst estimates, prompting two Wall Street firms to adjust their outlooks.
New Fortress Energy Completes 1-for-50 Reverse Stock Split
The liquefied natural gas operator consolidated its shares on a 1-for-50 basis ahead of an ongoing restructuring deal, with trading resuming Sunday on a split-adjusted basis.
Lesaka Technologies Reports Profitability Milestone, Outlines Ambitious Growth Plan
South African fintech Lesaka Technologies reported a turnaround in profitability and set aggressive targets for fiscal 2027–29, driven by acquisitions and expanded divisions.
Okta Stock Hits 52-Week High as Analysts Lift Targets on Strong Bookings
Okta shares reached $174.86, nearly doubling this year, as at least five Wall Street firms raised price targets following upbeat Q2 fiscal 2027 results.
Prudential Financial preferred shares hit 52‑week low of $15
The insurer's preferred stock fell to $15, its lowest level in a year, as the company announced a restructuring plan amid a slowdown in its Japan operations.
Molson Coors Brewing Co stock reaches 52-week low at $38.03
Stock trades nearly 31% below its 52-week high of $54.82, reflecting broader challenges in the brewing industry and softer consumer trends.
Lesaka Technologies Posts Q4 FY26 Profitability Turnaround, Sets Aggressive Growth Ambitions
Net revenue rose 8% year-over-year, adjusted EBITDA hit a record high, and full-year GAAP net income turned positive amid strategic expansions.
Nuveen Municipal Credit Income hits 52‑week low of $11.54
The fund’s shares fell to $11.54, below the prior low of $11.65, as the RSI indicated oversold conditions.
Whirlpool Stock Hits 52-Week Low as Q2 Earnings Miss Widens Concerns
Whirlpool shares fell to $35.37 after second-quarter adjusted earnings of minus $0.21 per share missed estimates, while North American appliance production data showed no recovery.
Melco Resorts Misses Q2 2026 Earnings as Stock Drops to 52-Week Low
Macau’s Melco Resorts & Entertainment reports weaker-than-expected results amid lower visitation and VIP gaming performance, pushing stock to a fresh low.
Urban Outfitters reports growth across brands, margin discipline at Barclays conference
URBN posted six straight quarters of double-digit top-line growth, with FP Movement and Nuuly approaching half-billion-dollar revenue thresholds.
US equities slide as Fed, oil prices and inflation concerns weigh on markets
Dow Jones, Nasdaq 100 and S&P 500 all decline amid geopolitical tensions, rising oil prices and investor fears of Fed rate hikes
Lovesac Posts Q2 EPS Beat, But Shares Drop on Margin Concerns
The Lovesac Company reported a $0.51 per-share profit for Q2 fiscal 2027, significantly beating forecasts of a $0.36 loss, but shares fell nearly 10% as results relied heavily on tariff refunds.
Ionis Pharmaceuticals Reports Setbacks in Key Programs Amid U.S. Healthcare Conference
Ionis Pharmaceuticals (IONS) highlighted two failed clinical trials and revenue pressures during its presentation at Wells Fargo’s 21st Annual Healthcare Conference, while emphasizing recent FDA approvals and pipeline momentum.
SYS-DAT posts 15.7% revenue rise in H1 2026 as shares slip 5.5%
The Italian ICT firm reported €52.3 million revenue, 23.7% higher EBITDA and a 5.5% share price drop despite strong organic growth and ongoing acquisitions.
Shentel’s Fiber Expansion Drives 2026 Revenue Growth Amid Debt Refinancing
Shentel’s fiber business, Glo Fiber, surpassed legacy revenue in Q2 2024 and is set to deploy over 510,000 fiber connections by year-end 2026, with guidance for 4% revenue and 12% EBITDA growth in 2026.
Shoe Station misses Q2 EPS and sales, cuts full-year outlook
Shoe Station Group reported a 33% miss on diluted EPS and a 7.2% revenue decline in Q2 fiscal 2026, citing weak foot traffic and compressed margins, then lowered its full-year guidance.
Enablence Raises C$25M in Private Placement
Enablence Technologies Inc. completes private placement, issuing 3.23 million shares at C$7.75 each to Collingwood Investments Incorporated, with Paradigm Capital Inc. as financial advisor.
Kinetik Holdings Stock Reaches 52-Week High at $56.76
The AI-driven hardware company reported strong second-quarter earnings and raised full-year EBITDA guidance, despite a rating downgrade by Clear Street.
Permian Resources Surges to All-Time High on Earnings Beat and Raised Guidance
Permian Resources shares hit $24.15, a new high, after the E&P company reported second-quarter earnings and revenue that topped estimates and generated record free cash flow.
Energy Transfer Hits 52-Week High as Q2 Earnings and Dividend Hold Steady
Energy Transfer stock surged to $21.78 on Q2 adjusted EPS of $0.59, well above the $0.37 forecast, supported by a 30.8% jump in adjusted EBITDA to $5.1 billion and a maintained 6.3% dividend yield.
Permian Basin Royalty Trust hits $35.52 high as YTD return hits 109.5%
The Permian Basin Royalty Trust’s stock reached an all-time high of $35.52 on September 10, 2026, with a year-to-date return of 109.5% and a one-year gain of 96.3%.
Dutch Bros Stock Hits 52-Week Low as After-Hours Sell-Off Follows Q2 Beat
Coffee chain’s shares slipped below $44.50 despite a second-quarter earnings beat, weighed down by softer guidance and cost pressures.
SL Science Holding shares hit 52-week low of $2.45
The stock fell 17% this week to $2.45, 83% below its 52‑week high, as the company seeks FDA orphan‑drug status for a glioblastoma therapy.
Nuveen Dividend Advantage Municipal Fund Hits 52-Week Low at $11.10
The municipal bond ETF marked its lowest price in a year as the broader muni market faces headwinds from interest-rate volatility and softening investor demand.
SMI sinkt vorbörslich leicht, Halbleiteraktien dominieren Verluste
Schweizer Aktienmärkte zeigen vor dem Wochenauftakt leichte Schwäche, getrieben durch Verluste bei 19 von 20 SMI-Titeln, während US-Zinsentscheidungen und Ölpreise weitere Risiken für globale Indizes schaffen.
Neurocrine Biosciences Expands Growth with Three Products, Reaffirms 2025 Guidance
The biotech firm projects $2.85 billion in revenue for 2025, driven by INGREZZA’s long-term exclusivity and pipeline expansion in psychiatry and neurology.
ETFs dominate global assets: $1.07T VOO leads $3T+ S&P 500 ETF market
Exchange-traded funds (ETFs) have surged past active funds, with the Vanguard S&P 500 ETF (VOO) leading $3 trillion in global index-tracking assets as of mid-September 2026.
AI-linked stocks fall as slowdown call worries investors
Shares in AI-linked companies in Asia drop as leading figures call for a slowdown in development, raising concerns about infrastructure costs and credit risk.
Verastem Discusses Dual-Track Growth Strategy at Cantor Conference
Verastem presents its dual-track growth strategy at the Cantor Fitzgerald Global Healthcare Conference, highlighting its commercial product and potential blockbuster G12D inhibitor.
Currency Exchange International Posts Q3 2026 Revenue Growth Amid Payments Surge
Currency Exchange International Corp. reported a 5% year-over-year rise in Q3 2026 revenue to $22.4 million, driven by a 54% jump in payments revenue, while banknotes revenue declined slightly.
Lesaka Posts Q4 2026 EPS Beat, Shares Rise on Growth Guidance
Lesaka Technologies Inc. reported stronger-than-expected Q4 2026 earnings, with adjusted EPS exceeding forecasts and revenue growth across divisions, though merchant division results lagged.
West Pharmaceutical Raises Full-Year Guidance on Strong HVP Demand
West Pharmaceutical Services lifted full-year organic revenue growth forecast to 10-11% and widened margin expansion targets, citing robust demand for high-value elastomer components and European Annex 1 regulatory tailwinds.
Lincoln Electric Says Recovery Builds as Q2 Volumes Rise First Time in Nine Quarters
The welding-equipment maker reported first volume growth since Q1 2024, with Q3 incremental margins tracking in the low 20s amid persistent inflation and a narrowing price-cost gap.
Syndax's Revuforj Revenue Tops $200M Run Rate as Market Share Surges to 85%
Revumenib hits well-north-of-$200M annual run rate in its second year with 85%+ share of the relapse-refractory AML KMT2A/NPM1 space.
Haivision Q3 2026 revenue drops 1.4% as tariffs weigh on margins
Revenue fell to CAD 34.5 million amid analyst misses and tariffs on key products, while adjusted EBITDA margins declined sharply.
Merit Medical outlines strategic review and 2026 guidance at Wells Fargo conference
CEO Martha Aronron said the review puts all options on the table as the company targets 7%‑7.5% revenue growth, 21%‑21.5% operating margin and 11%‑14% EPS growth for 2026.
Builders FirstSource Hits 52-Week Low as Earnings Miss, Exec Departs
Shares of BLDR fall to $58.13 after Q2 adjusted EPS dropped 51% year over year, missing forecasts, while its president of technology and digital solutions departs.
Gemini stock down 80% since IPO, sparking takeover speculation
Gemini's market value fell to about $753 million from a $4 billion peak as revenue, volume and assets contracted, prompting talk of a sale to acquire its U.S. crypto licences.
Napo Pharmaceuticals advances MVID trial toward 2027 filing
Jaguar Health's Napo unit presents data at ESPGHAN meeting, targeting mid-2027 NDA filing for microvillus inclusion disease treatment.
Avalanche Treasury Adds Virginia Gambale to Board with Blockchain, AI Expertise
Virginia Gambale joins Avalanche Treasury Co. as a board director, bringing over 20 years of experience in technology leadership and public markets advisory.
Outlook Therapeutics Eyes $500M U.S. Sales as LYTENAVA Launch Nears
CEO Bob Jahr outlines commercial rollout of FDA-approved bevacizumab eye formulation for wet AMD, with U.S. launch expected before end of 2026.
Tsakos Energy Navigation Ltd stock hits 52-week high at $46.59
Shares of the energy transportation company reached a 52-week high, reflecting strong performance and a 102.37% year-to-date gain.
P&G CEO Highlights Execution Focus Amid Commodity Pressures
Procter & Gamble’s CFO and CEO underscore operational turnarounds and R&D acceleration at Barclays’ consumer conference, amid Brent crude spikes and regional growth targets.
Growthpoint Reports FY2026 Payout Rise Amid Slowed Growth, Office Challenges Persist
Growthpoint Properties Limited raised its dividend payout ratio to 87.5% in FY2026 but saw slower growth in the second half of 2026, with office vacancies and funding costs weighing on its outlook.
Vince Reports Q2 Earnings Beat, OVO Deal Lifts Outlook
Vince Holding reported adjusted EPS of $1.02 against a $0.16 estimate, driven by strong top-line growth. An August OVO acquisition adds upside potential with plans to build a $100M+ business.
Central Garden & Pet Announces $340M TRIXIE Acquisition, Strong Cash Position Amid Growth Strategy
The company highlights organic sales growth, restructuring efforts, and a strategic European expansion through a major pet supplies acquisition.
Designer Brands beats Q2 2026 EPS, lifts full-year outlook
Adjusted EPS rose to $0.34, topping estimates, while revenue slipped 1% to $730.6 million. The retailer raised its 2026 EPS guidance to $0.47‑$0.52 and expects flat to modest sales growth.
Macy’s Q2 2026 earnings beat forecasts but shares decline
Revenue growth and adjusted EPS exceeded expectations, yet stock fell premarket as analysts adjusted expectations for a full-year earnings outlook.
MasterCraft Q4 sales surge 63% on Chaparral acquisition; shares rise premarket
Boat maker beats on top and bottom line as integration of Chaparral and Robalo brands lifts results; shares climb 5.75% in pretrade.
Yuanbao Insurance Posts Strong Q2 2026 Results, Shares Rise on Growth
Yuanbao Insurance reported a 30% revenue jump and 36% profit growth for Q2 2026, driven by AI-powered operations and new product lines, while shares climbed in premarket trading.
US equities and commodities face pre-market declines amid inflation fears, oil volatility
Dow Jones and Nasdaq pre-market losses signal further Wall Street weakness; copper prices retreat after record highs amid US import speculation.
SFS Confirms 2026 Outlook Ahead of Investor Day
Swiss metal processor SFS reaffirmed its full-year guidance, projecting 3-6% revenue growth and a 12-15% normalized EBIT margin, as it prepares for its biennial investor day on Thursday.
DAX Expected Lower Open Amid Oil Prices, AI Concerns
Frankfurt opens in negative territory as oil climbs on Gulf tensions and new AI safety warnings weigh on tech-sensitive indices.
BofA rates Aviva and Admiral Group as buys, cites attractive UK insurance yields
Bank of America reinstated coverage of the UK insurance sector, noting dividend yields of 4.8%‑7.6% versus 3.3% for the broader market and recommending Aviva and Admiral Group as buy candidates.
R&S net profit drops 25% in first half on weaker demand
Transformer maker R&S reported a 25.4% decline in H1 net profit to CHF 22.4 million, with revenue down 13% and EBITDA margin falling to 19% from 21.3%. Full-year guidance was reaffirmed.
COMP360 nears launch as COMPASS Pathways eyes 2027 market entry
Compass Pathways’ synthetic psilocybin treatment faces regulatory hurdles but aims to compete with Johnson & Johnson’s SPRAVATO in treatment-resistant depression.
Cicor secures €30m in European defense electronics contracts
The Swiss electronics supplier has landed major orders for microelectronics assembly in large-scale European defense and aerospace programs, expanding its client base to 16 of Europe’s top 20 defense firms.
Swiss Re Shares Hold Steady at CHF 138.75 as Investors Assess Half-Year Results
The reinsurer's shares traded at CHF 138.75 on the SIX Swiss Exchange following a strong first-half performance marked by growth in property-casualty reinsurance and corporate solutions.
DAX seen modestly higher ahead of US rate decision
The X-Dax out-of-hours indicator pointed to a 0.4% gain at 25,497 points as markets await Wednesday's Fed rate call.
Dax und EuroStoxx 50 steigen nach Fed-Zinserhöhung und Ölpreisdruck
Der deutsche Aktienmarkt und europäische Leitindizes profitierten von der Fed-Zinserhöhung und sinkenden Ölpreisen, während Branchen wie Autokonzern und Molekulardiagnostik besonders stark performten.
European stocks extend recovery on oil decline and US gains
EuroStoxx 50 rose 0.90%, FTSE 100 gained 1.19%, and the SMI climbed 0.57% as investors rotated into industrials and away from energy.
Jyske Bank Buys Back 51,815 Shares Worth 56.7 Million Kroner
Danish lender repurchased shares between Sept. 7-11 at an average price of 1,094.16 kroner, pushing its buyback program to nearly 1.86 billion kroner.
Blencowe Resources Drops Ex-CEO Ralston, Equity Awards Lapse After PDMR Review
Blencowe Resources terminates former CEO Mr Ralston's consultant engagement and declares his performance shares and options lapsed following a governance review over PDMR notification matters.
German equities fall after ECB raises interest rates
The DAX lost 0.7% to 25,407 points, marking its lowest point of the day, as markets reacted to the ECB's second rate hike of the year and revised inflation forecasts.
Wall Street erwartet weitere Verluste mit Fed-Fokus auf Zinsen und Inflation
US-Indizes zeigen schwache Entwicklung, während Ölpreise und Nahost-Konflikt die Stimmung belasten. Quartalszahlen von Tech- und Konsumgüterfirmen zeigen gemischte Ergebnisse.
SMI leitet sich mit Logitech an – US-Märkte profitieren von Fed-Unabhängigkeit und sinkenden Ölpreisen
Der Swiss Market Index schloss mit einem Plus von 0,6 Prozent, während US-Börsen nach der Fed-Zinserhöhung und fallenden Rohstoffpreisen wieder aufholten.
SoftBank Shares Drop 11% After OpenAI Rejects 2026 IPO Plans
SoftBank Group Corp. shares fell over 11% on Monday after OpenAI CEO Sam Altman stated the company will not pursue a public listing in 2026. The Nikkei 225 also declined 2%.
DWS Breaks Swiss ETF Asset Management Milestone at 100 Billion CHF
Swiss ETF assets under management by DWS Group exceed 100 billion CHF, reflecting rapid growth in passive investment products.
Cue Biopharma reports positive Phase 2 results for CUE-221
Cue Biopharma announced positive Phase 2 trial results for its CUE-221 candidate, with no additional details released at this time.
Swiss and US markets rise on Fed independence, Logitech leads SMI
Swiss indices closed higher on Thursday, with Logitech leading gains, while US markets benefited from falling oil prices and the Fed’s commitment to inflation control.
Sampo repurchases 4.27 million A‑shares in week 37
Sampo bought back 4,266,170 A‑shares at a volume‑weighted average price of €9.51 between Sept. 7‑11, part of its €350 million buy‑back programme.
Avalo Therapeutics outlines Phase III plans for IL-1 beta blocker
The Philadelphia-based biotech detailed its lotus trial data and Phase III design for hidradenitis suppurativa at the Cantor Fitzgerald conference.
Empire Company Reports Record Q1 EPS of CAD 1.04, Stock Flat
Canada's largest food distributor posted record quarterly earnings but a slight revenue miss left shares unmoved in premarket trading.
